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ABSTRACT
A NEUROBIOLOGICAL PATHWAY THAT MEDIATES STRESS-INDUCED DRUG
USE
Oliver Vranjkovic B.S.
Marquette University, 2015
Cocaine addiction represents a tremendous health and financial burden on our
society and the high rate of relapse to cocaine use in abstinent addicts represents a major
barrier to effective therapy. Thus, understanding the factors that contribute to relapse and
the underlying neurobiological processes is important for guiding the development of
treatment for addiction. Stressful life events often trigger drug use in recovering addicts.
The contribution of stress to drug use is problematic due to the unpredictable and often
uncontrollable nature of stress. A growing literature indicates that norepinephrine and
corticotropin releasing factor (CRF) in the brain play key roles in stress interactions with
motivational neurocircuitry that mediate stress-induced drug seeking. Previous work from
our lab has demonstrated that activation of the CRFR1 receptor within the ventral
tegmental area (VTA) is both necessary and sufficient for drug-seeking behavior during
periods of stress. However, the afferent CRF projection into the VTA, and how CRF
affects the neurocircuitry of VTA to evoke stress-induced relapse are poorly understood.
We report that stress-induced cocaine use involves a beta-2 adrenergic receptorregulated CRF pathway from the ventral bed nucleus of the stria terminalis to the VTA
and a CRFR1 receptor-regulated dopaminergic pathway to the prelimbic cortex. It is
hypothesized that dopamine released into the prelimbic cortex activates dopamine D1
receptors on pyramidal neurons that comprise a glutamatergic projection to the nucleus
accumbens core that is critical for relapse to drug use in abstinent cocaine addicts. It is
also reported that the ability of stressors to trigger drug use is determined by the amount
and pattern of prior drug use. Findings suggesting that excessive cocaine use establishes
susceptibility to stress-induced relapse by recruiting CRF regulation of this key stressorresponsive mesocortical dopaminergic pathway through increased CRFR1 expression are
described.
This dissertation defines a key pathway through which stress can promotes
relapse and describes its recruitment as result of repeated excessive drug use.
Understanding the processes through which stress contributes to cocaine seeking in these
rodent models should facilitate translational work aimed targeting these mechanisms
clinically and therefore the development of new medications or approaches managing for
addiction.
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Chapter I
General Introduction
Risk factors for cocaine addiction
The total cost of drug abuse and addiction due to use of tobacco, alcohol, and

illegal drugs is estimated at $524 billion a year, while illicit drug use alone, such as
cocaine, accounts for $181 billion in health care, productivity loss, crime, incarceration
and drug enforcement (NIDA). Addiction to cocaine and other illicit drugs, is a
chronically relapsing disorder in which drug use progresses from its initial stages of
limited, non-dependent intake to later stages of uncontrolled abuse (Koob & Volkow
2010, Volkow et al 2003). The major risk factors for developing cocaine abuse disorders
or relapse to cocaine are bipolar disorder, schizophrenia, antisocial personality disorder,
and other substance abuse disorders (DSM-V). Cocaine use amongst youth can be
attributed to prenatal cocaine exposure, postnatal cocaine use by parents, and exposure to
community violence during childhood (DSM-V).
Cellular mechanisms of cocaine
The positive reinforcing value of drugs drives the initials periods of drug use,
while later stages of addiction are driven, in part, by negative reinforcement such as the
relief of withdrawal which is induced by negative affective states (Koob & Volkow
2010). The primary reinforcing effects of drugs such as cocaine are thought to occur by
increased dopamine (DA) signaling that leads to enhanced activity of the brain’s pleasure
pathway which in turn leads to increased craving. Cocaine physically inhibits the
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dopamine transporters within the synapse and therefore increases extracellular dopamine
levels due to decreased reuptake into the presynaptic terminal. Chronic drug use and over
activation of this pathway is thought to devaluate natural rewards, diminish cognitive
control of behaviors, and increase salience of drug-related stimuli (Edwards & Koob
2010, Volkow et al 2003). One major factor that plagues drug users is the high rate of
relapse, as 70-90% of people have reported periods of relapse.
Stress promotes drug use and relapse
Numerous studies suggest that stress plays a crucial role in addiction.
Specifically, stress has long been considered an important factor contributing to drug
craving and relapse of drug use in humans (Kreek & Koob 1998). Interestingly, clinical
reports indicate that individuals with a history of drug use attribute episodes of relapse to
stressful life events (Sinha 2001, Wang et al 2001). Consistent with these results,
controlled clinical experiments in cocaine- and alcohol-dependent patients report a
significant increase in drug craving following exposure to a personalized stressor (Fox et
al 2009, Sinha et al 1999). Furthermore, population-based and clinical studies support a
strong correlation between addiction, chronic distress, and negative affect (Sinha 2008).
These studies have shown that stressors such as physical or sexual abuse, parental neglect
and poor family structure increase the likelihood of substance abuse, or relapse of drug
use (Sinha 2008). While stress and drug use are strongly correlated, the precise
mechanism by which stress contributes to drug use remains unclear, and in many cases
involves an interaction between stressful life events, cocaine-related cures, and the effect
of cocaine itself. In addition, the effects of drug use may vary across different
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subpopulations of addicts (Preston and Epstein, 2011), making it clear that management
and treatment of stress-related drug use may need to be individualized.
In addition, anxiety and depression are often cited by recovering addicts as key
contributors of drug craving and relapse (Sinha 2007). Intriguingly, epidemiological
studies have shown that cocaine dependence is highly correlated with numerous stressrelated disorders such as depression, anxiety, and post-traumatic stress disorder
(Rounsaville et al 1991). Lifetime cocaine use is strongly correlated with PTSD and
suicide risk; depressive symptoms with suicidal connotations are generally thought of the
most serious problems (Narvaez et al 2014). However, studies have also indicated that
the severity of traumatic events may predate cocaine use (Back et al 2001, Brady et al
2001). While it is clear that stress-related disorders and cocaine use (the initiation,
escalation or relapse) go hand in hand, developing and treating stress-related cocaine use
remains difficult because the appearance of stressors is unpredictable and in most cases
unavoidable. Therefore, understanding the neurobiological pathways that mediate stressrelated drug use remains an important goal for preventing relapse, the development of
therapeutics for the management of drug use, and the prevention of stress-related drug
seeking. To investigate the factors that contribute to stress-induced relapse observed in
clinical studies, preclinical animal models of relapse, or reinstatement procedures, have
been developed.
Methods in studying stress-induced cocaine use: Conditioned Place Preference
Several different animal models of addiction have been developed to better
understand the changes in neuronal chemistry, physiology, and behavior that lead to drug
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seeking during periods of stress. In general, these methods can be grouped into two
categories based on the method of drug delivery. Non-contingent models involve the
delivery of drugs by the experimenter; an example of a non-contingent model is
conditioned place preference. Conditioned place preference (CPP) examines the ability of
drugs of abuse to establish positive enforcement with learned contextual cues; these cues
can acquire additional appetitive properties when paired with cocaine or other drugs of
abuse (Tzschentke 2007). In the CPP model, different compartments of a two, or three
compartment chamber are paired with either cocaine or saline. CPP first consists of
determining natural preference, termed preconditioning. To define preconditioning
preference, the experimenter evaluates the natural value to each compartment by placing
the rodent in the center compartment of the chamber and allow free access to all three
compartments for 30 min in the absence of cocaine or saline and the time spent in each
compartment is compared, and one compartment is designated as the cocaine
compartment, and the other as the saline compartment. Three methods are used to
determine preference: in a biased approach, the compartment that was not preferred in the
preconditioning test is paired with the drug, while an un-biased protocol randomly pairs
the compartment with the drug, in particular when animals have no general preference
during preconditioning. Finally, a balanced protocol assigns the chamber so that no group
as a whole has a preference for a particular chamber (Aguilar et al 2009). After
preference has been established, the rodent enters the conditioning phase. During the 8day conditioning phase of the experiment, mice receive cocaine (15 mg/kg, i.p.) on the
odd days and saline injections on the even days. Immediately after the injection, mice
confined (guillotine door closed) to the drug-appropriate compartment for 30 min. A day
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after the final conditioning session, the mice are tested for the expression of cocaineinduced CPP by placing them in the center compartment and allowing them full access to
the apparatus for 30 min. A conditioned place preference is defined as the change in time
spent (in seconds) in the cocaine-paired compartment after conditioning compared with
the initial preconditioning session. Mice are determined to exhibit a conditioned place
preference if they spend more time in the cocaine-paired compartment during the postconditioning session compared to the preconditioning session.
Next, animals are allowed to explore the CPP chamber freely in order to measure,
and induce extinction behavior, using an approach that involves assessment of the
incentive motivation properties of the drug-paired environment, until there is no
significant difference between the times spent in the drug-paired compartment during
preconditioning. This usually occurs for an average of five to eight days at which, once
extinction criterion is met, animals undergo reinstatement testing.
Methods in studying stress-induced cocaine use: Self-Administration
Another model of addiction is a contingent model in which the animal requires an
operant response, such as activating a lever, or activating photobeams through a nosepoke to receive an intravenous infusion of cocaine; this is coined the self-administration
model (SA). To study the neurobiological mechanisms involved in reinstatement, studies
have utilized the reinstatement of drug seeking model following SA. In this model,
rodents are trained to self-administer a drug of abuse (such as cocaine), followed by an
extinction phase in which the cocaine is replaced with saline, or they are forced into
abstinence in which the rodents have no more exposure to the drug of abuse and the
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environment paired with drug use, and are sequestered in their home cage. If a rodent
undergoes abstinence, exposure to the drug-paired environment will trigger a robust drugseeking behavior phenotype from days to months after the last drug-administration
session (Conrad et al 2008). In the case of extinction, lever responding will progressively
diminish. Following extinction training, rats may be exposed to either a cue, noncontingent infusion of the drug of abuse, or a stressor (such as a mild-non noxious
footshock) to elicit previous drug seeking behavior, and therein overcoming the
extinction training and increasing lever responding. The SA model allows for the analysis
of the neurobiological mechanism in drug-seeking behavior because it directly measures
intake behavior.
Stress as a trigger for relapse
Since stress has been cited as a major factor that contributes to drug use in
humans, studies examining the neurobiological mechanism involved have been
developed; these studies involve the assessment of stress-induced reinstatement. Stressinduced reinstatement may involve different types of stressors such as a cold forced swim
(Conrad et al 2010), or food restriction (Chen et al 2014, Shalev et al 2003); the most
common type of a stressor utilized for self-administration experiments is an
uncontrollable intermittent electric-footshock delivered throughout the steel floors of the
self-administration chamber (Ahmed & Koob 1997, Erb et al 1996). Reinstatement
testing, more specifically stress-induced reinstatement, is most commonly tested in the
CPP model by either a forced-swim stressor (Figure 1.1 A-C (Mantsch et al 2010).
Stress-induced reinstatement in most cases significantly increases the time spent in the
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cocaine-paired compartment compared to the previous extinction day, and the
preconditioning day. Once stress-induced reinstatement has been established, different
neuropharmacological agents may be employed in order to prevent, or in some cases
evoke, stress-induced drug seeking, allowing for a better understanding of the different
neurobiological mechanisms that contribute to drug seeking during periods of stress. This
is important because stress is known to influence the rewarding effects of drugs of abuse
(Cleck & Blendy 2008, Der-Avakian et al 2005), and stress has a prominent role in
relapse to drugs of abuse (Sinha 2001).
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Figure 1.1 Models of studying
stress-induced relapse in rodents:
Stress-induced cocaine seeking in
mouse (A–C) and rat (D–F) models.
Stress-induced reinstatement of
extinguished cocaine-induced CPP is
shown in Figs. A-C. Preference for a
cocaine-paired compartment (4 ! 15
mg/kg, ip) was established (A;
increase in time spent postconditioning vs. pre-conditioning)
and extinguished (B) in C57BL/6
mice (n = 4) prior to reinstatement of
preference by pre-exposure to a
forced swim session (C; 6-min swim
in 22 °C water; *P < 0.05 vs. Bas). !

Stress-induced reinstatement in rats following cocaine self- administration and extinction is shown in
Figs. D–F. Following training, rats (n = 5) self- administered cocaine (1.0 mg/kg/inf) by pressing a lever
during daily 6-h sessions for 14 days (D) prior to undergoing extinction over a 10-day period during
daily 2-h sessions (E) and reinstatement testing (F). Stress-induced reinstatement was observed as the
ability of footshock stress (0.5 mA; 0.5” duration delivered an ave. of 40-s apart over a 15-min session)
to increase responding on the cocaine lever (*P < 0.05 vs. Bas).

In the case of SA, the conditions under which stress evokes reinstatement
involves animals with a specific history of self-administration; animals that undergo selfadministration for 2 hours will not show reinstatement to an electric footshock stressor,
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while animals that undergo self-administration for 6 hours (Figure 1.1 D-F) or more will
show reinstatement (Mantsch et al 2008a, Mantsch et al 2008b). Preliminary studies have
indicated that elevated glucocorticoids during 6-hr SA are involved in establishing
susceptibility to stress-induced drug seeking (Mantsch et al 2008b) though more research
needs to be conducted to better understand the neurobiological mechanism involved in
this relapse susceptibility. The Mantsch lab has shown that animals with 6hr access to
cocaine also show an escalating pattern of cocaine self-administration. In addition, these
animals are more susceptible to reinstatement by cocaine, footshock, or intra
cerebroventricular injections of corticotropin releasing factor -( Mantsch et al., 2008a). In
addition, surgical adrenalectomy, which eliminates corticosterone production, slows the
escalation, and prevents the establishment of stress-induced reinstatement when
conducted prior to but not after repeated daily 6-hr cocaine self-administration (Mantsch
et al., 2008b). This suggests that corticosterone, and other adrenal hormones, may induce
neuroplastic changes, possibly in the mesocortical system to make rats more susceptible
to stress-induced relapse. These neuroplastic changes have been proposed to promote
drug use during periods of stress through actions of corticotropin releasing factor (an
important peptide in stress-induced reinstatement) or its receptor which may be upregulated by drug use. Both factors are explored in this body of work.
Using the approaches mentioned above has allowed us to better understand the
neurobiological mechanisms that contribute to drug use during stress. The CPP model has
allowed us to explore which noradrenergic receptors mediate this process; this is
important because clonidine, an agonist at the alpha-2 adrenergic receptor (AR) has been
shown to decrease drug craving during periods of stress (Jobes et al 2011, Shaham et al
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2000b). Our studies have also shown that the beta-2 AR is both necessary and sufficient
in promoting drug use during periods of stress (Mantsch et al. 2010, Vranjkovic et al.
2012). Using this information, we moved our studies into the SA model and showed that
activation of the beta-2 AR within the ventral bed nucleus of the stria terminalis
mobilizes a corticotropin releasing factor pathway projection into the ventral tegmental
area (Vranjkovic 2014; this data is presented in this dissertation).
Neurocircuitry involved in stress-induced cocaine seeking
Using the self-administration/reinstatement approach in rats, we have focused on
defining the neurocircuitry (Figure 1.2) involved in stress-evoked drug seeking.
Particularly, stress-induced reinstatement appears to involve a glutamatergic projection
from the prelimbic cortex to the nucleus accumbens core (Kalivas and McFarland, 2003),
which likely regulates motor outputs to produce drug-seeking behavior. This pathway
may be regulated by glutamate release from the prefrontal cortex, because studies have
shown that inhibition of the nucleus accumbens core with GABA receptor agonist
cocktail blocks footshock-induced reinstatement in rats (McFarland et al., 2004) while
other groups have found that dopamine release within the prelimbic cortex is required for
stress-induced drug seeking (Capriles et al., 2003, McFarland et al., 2004). Specifically,
administration of fluphenazine into the prelimbic, but not the core of the nucleus
accumbens blocked footshock-induced reinstatement; the same study showed that a
footshock stressor increased both glutamate and dopamine release within the prelimbic
cortex, however, only glutamate but not dopamine was increased within the nucleus
accumbens core (McFarland et al., 2004). In addition studies have shown that AMPA
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administration within the core induced reinstatement while an AMPA antagonist was able
to block cocaine primed reinstatement (Cornish and Kalivas., 2000) . This dopamine
likely acts on pyramidal D1 receptors to increase the excitability of pyramidal neurons
that specifically project to the nucleus accumbens core (Lewis and O’Donnell, 2000;
Seamans et al., 2001).
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Neuroanatomical projections involved in stress-induced cocaine seeking: An electric footshock stressor will activate a
noradrenergic projection from the ventral noradrenergic bundle into the ventral bed nucleus of the stria terminalis. Here
norepinephrine will activate beta-2AR receptors and release corticotropin releasing factor (CRF). CRF will increase the drive
on CRF ventral tegmental area (VTA) projecting neurons. A CRF projection from the vBNST into the VTA will be activated,
and CRF will be released within the VTA. CRF will activate CRFR1 on VTA dopamine neurons that project into the
prelimbic cortex. DA within the prelimbic cortex will activate D1R and increase the firing rate of pyramidal neurons that
project into the core of the nucleus accumbens. This will activate sub-motor circuits to engage in drug seeking behavior.
(Figure adapted from Mantsch et al., 2015)

The aim of this body of work is to identify the stress-related neurocircuitry that
acts up-stream from the cortical-accumbens pathway. Here we will examine the actions
of the neuropeptide corticotropin releasing factor (CRF) in different stress-related brain
nuclei, most notably the bed nucleus of the stria terminalis; specifically we will examine
its interaction with the noradrenergic system within the bed nucleus. We will also
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The bed nucleus of the stria terminalis (BNST) is considered the central
coordinator between stress-responsive regions such as the amygdala, the paraventricular
nucleus of the hypothalamus, and the brainstem and motivation systems such as the
ventral tegmental area (VTA), and the nucleus accumbens (Georges & Aston-Jones 2001,
Jalabert et al 2009). Structurally, the BNST is a rostral forebrain structure that is enclosed
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by the lateral ventricles, lateral septum, fornix, the nucleus accumbens, the preoptic area,
and the hypothalamus (Crestani et al 2013).
It is made up of 20 different subregions based on cyto- and chemo-architectonic
studies; the BNST has been subdivided along an anterior to posterior axis. The anterior
BNST is involved in autonomic control, while the posterior division is involved in
controlling neuroendocrine responses (Bayer 1987, Ju & Swanson 1989, Ju et al 1989). In
addition, the BNST can be divided into the dorsal medial, dorsal lateral, and ventral
subregions (figure 1.3) though some early anatomical studies have suggested that the
dorsal lateral and ventral portions of the BNST are a continuous structure (Swanson
1989). Recently, studies have shown that both the dorsal and ventral lateral divisions of
the BNST are critical in bridging the pathway between stress and reward. The role of the
dorsal BNST in stress-related drug use has been extensively studied by the Winder group
(Flavin & Winder 2013, McElligott & Winder 2009). The current body of work will
examine the ventral portion because studies have suggested that it has a direct
involvement in stress-induced drug seeking as inhibition of the ventral BNST by a
GABA agonist cocktail has been shown to prevent footshock-induced drug seeking
(McFarland et al., 2004).
Bed Nucleus of the Stria Terminalis: Stress-Related Connectivity
The BNST is a critical modulator of stress-induced relapse of drug seeking
(Aston-Jones et al 1999, Aston-Jones & Druhan 1999, Leri et al 2002, Rodaros et al
2007) partly due to its connectivity with different limbic brain structures. The BNST
receives dense glutamatergic projections from the infralimbic cortex, prelimbic cortex,
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insular cortex, entrorhinal cortex, and the orbital frontal cortex (McDonald 1998) and a
dense GABAergic projection from the amygdaloidal nuclei (Dong & Swanson 2006).
Interestingly, the BNST sends both GABAergic and glutamatergic projections to the
VTA, a region critical in motivated behavior. These projections synapse in part onto
putative VTA GABA neurons, indicating that the BNST can directly modulate VTA
firing (Dumont & Williams 2004, Jalabert et al 2009, Kudo et al 2012, Silberman et al
2013). Specifically, recent data has shown that stimulation of the ventral portion of the
BNST (vBNST) potently and consistently activates VTA dopamine neurons (Georges &
Aston-Jones 2001, Massi et al 2008). This may indicate that dopamine firing within the
VTA is, in part, dependent upon BNST-mediated inhibition of local VTA GABA
neurons. In addition, other studies have shown that activation of the ventral BNST have
an excitatory input on to VTA DA neurons (Georges and Aston Jones 2002). It is also
important to note that both the ventral pallidum (Mahler et al 2014), and the tail of the
VTA (tVTA or RMTg) have been shown to send GABA inputs to the VTA that are
prominent during reinstatement behaviors (Barrot et al 2012, Sanchez-Catalan et al
2014). This indicates that multiple GABAergic inputs into the VTA, and possibly
glutamatergic inputs, may regulate dopamine release in terminal regions. In this body of
work, we have focused on the interaction between the vBNST and the VTA.
The Role of Norepinephrine in stress-related drug use
Norepinephrine is an important stress-related neuromodulator that is released
within the BNST in response to aversive stimuli (Park et al 2012), and during periods of
stress (Pacak et al., 1995) and has been suggested to promote drug use during times of
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stress (Brown et al., 2009). Central noradrenergic (NE) neurons are activated by stress
and play an important role in the stress response. Noradrenergic projections in the brain
originate from seven distinctive cell bodies in the brainstem (A1-A7) (Dahlstrom & Fuxe
1964). These projections are divided into the dorsal noradrenergic bundle, which
provides sole NE projections to the cortex, hippocampus, thalamus, and cerebellum; or
the ventral noradrenergic bundle, which provides sole NE projections to the
hypothalamus, and regions of the limbic forebrain such as the amygdala and the BNST.
These projections are thought to be largely ipsilateral, and innervate a majority of the
CNS (Moore & Bloom 1979). Importantly, the ventral forebrain bundles sends NE from
the A2 region into the BNST (Wang et al 2001). Interestingly, it was determined that the
ventral, but not the dorsal, NE pathway is responsible for footshock-induced
reinstatement. For example, animals were given 6-hydroxydopamine (6-OHDA; a
neurotoxin that enters the neuron through monoamine transporters) lesions in either the
dorsal or ventral forebrain bundle and subsequently tested for footshock-induced
reinstatement of heroin seeking; only lesions in the ventral NE pathway significantly
attenuated the effects of footshock on reinstatement for heroin (Shaham et al 2000b),
morphine (Wang et al 2001), and opioids (Aston-Jones et al 1999). Taken together, this
suggests that the innervation of NE from the ventral forebrain bundle to the BNST is
crucial in mediating reinstatement to drugs during times of stress.
In addition to the ventral forebrain bundle, the locus coeruleus (A6 group) is
another major NE input into limbic forebrain structures such as the prefrontal cortex, and
the BNST. The locus coeruleus has a major role in mediating the sleep-wake cycle,
attention and memory, cognitive flexibility, and stress responses (Schwartz & Roth
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2008). Recent studies have suggested that the kappa-opioid system interacts with the LC
to contribute to drug-induced cocaine seeking (Al-Hasani et al 2013, McCall et al 2015,
Siuda et al 2015).
Noradrenergic receptors and their involvement in stress-related drug use: alpha-2
Adrenergic receptors
Norepinephrine can activate five distinct adrenoceptor (-AR) subtypes: alpha-1
AR (Gq), alpha-2 AR (Gi), beta-1 AR, beta-2 AR, and beta-3 AR (all Gs), all of which are
coupled to a G-protein and activate unique secondary messenger signals. All of the
receptors are distributed throughout the central nervous system (Asanuma et al 1991,
Bing et al 1992, Levin 1982, Young & Kuhar 1980). Both alpha-1 AR and the beta-ARs
are largely located on post-synaptic cells; whereas alpha-2 ARs mainly assert their effects
on the presynaptic cell to serve as auto/heteroreceptor: to function as a negative feedback
system for neurotransmitter release. However, it has also become evident that many
alpha-2 ARs are postsynaptic and may regulate brain function in a manner that can
contribute to drug-seeking behavior (see e.g., (Zhang et al 2009)). Importantly, many
studies examining the role of norepinephrine in stress have used the alpha-2 AR agonist
clonidine and related drugs to prevent further NE release, and therefore block stressinduced reinstatement; importantly, clonidine has been shown to block stress-induced
cocaine seeking in humans (Jobes et al 2011). The alpha-2 AR antagonist yohimbine and
related agents, which stimulate NE release, have been used to mimic a stressor in
preclinical settings and has been shown to induce cocaine-seeking behavior (Mantsch et
al 2010, Shepard et al 2004).
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Stress-induced reinstatement studies show that activation of noradrenergic

receptors plays a crucial role in either forced swim or footshock stress induced
reinstatement of drug seeking. For example, we have used the alpha-2 AR antagonists
yohimbine, and BRL4408 (Kiss et al 1995) to induce reinstatement of extinguished
cocaine CPP (Mantsch et al 2010) and yohimbine has been shown to reinstate drug
seeking following self-administration (Shepard et al 2004). Systemic injections of the
alpha-2 AR agonist clonidine have been shown to block footshock-induced reinstatement
of cocaine seeking (Erb et al 2000), and forced swim-induced reinstatement of CPP
(Mantsch et al 2010). In addition, central injections of clonidine into the lateral or fourth
ventricles blocks footshock-induced reinstatement of heroin seeking (Shaham et al
2000b). While using these drugs has implied that the noradrenergic system plays a major
role in stress-induced drug seeking, their use has some limitations. For example,
yohimbine has other targets besides the alpha-2 AR; yohimbine has been shown to
enhance turnover of dopamine and serotonin (Millan et al 2000), so this promiscuous
effect of yohimbine makes it difficult to pinpoint its mechanism of action. However,
work from the Erb lab has shown that central injections of norepinephrine induced
reinstatement of cocaine seeking (Brown et al 2011), suggesting that norepinephrine does
indeed have a prominent role in promoting drug seeking by ARs in the brain.
Noradrenergic receptors and their involvement in stress-related drug use: alpha-1
adrenergic receptors
Studies have examined the role of alpha-1 ARs on stress-induced reinstatement.
These studies have produced mixed results: some studies found that the alpha-1 AR
antagonist prazosin can block yohimbine-induced reinstatement of food, and alcohol
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seeking, as well as footshock-induced reinstatement of alcohol seeking (Le et al 2011),
whereas we observed a failure of prazosin to block forced-swim induced reinstatement of
cocaine CPP (Mantsch et al 2010). More studies need to be performed to fully understand
the role of alpha-1 ARs in stress-induced reinstatement, in part because it may have
indirect effects through modulation of BNST activity. For example, application of an
alpha-1 AR agonist induced a long-term depression in excitatory neurons of the BNST
(McElligott & Winder 2008), which might be involved in promoting mood disorders and
could regulate drug seeking. However, research on the role of the alpha-1 ARs in stressrelated drug use has been overshadowed by the positive results with the beta-ARs.
Noradrenergic receptors and their involvement in stress-related drug use:
beta adrenergic receptors
Studies have indicated that the beta-ARs play a crucial role in stress-induced
reinstatement. Studies from our lab have found that pretreatment with the nonspecific
beta-AR antagonist propranolol blocks stress-, but not cocaine-induced reinstatement
(Mantsch et al 2010). Furthermore, we have shown this to be specific to beta-2 ARs as
the beta-2 AR antagonist ICI 118,551, and not the beta-1 AR antagonist betaxolol,
blocked forced swim-induced reinstatement (Mantsch et al 2010). Further studies from
our lab have shown that beta-ARs, specifically beta-2 ARs, are both necessary and
sufficient for stress-induced reinstatement because 1) the non-specific beta-AR agonist
isoproterenol is sufficient to induce reinstatement; 2) beta-AR knockout mice failed to
reinstate following forced swim; 3) the beta-2 AR agonist clenbuterol is sufficient to
induce reinstatement (Vranjkovic et al 2012). Interestingly, other studies have indicated
that beta-ARs are necessary for footshock-induced reinstatement in both the central
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nucleus of the amygdala, and the vBNST, as a cocktail of betaxolol and ICI 118,551
(beta-1 AR, and beta-2 AR antagonist respectively) prevented reinstatement when
injected into either of the two structures (Leri et al 2002). Taken together, these studies
indicate that beta-AR activation within the central nucleus of the amygdala and the
vBNST might be a key contributor to stress-induced reinstatement. Furthermore, studies
have suggested that the noradrenergic system directly interacts with, and may stimulate
the release of corticotropin releasing factor to induce cocaine seeking because central
injections of NE causes reinstatement, and this is blocked by pretreatment with a
nonspecific CRF receptor antagonist (Brown et al 2009).
Introduction to Corticotropin Releasing Factor
Corticotropin Releasing Factor (CRF) is a 41-amino acid peptide that has been
found to play a critical role in the behavioral and neuroendocrine responses to stress.
CRF binds to the 7-domain transmembrane receptors CRFR1 and CRFR2. CRFR1 and
CRFR2 share approximately 70% amino acid identity, however, CRF has a greater
affinity for CRFR1 compared to CRFR2 (Bale & Vale 2004). In addition, CRF interacts
with the CRF-binding protein (CRF-BP). The CRF-BP has a high affinity for CRF, and it
most likely prevents CRF from activating its receptors by directly binding CRF, and
promoting its clearance and degradation (Woods et al 1999).
Genetically, CRFR1 and CRFR2 are produced from distinct genes with several
splice variants (Bale and Vale, 2004). Both CRFR1 and CRFR2 are expressed throughout
the central nervous system; CRFR1 is expressed more abundantly than CRFR2 (Steckler
& Holsboer 1999). There is a 70% sequence homology between CRFR1 and CRFR2,
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with an 8% homology at the transmembrane and intracellular domain levels (Lovenberg
et al., 1995).
CRH Receptor Subtypes and Emotion
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promotes the release of corticosterone from the adrenal cortex. In addition to its
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endocrine role, CRF acts within the brain. Within the central nervous systems, CRF, and
other neuropeptides in general, have a very unique role.
Neuropeptide Signaling
Neuropeptides act differently compared to small amino acids transmitters such as
glutamate, GABA, or glycine. In general, these neurotransmitters (i.e., glutamate, GABA,
and glycine) are rapidly released at a presynaptic active zone; they diffuse across a
synapse, which is only a few nanometers in length, and rapidly activate their receptors,
and are then rapidly degraded or transported within an astrocyte or the presynaptic
terminal (van den Pol 2012). In contrast, neuropeptides are contained in dense-core
vesicles and may be released at multiple sites along the neuron. Once released, the
neuropeptide can travel a significantly greater distance (in the order of microns; volume
transmission) and therefore can diffuse throughout a specific brain area. Neuropeptides
are not degraded quickly so they remain within a synapse longer and diffuse vast
distances (Nassel 2009, Palkovits 1995). Binding proteins may interact with the
neuropeptides to inhibit their actions (Kormos & Gaszner 2013).
Classical neurotransmitters are often synthesized within the presynaptic terminal.
The enzymes required to convert the precursors for classical neurotransmitters are
synthesized in the cell body; they travel down the axon and convert the precursor
molecule to the proper neurotransmitter, which is then loaded into the vesicle at the
presynaptic site. In contrast, neuropeptides are synthesized as pre-propeptides and are
modified within the endoplasmic reticulum to pro-peptides. Subsequently, they travel to
the Golgi apparatus and are packaged into dense-core vesicles. Within the vesicles, pro-
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peptides are modified by hydrolysis, glycosylation, phosphorylation, and disulfide bond
formation to produce the final product (van den Pol 2012).
In addition, compared to classical neurotransmitters, neuropeptides exclusively
activate G-protein coupled receptors; these G-protein receptors usually have a high
affinity for their peptides (it would take nanomoles to activate CRFR1 by CRF, as
compared to micromoles of glutamate for NMDA receptors).
van den Pol
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Figure 1.6 Actions of Neuropeptides: Neuropeptides display volume
transmission in which they can act locally, or affect neurons that are a long
distance away. They have no reuptake mechanism, and they are not degraded
within the synapse, allowing for a unique signaling mechanism. They are
released from the same terminal such as GABA or glutamate, but at different
locations. Figure adapted from van den Pol 2012)
Neuron. Author manuscript; available in PMC 2014 February 08.

Furthermore, all neuropeptides are thought to be co-released with classical
neurotransmitters or neuromodulators. G-protein activation of neuropeptides will change
many aspects of the cell’s physiology; importantly, they have been shown to modulate
receptor trafficking, and alter the conductance of different ion channels (van den Pol
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2012). Importantly, neuropeptides are produced throughout the central nervous system,
where they can act locally, or project vast distances. These characteristics allow for
neuropeptides such as CRF to act on multiple different synapses to both promote, and
inhibit the activity of the same cell population.
The role of Corticotropin Releasing Factor in stress-induced reinstatement of drug
seeking
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In addition to the PVN, other brain nuclei produce CRF as a neuromodulator in
response to various physiological and emotional stressors. Accordingly, CRF cell bodies
and receptors are widely distributed throughout the brain (Chen et al 2015, De Souza et al
1985, Perrin & Vale 1999). Importantly, CRF has been found in the BNST, both the
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dorsal and the ventral subdivision (Chen et al 2015), and expression of CRFR1 and
CRFR2 have been reported within the BNST and VTA (Justice et al 2008, Sawchenko et
al 1993).
Given the importance of CRF in stress, early neurobiological investigations of
stress-induced reinstatement focused on the role of CRF. Experiments found that
intracerebroventricular pretreatment with the non-selective CRF receptor antagonists DPhe CRF, and alpha-helical CRF9-41, significantly attenuates, or blocks, footshockinduced reinstatement of heroin, cocaine, and alcohol seeking (Erb et al 1998, Le et al
2000, Liu & Weiss 2002, Zislis et al 2007). Conversely, central injections of CRF itself
reinstate drug seeking (Erb & Brown 2006, Mantsch et al 2008a). These studies strongly
suggest that CRF plays an important role in reinstatement of drug seeking during periods
of stress. However, the site of action of CRF and the receptor that CRF acts on was just
recently discovered.
The effects of CRF on footshock-induced reinstatement have been attributed to
actions at the CRFR1 receptor. Administration of the selective CRFR1 receptor
antagonist, CP-154, 526, prior to footshock stress blocked reinstatement of cocaine and
heroin seeking (Blacktop et al 2011, Gehlert et al 2007, Shaham et al 2000a). In contrast,
pretreatment with the selective CRFR2 receptor antagonist, antisauvagine failed to block
footshock-induced reinstatement of extinguished nicotine seeking (Gehlert et al 2007, Lu
et al 2000), or footshock-induced reinstatement of extinguished cocaine seeking
(Blacktop et al., 2011). Interestingly, the actions of CRF on CRFR1 have been localized
in part to the VTA. For example, studies have shown that CRF is released transiently in
the VTA and that CRF release is enhanced during electric footshock (Wang et al 2005).
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Recent data suggest that activation of CRFR1 in the VTA during electric footshock
mediates stress-induced reinstatement of cocaine, heroin, and nicotine seeking (Blacktop
et al 2011, Grieder et al 2014, Wang et al 2006). Therefore, from these studies, it can be
concluded that CRFR1 activation within the VTA is an important contributing factor in
the neurobiology of stress-mediated relapse. However, other studies have suggested that
the CRFR2 receptor and not the CRFR1 receptor is involved in stress-induced drug
seeking (Wise and Morales, 2010). Additionally, several different brain areas may
contribute to stress-related drug use in conjunction with CRF including the locus
coeruleus (Al-Hasani et al 2013, McCall et al 2015), the central nucleus of the amygdala
(Erb et al 2001b), and the dorsal raphe nucleus (Zorrilla et al 2012). The source of the
CRF input into the VTA is not yet known, though the BNST has been placed as a likely
candidate.
Convergence of the noradrenergic and CRF systems within the BNST
The BNST has two stress-related noradrenergic inputs that modulate its activity
and may lead to drug seeking during periods of stress. The first stress-related input is into
the ventral BNST (vBNST); it receives arguably the strongest NE projections from the
ventral forebrain bundle (Forray & Gysling 2004). In addition, NE release within the
vBNST has been shown to contribute to stress-induced reinstatement through the actions
of the beta-adrenergic receptors (Leri et al 2002). Signaling through beta-ARs can
increase both GABAergic and glutamatergic transmission through presynaptic
mechanisms; beta-AR transmission increase IPSC frequency within the BNST (Dumont
& Williams 2004, Egli et al 2005, McElligott et al 2010, Nobis et al 2011). Specifically,
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NE can enhance, or decrease glutamate transmission in the dBNST, while its effects in
the vBNST are less clear. NE, via a beta-AR mechanism, has been reported to inhibit
glutamate transmission in the vBNST (Egli et al., 2005). However, studies have shown
that beta-1 AR activation within the BNST produces a CRF-dependent increase of
excitatory transmission; specifically, activation of beta-AR receptors causes an increase
in spontaneous EPSC. However, in the presence of a CRFR1 antagonist, this effect is not
observed, indicating that beta-AR dependent EPSCs are mediated by activation of
CRFR1 (Nobis et al. 2011). This suggests that beta-ARs within the BNST may contribute
to stress-dependent reinstatement, since stress-dependent norepinephrine release
modulates BNST activity, most likely activating excitatory signaling through CRFdependent actions of beta-AR within the BNST. Based on our work, we believe that
activation of the beta-2 AR (Mantsch et al 2010, Vranjkovic et al 2014) within the BNST
modulates stress-responsive signaling in a CRF-dependent manner.
The second stress-related input to the BNST is CRF. The BNST contains a local
pool of CRF-positive cells that not only act within the BNST but also send CRF to other
putative brain regions (Sakanaka et al 1986, Sink et al 2013, Wang et al 2011). Notably,
stress exposure increases crf mRNA in the BNST (Funk et al 2006). For example,
footshock has been shown to increase crf mRNA within the dorsal, but not ventral, BNST
of withdrawn heroin animals (Shalev et al 2001). This suggests that CRF within the
dBNST might act on other targets such as the vBNST to initiate reinstatement.
Furthermore, injections of CRF within the BNST reinstates drug-seeking behavior,
whereas CRF injections within the amygdala fail to promote the same response (Erb &
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Stewart 1999). This further indicates that CRF signaling within the BNST is crucial for
reinstatement.
Neuroanatomical evidence has shown that ventral NE projections, which are
critical to stress-induced reinstatement, make direct synaptic contact with CRF cells
within the ventral BNST (Hornby & Piekut 1989, Phelix et al 1994). Interestingly, within
the BNST, CRF enhances beta-AR transmission though activation of CRFR1 (Nobis et al
2011). In addition, activation of the beta-AR depolarizes BNST CRF neurons, and CRF
enhances the frequency of spontaneous EPSCs in BNST neurons that project to the VTA
(Silberman et al 2013). These findings suggest that beta-AR activation may enhance CRF
release from local BNST CRF sources, leading to enhancement of excitatory
neurotransmission on VTA-projecting neurons by the activation of either CRFR1 on
VTA-projecting cells, or the activation of CRFR1 on glutamate cells that interact with
BNST cells projecting to the VTA. These findings place the BNST as a main candidate
for a CRF projection to the VTA. However, no studies have shown that a direct BNST to
VTA CRF projection mediates stress-induced reinstatement. In addition, no studies have
analyzed the role of interactions of CRF and NE within the BNST in mediating stressinduced reinstatement.

CRF acts within the VTA to promote drug seeking during periods of stress
The VTA has been implicated as a key area where a number of pathways
converge to regulate motivated behavior and reward to promote drug-seeking behavior
when faced with a stressor. The VTA is the main source of dopamine within the central
nervous system and via its two primary spokes, the mesocortical, and mesolimbic
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systems, the VTA can coordinate drug-seeking behavior. Specifically, ~70% of VTA
neurons are dopaminergic, ~30% of neurons are GABAergic, and about ~1-2% are
glutamatergic (Nair-Roberts et al 2008, Walsh & Han 2014, Yamaguchi et al 2015).
Within the VTA, drug-dependent neuroplasticity can make an addict more
susceptible to relapse when faced with a stressor (Mantsch et al., 2014). In order to
develop therapeutics for the treatment of stress-dependent drug seeking, we need to better
understand the neurobiological mechanisms through which stressors trigger drug seeking.
Actions of CRF within the VTA have been shown to promote drug use during
periods of stress. Studies have shown that CRF administration into the VTA is sufficient
to cause drug-seeking behavior (Blacktop et al 2011, Wang et al 2005, Wang et al 2007),
and that the actions of CRFR1 (Blacktop et al 2011, Chen et al 2014), CRFR2 (Wang et
al 2005, Wang et al 2007) and the CRF binding protein (Wang et al 2007) are necessary
for stress-induced drug, and food (Chen et al 2014) seeking following cocaine selfadministration. CRF inputs into the VTA have been shown to come from the oval bed
nucleus of the stria terminalis, the paraventricular nucleus of the hypothalamus, and the
central nucleus of the amygdala (Rodaros et al 2007); however, only the CRF input from
the oval bed nucleus has been shown to be involved in stress-related drug-seeking
behavior (Erb et al 2001a, Erb & Stewart 1999, Rodaros et al 2007). Studies have shown
footshock stress promotes CRF release within the VTA in both drug-naïve, and drugexperienced rodents (Wang et al 2005).
Interestingly, a recent study has suggested that chronic nicotine selfadministration upregulates local VTA CRF production, and that this CRF gets released in
the posterior VTA in an autocrine fashion to activate CRFR1 on DA cells to promote
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stress-induced nicotine relapse (Grieder et al 2014). This suggests that within the VTA,
CRF may be released from terminals that originate from the amygdala, bed nucleus, or
the paraventricular nucleus of the hypothalamus, or from VTA cell bodies during periods
of stress where it most likely acts on CRFR1 to modulate VTA activity.
CRF receptor subtypes within the VTA
Polymorphisms in genes that encode CRF receptors are associated with
exacerbated stress responses and propensity to develop drug addiction (Blomeyer et al
2008, Clarke & Schumann 2009, De Luca et al 2007, Enoch et al 2008, Treutlein et al
2006) indicating that CRF receptor function can contribute to substance abuse/addiction.
CRF, and both of its receptors (CRFR1 and CRFR2) are expressed within the VTA
(Ungless et al., 2003, Korotkova et al., 2006, (Grieder et al 2014). CRFR1 is expressed at
much lower levels in VTA compared to other brain areas and is localized to both
dopaminergic and GABAergic cells. Repeated drug use may increase the expression of
CRFR1, partly; CRF binding is increased within the VTA due to chronic cocaine
administration as assessed through receptor autoradiography (Goeders et al., 1990).
Stress seems drive DA activation within the VTA through a CRF-dependent
mechanism. We have shown that CRFR1 receptor activation is both necessary and
sufficient for stress-induced drug seeking (Blacktop et al., 2011). In addition, deletion of
CRFR1 within VTA DA neurons has been shown to be anxiogenic, and decrease DA
release within the prelimbic cortex (Refojo et al., 2011). Moreover, a VTA viral-mediated
knockdown of CRFR1 decreased food deprivation stress-induced reinstatement of
cocaine seeking in mice (Chen et al., 2014). We hypothesize that stress induces an
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activation of VTA DA neurons that project into the prelimbic cortex (Deutch et al., 1991)
and therefore increases the release of DA within the prelimbic cortex ( Thierry et al.,
1976; Sorg and Kalivas, 1993). While some studies have suggested this is a CRFR1
dependent process (Refojo et al., 2011), no studies have directly shown this to be the case
as it relates to stress-induced drug seeking
Traditional in situ hybridization methods have failed to detect CRFR2 within the
VTA (Van Pett et al., 2000); this may indicate that CRFR2 are localized on projecting
presynaptic terminals within the VTA. In addition, other studies have suggested that both
CRFR1 and CRFR2 within the VTA mediated EPSC potentiation and attenuation
respectively (Williams et al., 2014). In addition, the same study showed that CRFR2
activation facilitated GABA release within the VTA (Williams et al., 2014). These
studies have indicated that while CRFR1 within the VTA may directly mediate stressinduced drug seeking, it may do so in coordination with the CRFR2 receptors in a poorly
understood fashion.
Actions of CRF on VTA neurons
The cellular effects of CRF within the VTA are diverse and have been shown to
include regulation of both glutamatergic and GABAergic inputs; CRF has been
hypothesized to directly modulate VTA DA firing at presynaptic, postsynaptic, and
extrasynaptic sites. Studies have indicated that aversive stimuli may differently act upon
VTA DA projections to either the prelimbic cortex or the nucleus accumbens.
Specifically many studies have indicated that aversive stimuli (through actions of CRF
within the VTA) increase DA release within the prefrontal cortex (Abercrombie et al
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1989, Lammel et al 2008, Lammel et al 2012, Refojo et al 2011, Wanat et al 2008), while
within the nucleus accumbens, some aversive stimuli such as quinine, an aversive tastant,
may decrease DA release (Twining et al 2015). This may be attributed to differential
actions of CRF on VTA DA-projecting neurons; CRF may enhance DA signaling into the
prelimbic cortex, while have differential effects on, possibly attenuating, the DA
projection to the nucleus accumbens.
Specifically, studies have shown that CRF, through activation of CRFR1 within
the VTA, increases VTA DA Ih currents and dopamine neuron excitability through a
PKC-dependent mechanism (Wanat et al., 2008). Other studies have shown that chronic
cocaine use potentiates the magnitude and duration of CRF-induced NMDA currents, and
that only mice treated with cocaine showed a CRF-dependent enhancement of AMPA
transmission (Hahn et al., 2009). In addition, other studies have suggested that the
potentiation of the NMDA receptor-mediated signaling is attributable to CRFR1
activation (Sparta et al., 2013). These studies suggest that CRF within the VTA enhances
excitatory transmission, in part through regulation of NMDA and AMPA receptors.
Other studies have suggested that activation of CRFR1 within the VTA decreases
VTA DA cell excitability (Beckstead et al., 2009), and dopamine release within the
nucleus accumbens (Wanat et al., 2013;Twining et al., 2015). Specifically, Beckstead et
al showed that CRF facilitated GIRK currents and reduced DA neuron excitability via
activation of CRFR1. Moreover, CRF administration into the VTA has been reported to
cause a decrease in basal nucleus accumbens DA (Wanat et al., 2013), while a CRFR1
antagonist administered into the VTA blocked the drop in accumbens DA, which is
observed with intra-oral quinine (Twining et al., 2015). Interestingly, intra-oral quinine
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also induces reinstatement. Therefore, these studies suggest that, during periods of stress,
CRF may act to decrease the VTA DA projection into the accumbens (Twining et al.,
2015).
Glutamate-CRF actions within the VTA promote drug use
The VTA receives glutamatergic inputs from many brain regions (Geisler et al
2007). Glutamatergic inputs to VTA DA neurons have been found to originate from the
medial prefrontal cortex, mesopontine tegmentum nucleus, lateral habenula,
periaqueductal gray, and the dorsal raphe (Charara et al 1996, Clements & Grant 1990,
Omelchenko et al 2009, Omelchenko & Sesack 2007, Omelchenko & Sesack 2010, Qi et
al 2014, Sesack & Pickel 1992). However, it is important to note that some of these
glutamatergic regions also project to non-DA neurons within the VTA, and that
glutamatergic inputs and outputs to the VTA can manipulate behavior in different ways.
For example, reward-mediating inputs can come from the laterodorsal tegmental area,
while aversion-mediating inputs can originate from the lateral habenula (Lammel et al
2012). These observations are an important indication that isolating selective inputs to the
VTA using current techniques, such as optogenetics, is critical in order to link specific
behaviors to specific inputs. Therefore, using current advances in optogenetics and
chemogenetics, specific inputs onto specific cell populations is an important future
research objective.
CRF actions within the VTA have mainly focused on the interaction between
CRF and glutamate. Studies have shown that CRF-containing neurons make
morphologically asymmetric synapses with VTA DA neurons, suggesting that CRF-
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releasing terminals are predominantly glutamatergic (Tagliaferro & Morales 2008). CRF
directly excites both DA and non-DA neurons within the VTA (Korotkova et al 2006,
Wanat et al 2008). In addition, CRF increases NMDA current that uses a CRFR2dependent mechanism (Ungless et al 2003), while actions on CRFR1 have been shown to
potentiate both NMDA and AMPA currents in cocaine-experienced mice (Hahn et al
2009). VTA glutamate levels are increased by the direct administration of CRF within the
VTA (Wang et al 2005) while administration of the AMPA/NMDA receptor antagonist
kynurenic acid into the VTA has been reported to prevent both footshock-induced
reinstatement and the increase in VTA DA levels (Wang et al 2005, Wise & Morales
2010). This suggests that CRF enhances glutamatergic transmission on VTA DA cells.
However, it is important to note that VTA DA neurons do not ubiquitously project to the
same terminals; the balance between VTA DA projection activation and inhibition may
coordinate a differential behavioral response based on the output of the VTA DA
neurons; for example, studies have shown that laterodorsal tegmentum neurons
preferentially synapse on DA neurons projecting into the nucleus accumbens lateral shell,
while lateral habenula neurons synapse primarily on DA neurons that project to the
medial prefrontal cortex, and GABAergic neurons located within the tail of the
VTA(Lammel et al 2014, Lammel et al 2012). This is important because studies have
shown that the lateral habenula is activated during aversive stimuli (Barrot et al 2012,
Jhou et al 2013, Stamatakis & Stuber 2012) which suggests that the stress-dependent
increase of DA release within the prefrontal cortex may be dependent on activation of
VTA DA neurons by the lateral habenula.
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GABA neurotransmission within the VTA during stress-induced relapse
Much research has focused on the role of excitatory neurotransmission within the

VTA that leads to relapse during periods of stress. However, the inhibitory
neurotransmitter γ-aminobutyric acid (GABA) may have diverse functions in controlling
DA cell firing within the VTA. It is important to note that the VTA is not only comprised
of DA neurons, but also a subset of GABAergic neurons that are interneurons (Cruz et al
2004, Steffensen et al 1998) or GABAergic-projecting neurons (Pupe & WallenMackenzie 2015, Walsh & Han 2014). Specifically, ~70% of VTA neurons are
dopaminergic, ~30% of neurons are GABAergic, and about ~1-2% are glutamatergic
(Nair-Roberts et al 2008, Walsh & Han 2014, Yamaguchi et al 2015). Interestingly, very
small subsets of neurons have been found to co-release DA along with either glutamate,
or GABA in their terminal region (Stuber et al 2010, Sulzer et al 1998, Tritsch et al
2012). In addition, the VTA receives GABAergic input from various other brain areas
such as: the nucleus accumbens (Bocklisch et al 2013, Yim & Mogenson 1980), the
periaqueductal gray (Omelchenko & Sesack 2010, Zhang et al 2015), the bed nucleus of
the stria terminals (Kudo et al 2012), the lateral septum (Luo et al 2011), laterodorsal
tegmentum (Omelchenko & Sesack 2005), and the rostromedial tegmental area (Barrot et
al 2012, Jhou et al 2009). Once released, GABA may act on either GABAA receptors, to
open up a Cl- channel to hyperpolarize the cell and thus decrease the chance of firing an
action potential, or it can activate GABAB receptors, which will also decrease the
membrane potential by activating a potassium channel (GIRK) through a G-protein (Gi)
that is coupled onto the GABAB receptor (Johnston 1996, Kasten & Boehm 2015). Both
GABAA and GABAB receptors are located on VTA DA neurons where they can modulate
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DA activity (Creed et al 2014, Enoch 2008, Lomazzi et al 2008); the diversity of these
VTA DA neurons can contribute to the complexity of how stress-related inputs regulate
VTA DA neurons. For example, studies have shown that CRF modulates DA and
GABA-mediated inhibition within the midbrain by activating inhibitory postsynaptic
currents through GIRK channels on DA cells. Specifically, CRF enhances the amplitude
and slows the kinetics of inhibitory postsynaptic current through interactions with
GABAB receptors and D2 receptors (Beckstead et al 2009).
Studies have shown that stress may “turn off the brakes” on VTA DA cells by
blocking long-term potentiation of GABAergic neurons that synapse onto DA cells
(Graziane et al 2013). In addition, GABA release is increased within the VTA during
periods of stress in animals that received daily non-contingent cocaine injections
(Sotomayor-Zarate et al 2015). Some studies have suggested that CRF interacts with
GABA neurons; studies have shown that CRF regulates GABA release through a presynaptic mechanism (Kasten & Boehm 2015, Williams et al 2014). This would suggest
that GABA acts to disinhibit DA firing. However, other literature has suggested that
GABA directly acts to decrease DA firing. Studies have shown that footshock excites
VTA GABA neurons while concurrently inhibiting DA neurons (Tan et al 2012). In
addition, footshock stressors have been shown to reduce the firing of VTA DA neurons
(Ungless et al 2004). Interestingly, we have recently found that GABAB receptors are
necessary for both stress-, and CRF-induced drug seeking; our data indicates that GABAB
activation may be upstream from the actions of CRF (Blacktop et al., 2015). This
demonstrates that VTA neurons may have a dual action in response to aversive stimuli;
some neurons will increase their firing rate, while others will have a decrease in firing. It
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is important to understand the projection areas of these differentially responding VTA
neurons.
VTA projections to the PFC
Recent innovations in optogenetics and viral mediated-gene transfer have led to
findings that DA neurons located in the medial posterior VTA selectively project to the
medial prefrontal cortex (Lammel et al 2008). These neurons are very unique because
they have the ability to fire at a very high frequency, have longer waveforms, and have
significantly smaller after-hyperpolarization curves, indicating that these neurons have
the potential to fire rapidly. Interestingly, these neurons express relatively low amounts of
the DA transporter, and they lack somatodendritic D2 receptors and autoreceptor DA D2
receptors on their presynaptic terminals which interact with G-protein inward rectifying
receptors, in addition, these pyramidal neurons have been shown to lack GIRK channels
as well (Lammel et al 2008).
Studies have indicated that VTA DA neurons innervate pyramidal neurons (the
principal glutamatergic neuron of the prefrontal cortex) located in layers II, and V/VI
within the prelimbic cortex (Swanson 1982). Pyramidal neurons in this layer may be
found in two types of state: a down-state in which the neurons display a negative resting
membrane potential and therefore are less excitable, and an up-state which is
characterized by a plateau depolarization and therefore are more excitable (Peters et al
2000). Electrical stimulation of VTA DA neurons have been shown to evoke a longlasting transition of pyramidal neurons from the down-state to the up-state and this effect
was blocked by administration of a D1 receptor antagonist (Lewis & O'Donnell 2000).
The activation of D1 receptors within the prefrontal cortex is thought to increase current
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through the NMDA receptor via a PKA-, and Ca+2-dependent mechanism (Wang &
O'Donnell 2001). In addition, studies have suggested that activation of D1 receptors on
pyramidal neurons also inhibits G protein-dependent inward recertifying currents
(Witkowski et al 2008). These results suggest that VTA DA neurons control the
probability of prefrontal pyramidal firing and/or synchronize pyramidal neuron activity.
This is very important because the prefrontal cortex is necessary for stress-induced drug
seeking, particularly pyramidal neurons (McFarland et al 2004), and drug seeking during
periods of stress may be mediated by the activation of D1 receptors in this region
(Capriles et al 2003). However, no studies have directly shown that mesocortical DA
neurons are recruited in a CRF-dependent manner to promote drug use during periods of
stress.
The prefrontal cortex is involved in cocaine use during periods of stress
Drugs of abuse decrease the value of natural reward, diminish cognitive control, and
enhance glutamatergic drive to drug-associated stimuli within the cortico-accumbens
pathway (Kalivas & Volkow 2005). It is well accepted that the reinforcing properties of
cocaine and other drugs of abuse involves the activation of the mesocorticolimbic reward
pathway, which includes DA neurons originating from the VTA and projecting to the
ventral striatum and PFC. The PFC is involved in driving cognitive processes, and
executive functioning by processing information from vast sensory modalities to form
memories, perception, and decision-making (Siddiqui et al 2008). Our early
understanding of the PFC comes from Phineas Gage who was unfortunate enough to have
a metal rod obliterate his left PFC in an explosion. Phineas Gage developed both memory
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problems and a change in personality. However, our understanding of the role of the PFC
in stress-related drug use remains unclear.
Preclinical studies have indicated that acute cocaine administration increases the
activity of the PFC. Studies have shown that non-contingent cocaine administration
increases blood flow to the dorsolateral PFC and self-administration of cocaine increases
blood flow to both the dorsolateral PFC and the anterior cingulate cortex (Howell et al
2002, Howell et al 2010). Blood oxygen level-dependent (BOLD) responses are elevated
in subregions of the PFC such as the dorsolateral prefrontal cortex, anterior cingulate,
anterior orbital gyrus, orbitofrontal cortex, medial orbital gyrus, and frontopolar cortex
(Goldstein & Volkow 2011). In addition, intracerebroventricular administration of
cocaine resulted in a large fMRI response within the PFC, and other brain areas (Febo et
al 2004). This increase in activity of the prefrontal cortex has been proposed to induce
neuroplastic changes that transform drug habits from recreational to regular and even
uncontrollable use (Goldstein & Volkow 2011). In addition, BOLD signals have
indicated that the human PFC response is linked to both liking and wanting of cocaine
because BOLD signals in most PFC regions are correlated with the “rush” ratings
(Breiter et al 1997) and are increased when cocaine administration is expected (Kufahl et
al 2008). Theses human studies make it very apparent that subregions of the PFC are
highly involved in drug-seeking behavior.

Cocaine intake induces hypofronatality within the prefrontal cortex
It has been hypothesized that chronic cocaine intake may cause hypofrontality
within the prefrontal cortex, which may be reversed when addicts are exposed to
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environments that are previously associated with drug taking (Childress et al., 1999). It
has been hypothesized that hypofrontality also occurs with repeated cocaine intake in
rats; studies using rats trained to self-administer cocaine showed that overall firing and
burst rates were significantly decreased after the first cocaine exposure relative to prior
activity; these effects dissipated after 10 days of drug SA, and were replaced by a
significant increase in burst duration and firing rate (Sun & Rebec 2006). Interestingly,
imaging data has indicated that activity of the PFC in drug addicts is lower compared
with controls (Volkow et al., 2003); these studies however cannot determine whether this
hypofronatality is induced by cocaine or a pre-existing condition. In addition, BOLD
signals cannot differentiate the activity between pyramidal neurons or interneurons.
However, theories have proposed that while drug addiction devaluates natural rewards
through hypofronatality, drugs, and drug-related cues, may enhance the activity of the
prefrontal cortex (Volkow et al 2003). In addition, extensive drug use (such as our longaccess self-administration model) has been hypothesized to enhance the activity of the
cortico-striatal pathways by priming the system to triggers such as cues or exposure to a
stressor (Sinha 2013). Furthermore, studies have indicated that magnitude of stressinduced craving correlates with levels of prior-drug use in humans (Fox et al 2005). This
would suggest that a history of increased drug use might prime the prefrontal cortex to be
more active when exposed to a stressor. However fMRI assessment of the PFC in cocaine
addicts upon exposure to stress-related imagery has shown that BOLD signal is actually
reduced rather than increased (Sinha et al., 2009).
Interestingly, studies have also suggested that chronic drug use alters CRF activity
(Sinha 2013). Therefore, it is intriguing to speculate that a CRF-dependent mechanism
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may control the activity of the prefrontal cortex during stressful stimuli that in a manner
that elicits relapse to drug use.

Neuroanatomy of the rat prefrontal cortex
In the rodent, the prefrontal cortex is comprised of three different topographical
regions (medial, orbital, and lateral parts(Ongur & Price 2000). The medial PFC can be
subdivided into four main structures: the medial granular, the anterior cingulate, the
prelimbic cortex (PL), and the infralimbic cortex (IL; (Hoover & Vertes 2007). The
medial PFC can be divided into dorsal and ventral divisions; the dorsal medial PFC is
involved in motor behaviors (medial granular), while the ventral medial PFC is involved
in emotional, and cognitive processing (anterior cingulate, PL, and IL; (Heidbreder &
Groenewegen 2003). While this work focuses mainly on the VTA DA projection to the
prelimbic cortex, this region does receive numerous projections from other areas.
Notably, the main projections to the PL and IL are the orbital medial prefrontal, agranular
insular, perirhinal and entorhinal cortices, the hippocampus, the claustrum, the medial
basal forebrain, the basal nuclei of the amygdala, the midline thalamus, and the locus
coeruleus of the brainstem (Hoover & Vertes 2007). Conversely, both the PL and IL
cortices project to multiple brain areas, all of which may be reviewed by the works of
Vertes; the important projections as it pertains to stress-evoked drug use, are the lateral
septum, the bed nucleus of the stria terminalis, and the parabrachial nucleus of the
brainstem for the IL and the nucleus accumbens, and mediodorsal nucleus of the
thalamus for the PL (Vertes 2004). These projections suggest that the IL is involved, in
part, in visceral/autonomic activity, while the PL is involved in cognitive function (Vertes
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2004). The infralimbic cortex sends a glutamatergic projection to the shell of the nucleus
accumbens that is thought to be involved in extinction learning (LaLumiere et al 2010,
LaLumiere et al 2012). Furthermore, it has been shown that the glutamatergic projection
from the IL to the shell of the accumbens exerts suppression of drug seeking (Peters et al
2009, Peters et al 2008). Specifically, inactivation of the infralimbic cortex, or the shell of
the nucleus accumbens, reinstates drug seeking in the absence of drugs, cue, or stressful
triggers (Peters et al 2008)
The prelimbic cortex is involved in stress-related cocaine use
While much attention has been placed on the role of the PFC as it pertains to drug
taking, the PFC also has a prominent role in stress-related relapse to drug use. Stressrelated drug use has been mimicked in the rodent using a mild-non-noxious footshock
stressor. Interestingly, in 1976, Glowinski found that an electric-footshock stressor
significantly increased DA, but not norepinephrine, release within the prefrontal cortex
while DA release was not increased within the ventral striatum (Thierry et al 1976). In
addition, retrograde tracing studies have shown that a restraint stressor increased Fos
protein (a neuronal activity marker) immunoreactivity within VTA DA neurons that
project to the PFC; however, Fos expression was not increased in any DA projections to
the nucleus accumbens (Deutch et al 1991), in addition studies have shown that a tailshock increased DA reactivity by 95% within the PFC; and to much lesser extents in the
nucleus accumbens, and other terminal areas (Abercrombie et al 1989). These studies
pioneered the idea that stress may selectively activate DA projections from midbrain DA
neurons to the PFC, which likely precipitate drug use during periods of stress (Capriles et
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al 2003, McFarland et al 2004). Many studies have shown that aversive stimuli, such as
footshock, increase DA release in terminal regions of the mesocorticolimbic DA system
(Abercrombie et al 1989, Gresch et al 1994, Kalivas & Duffy 1995). This is also seen
with other triggers for relapse, such as exposure to cues previously associated with the
drug, and the drug itself (see Mantsch et al., 2015 for review). The prefrontal cortex
appears to process these different triggers to relapse by engaging the nucleus accumbens
core. Electrophysiological data has suggested that prefrontal cortical DA activation is
involved in cocaine seeking rather than the hedonic process of cocaine itself (Rebec &
Sun 2005).
Topographical organization of the DA projection from the VTA to the PFC
As mentioned previously, dopamine originates from the VTA/substantia nigra (or
A10) and projects to most limbic system structures, especially the prefrontal cortex
(Swanson 1982). Most cells that project to the prefrontal cortex from the VTA are located
in medial/caudal parts of the VTA (Lammel et al 2014) and are mostly topographically
organized wherein dorsomedial parts of the VTA project to the anterior cingulate, while
ventromedial parts of the VTA project to the dorsomedial prefrontal cortex (Swanson
1982).
Interestingly, roughly 11% of cells that project to the PFC cross the midline and
66% of cells that project to the PFC are dopaminergic (Swanson 1982). Most studies
have examined the DA projection from the VTA to the PFC in mice using TH-cre/DATcre GFP mouse line. Combining this approach with retrograde tracers, studies have
started to suggest that VTA DA projections differentially encode reward and aversion in
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mice (Lammel et al., 2012) and non-human primates (Kormos & Gaszner 2013). While
mouse and rodent brains are fairly similar, the lack of genetically modified rats has made
it difficult to pinpoint VTA DA neurons that are 1) activated by aversive stimuli and 2)
are topographically located within the VTA.
Activation of DA receptors
Once DA is released into the synaptic cleft, it can act on five major receptor
subtypes, designated D1-D5. All of these receptors belong to the seven transmembrane
domain G-protein coupled receptors. The DA receptors are commonly categorized as
either D1-like (D1 and D5) or D2-like (D2, D3, and D4) based on sequence homology and
G-protein coupling. Activation of D1-like receptors activates the G-protein Gsα, leading to
activation of adenylyl cyclase, and an increase in second messengers such as cAMP,
while activation of D2-like receptors are inhibitory through actions of the G-protein Gai.
Dopamine receptor location within the PFC
D1-like and D2-like receptors are found within the PFC, specifically within layers
II-VI of the PFC with the highest density observed within layer V and VI of the
prefrontal cortex; these layers also receive a prominent projection from the VTA as
compared to layers II-III (Swanson 1982, Vincent et al 1993). Studies have suggested
that D1-like receptors are located post-synaptically (Levey et al 1993) on pyramidal
neurons (Vincent et al 1993) while D2-like receptors interface with the extrasynaptic
space of the presynaptic projecting neurons where they act as autoreceptor to inhibit DA
release (Goldstein et al 1990). However, some D2-like receptors have been localized to
GABAergic interneurons and some expression has been observed on astrocytes (Vincent
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et al 1993). Interestingly, some studies have reported that D1-like receptors are also
present on parvalbumin-containing interneurons; these neurons control the
synchronization of PFC pyramidal neurons (Muly et al 1998). This serves to show the
complexity of the PFC, in that DA within the PFC can act to either increase or decrease
the excitability of pyramidal neurons based the location of DA release and/or targeted
receptor, and neuroplastic changes can occur in many different areas to shape the output
of the prelimbic cortex. However, in the case of the projection from the VTA, D1-like
receptors are preferentially expressed postsynaptically on pyramidal neurons in the PFC
(Boyson et al 1986). Therefore, DA will act on D1-like receptors to increase the
likelihood of firing rate of PFC pyramidal neurons (Lewis & O'Donnell 2000); these PFC
neurons are thought to project to the core of the nucleus accumbens (NAc) whereby DA
indirectly modulates the NAc by increasing the size of the NMDA component of an
excitatory postsynaptic potential on these neurons (Lewis & O'Donnell 2000, Seamans et
al 2001, Yang & Seamans 1996). The pyramidal neuron projections from the PFC to the
NAc is glutamatergic. This suggests that during periods of stress, DA release from the
VTA to the PFC is increased and activates D1-like receptors on pyramidal neurons,
leading to an increase in the firing rate of glutamatergic projection neurons to the NAc,
and therefore promoting drug seeking.
Prelimbic interneurons regulate pyramidal neurons through actions of both D1 and
D2 receptors
While mesocortical DA fibers innervate pyramidal neurons (Goldman-Rakic et al
1989, Verney et al 1990), they also innervate GABAergic interneurons (Sesack et al
1995, Vincent et al 1993). These GABAergic interneurons are important in initiating and
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maintaining rhythm and synaptic kinetics within the prefrontal cortex (Gupta et al 2000)
through their variable intrinsic firing rates (Markram et al. 2004). Parvalbumin
interneurons constitute the majority of interneurons within cortical layer V (Markram et
al. 2004) where they synapse close to pyramidal neurons and other local interneurons
(Kawaguchi and Kubota 1997, 1998). DA can increase the excitability of interneurons, as
evidenced by the finding that bath application of the D2 agonist quinpirole or the D1
agonist SK38393 induces an increase in the interneuron excitability (Tseng and
O’Donnell 2007) and therefore may increase GABAergic synaptic transmission onto
pyramidal neurons within the prefrontal cortex. At low DA levels, D1 receptors are
activated therefore increase interneuron excitability (Gorelova et al., 2002, TranthamDavidson et al., 2004a,Trantham-Davidson 2004b) and D1 agonists have been shown to
enhance spontaneous (sIPSCs) inhibitory neurotransmission, indicating that the intrinsic
excitability of interneurons is increased (Seamans et al., 2001). By contrast, activation of
D2 receptors during times of high DA concentrations has been shown to decrease cortical
IPSCs via a postsynaptic mechanism on interneurons (Trantham-Davidson 2004b) and D2
receptor agonists reduce the postsynaptic response to a GABAA agonist, indicating that
signaling through D2 receptors may work via a postsynaptic mechanism to reduce the
GABA tone of interneurons (Seamans et al., 2001). Other studies have shown that DA
can decrease IPSCs in the prefrontal cortex by acting on presynaptic D1 receptors likely
located on interneuron terminals (Gonzalez-Islas and Hablitz et al, 2001). All of these
studies suggest that dopamine interactions with interneurons within the prefrontal cortex
is very complex, since it can control interneuron firing, and since these interneurons can
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coordinate pyramidal neuron firing by either synchronizing them, or inhibiting other
interneurons.
Evidence implicating DA in footshock-induced reinstatement of cocaine seeking
comes from Capriles and colleagues (2003). This group showed that local administration
of the D1-like and not the D2-like receptor antagonist into the PFC or the orbital frontal
cortex blocked footshock-induced reinstatement (Capriles et al 2003). In addition, other
findings have shown that either administration of fluphenazine (a D1/D2 like receptor
antagonist) into the PFC (McFarland et al 2004) inhibits stress-induced reinstatement.
The actions of D1 receptors on pyramidal neurons are thought to increase the excitability
of pyramidal neurons that project to the nucleus accumbens core. Within layer V of the
prefrontal cortex, activation of D1-like receptors has been shown to increase the size of
the NMDA current (Seamans et al 2001). This suggests that VTA DA projections to the
PFC are important in stress-induced reinstatement.
CRF may regulate the DA projection to the prelimbic cortex
Recent research suggests that stress, in part through the actions of CRF, activates
the mesocortical DA system to induce reinstatement following footshock. This
interaction between CRF and DA systems has been shown by both behavioral and
neuroanatomical studies, which suggests that these systems converge in key brain regions
known to play an important role in stress-evoked reinstatement. Early studies employed
microdialysis to measure catecholamine release in the PFC and the medial hypothalamus
during systemic and central administration of CRF. These studies demonstrated that
intracerebroventricular CRF injections increase DA release in the PFC (Lavicky & Dunn
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1993). Patch-clamp recordings from VTA slices demonstrated that CRF, through the
actions of CRFR1, dose-dependently increased VTA dopamine firing (Wanat et al 2008).
In addition, studies have reported that bath application of CRF to VTA DA neurons
induces an increase in NMDA receptor-meditated excitatory postsynaptic potential
(Ungless et al 2003). This effect is attributed to activation of CRFR2 receptors and the
CRF-binding protein; this is interesting because many studies have suggested that drug
seeking (Blacktop et al 2011, Boyson et al 2014, Grieder et al 2014), or food seeking
during periods of stress (Chen et al 2014), is attributed to actions on CRFR1 and not
CRFR2. However, some studies have suggested that CRFR2 and not CRFR1 is involved
in drug-seeking behavior(Ungless et al 2003, Wang et al 2007). This difference may be
attributed to different receptor localization, or it may be attributed to differences in prior
drug-taking behavior (Mantsch et al 2015, Mantsch et al 2014). Interestingly, recent
reports have shown that CRFR1 mediates DA release within the PFC and controls
anxiety since a deletion of CRFR1 within midbrain DA neurons decreased DA release
within the PFC, and increased anxiety levels in mice (Refojo et al 2011). CRF neurons
that project to the VTA may contain, and therefore may co-release, glutamate onto VTA
DA neurons. Electron microscopy work has shown that CRF terminals that synapse onto
tyrosine hydroxylase-positive cells (TH; the precursor for DA) form asymmetric synapses
and therefore most likely release glutamate (Tagliaferro & Morales 2008). This suggests
that the presence of, and release of CRF during a footshock stressor may promote
glutamatergic excitation of VTA DA neurons. However, as previously noted, many
CRF-releasing inputs are likely GABAergic. It is not clear whether stress-induced
reinstatement is dependent on DA cells that are activated by CRF to precipitate stress-
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related drug use, since electron microscopy has only focused on CRF terminals that
synapse onto DA neurons, and not GABAergic cells.
Dopamine within the nucleus accumbens during stress-induced reinstatement
In addition to the PFC, the nucleus accumbens receives VTA DA projections.
Microdialysis studies have shown that stress can increase DA levels within the NAc shell
(Kalivas & Duffy 1995, Sorg & Kalivas 1991). Temporary inactivation of the NAc core
and shell with GABA receptor agonists prevents footshock-induced reinstatement
(McFarland et al 2004). However, local infusion of fluphenazine (the non-specific DA
antagonist) into the NAc core fails to block footshock-induced reinstatement, suggesting
that activity at the DA receptors within the NAc core does not mediate relapse due to
stress; however shock-induced reinstatement of heroin seeking has been reported to be
blocked by a D1 receptor antagonist (Shaham et al., 1996). Moreover, it has been found
that, in contrast to glutamate, DA levels in the NAc core are not changed during
footshock stress-induce reinstatement of cocaine seeking (McFarland et al 2004). Taken
together these studies suggest that stress-induced reinstatement may depend on activation
of VTA DA neurons projecting to the PFC, which in turn stimulates glutamate release
within the NAc, but not on elevated NAc DA.

Anatomy of the nucleus accumbens
Generally, the NAc, also termed the ventral striatum, is divided into two
subregions, based on different cytoarchitecture, and unique functions. The first subregion
is the nucleus accumbens core; this subdivision is considered an extension of the dorsal
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striatum (motor pathway), which is involved in instrumental learning and reinstatement
behavior, specifically during periods of stress (Cardinal & Everitt 2004, Ito et al 2000, Ito
et al 2004). The NAc core receives glutamate input from the prelimbic cortex (PL);
specifically layers V/VI (Gabbott et al 2005, Reynolds & Zahm 2005). This is thought to
represent the final common pathway in mediating reinstatement of drug-seeking behavior
in response to a cue, a stressor, or the drug itself (Kalivas & Volkow 2005). The second
subregion is the nucleus accumbens shell, which is an extension of the extended
amygdala; this part of the NAc is critical for the reinforcing/rewarding effects of drugs of
abuse. In contrast to glutamatergic projections from the PFC to the core, PFC projections
to the shell are thought to inhibit drug-seeking behavior, especially since inhibiting these
projections can induce reinstatement without the presence of a cue, a stressor, or a drug
(Kalivas 2005, Pierce & Kumaresan 2006). In addition, a recent study has indicated that
the dorsomedial shell encodes reward, while the ventromedial shell encodes aversion in a
dynorphin-dependent manner (Al-Hasani et al 2013). The shell receives glutamatergic
input from the infralimbic cortex (Gabbott et al 2005, Reynolds & Zahm 2005).
Both the core and the shell have similar, but yet distinct output pathways. Both of
these regions have a distinct topographical projection to the ventral pallidum and the
entopeduncular nucleus (Groenewegen & Russchen 1984). The core projects to the
dorsolateral part of the ventral pallidum while the shell projects to the medial part of the
subcommissural ventral pallidum (Groenewegen et al 1993). The core has a midbrain
projection to the substantia nigra pars reticulata (which sends input to the thalamus)
(Deniau et al 1994), while the shell projects to the VTA (Ikemoto 2007). In addition, the
core has some sparse projections to the lateral hypothalamus, while the shell projects
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diffusely throughout the lateral hypothalamus, but mainly to the extended amygdala
(Heimer et al 1991, Kelley 1999).
Medium spiny neurons within the nucleus accumbens are GABAergic and can be
subdivided into either the direct or the indirect pathway based dopamine receptor
expression. Although the presumed organization of NAc MSN outputs has been recently
called into question (Kupchik et al., 2015), it has been suggested that one subpopulation
of medium spiny neurons expresses D1R and sends projections to midbrain regions, most
notably the substantia nigra, while another subset of MSNs express D2R and putatively
sends projections to the ventral pallidum (although projections to the SN have been
identified). It is believed that direct and indirect pathway have complementary, and
possibly, opposing actions on behavior that are controlled by the cortico-accumbal
pathway (Gerfen and Sumeier 2011). Studies have shown that the D1R-regulated
pathway increases conditioned place preference for cocaine, whereas activation of the
D2R-regulated pathway decrease conditioned place preference for cocaine (Lobo et al.,
2010). Studies have also shown that activating glutamatergic inputs onto subpopulations
of MSNs in the NAc determine cocaine susceptibility and AMPA/NMDA ratios can be
differentially altered in excitatory synapses on different MSN population in mice exposed
to cocaine (Bock et al., 2012). It has been hypothesized that the activation of the “direct”
(D1R) pathway causes an increase in the motivation to seek cocaine, while the “indirect”
(D2R) pathway serves to decrease cocaine-seeking behavior when activated (Bock et al.,
2012).
The NAc is an important brain region that serves as the gateway through which
the limbic system (basolateral amygdala, VTA, PFC, and NAc) communicates with the
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motor subcircuit (motor cortex, dorsal striatum, and the substantia nigra; (Groenewegen
et al 1996, Kalivas 2009). Studies have found that the NAc can act to engage and
implement adaptive behaviors for a desired outcome by priming the motor system (Doya
2008). For example, if a response such as activation of a lever leads to a positive outcome
(such as delivery of a sucrose pellet) the NAc will engage the motor subcircuit to
recognize this response. It has been proposed that as behavior becomes
persistent/habitual, activation of the NAc diminishes, while the motor system becomes
more organized to adapt to this behavior. However, if lever activation fails to yield an
expected outcome, then the limbic subcircuit is strongly engaged, while the motor
subcircuit becomes more disorganized (Kalivas 2009). This allows the limbic system to
prime the motor system to maximize adaptive behavior through interactions of the NAc
with the motor system. When it comes to relapse to cocaine use, the current thinking
states “drug seeking arises from an impaired ability of the limbic subcircuit to effectively
process and/or use the negative environmental contingencies associated with relapse”
(Kalivas 2009); in other words, drug use can hijack the limbic system so that the learned
behavior is never truly extinguished, and that environmental stimuli such as a footshock
stressor may overcome the learned behavior of extinction and promote drug use through a
mechanisms in which DA from the VTA potentiates PFC pyramidal neuron firing to
activate the nucleus accumbens core.
The primary neurons of the NAc are medium spiny neurons (MSN) and they are
critical for goal-directed behavior. These MSNs are mainly GABAergic. The MSNs of
the NAc integrate emotional salience from the amygdala, contextual cues from the
hippocampus, and executive or motor control from the PFC to produce a response by
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influencing motor regions that execute motivated-behavior (Groenewegen et al 1999,
Kelley 1999). Rodent models have shown that activation of NAc MSN by AMPA
receptors is required for cocaine-seeking behavior, a process that is facilitated by
neuroplastic changes that occur on AMPA containing synapses of MSNs with repeated
cocaine use (Wolf 2010). Studies have indicated that prefrontal glutamatergic innervation
of the NAc is changed with chronic drug use, in that the compulsivity of drug use in
addicts becomes more desirable than natural rewards (Kalivas & Volkow 2005). This
neuroadaptation to drug use is mediated by at least three different mechanisms, 1)
changes in AMPA receptor expression within the NAc (e.g. an increase in Ca+2
permeable AMPA, the Glu-A2 lacking AMPA receptors); 2) impaired cysteine-glutamate
exchange leading to a decrease in extracellular glutamate release and therefore decreased
negative feedback through metabotropic glutamate receptors; 3) changes in the intrinsic
excitability of MSNs (Wolf 2010). These adaptations serve to increase the excitability of
MSNs. However the NAc also receives a distinct DA projection from the VTA, which
may also effect the excitability of MSNs.
Dopamine in the nucleus accumbens is critical for the rewarding and stimulant
effects of cocaine. It has been shown that DA infused into the NAc core will induce an
increase in locomotion, which can be inhibited by inactivating the globus pallidus with
injections of GABA (Jones & Mogenson 1980). Studies have shown that DA receptor
agonists are self-administered by rodents, and non-human primates when given
systemically, and when infused directly into the nucleus accumbens (Carlezon et al 1995,
Woolverton et al 1984, Yokel & Wise 1978). Microdialysis studies have shown that both
non-contingent, and contingent administration of cocaine (and other drugs of abuse)
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increases dopamine levels within the NAc (Di Chiara & Imperato 1988, Di Ciano et al
1998, Di Ciano et al 1995, Imperato et al 1992, Kalivas & Duffy 1990, Kalivas & Duffy
1993, Wise et al 1995, Wise et al 2008). Interestingly, the same studies have shown that
rats will administer cocaine in order to keep DA levels consistent within the NAc such
that when DA levels start to decrease, the animal will self-administer more cocaine in
order to keep the levels stable (Wise et al 1995). Therefore, these studies suggest that
fluctuating DA levels within the NAc correlate with increased drug use.
Studies have also examined the role of the nucleus accumbens core during either
cocaine self-administration, or following extinction training during reinstatement
behavior. Since, intra- nucleus accumbens core administration of DA receptor antagonists
increases cocaine self-administration suggesting that inhibition of DA receptors decreases
the rewarding properties of cocaine (Caine et al 1995, Koob et al 1994). While
administration of wither AMPA or NMDA within the nucleus accumbens during selfadministration caused a significant leftward shift of cocaine responding which suggested
enhancement of cocaine reward (Cornish et al 1999).
Dopamine in the NAc core does not appear to be necessary for cocaine seeking;
however, glutamatergic neurotransmission in the NAc is critical (Cornish and Kalivas,
2000). Administration of either AMPA or NMDA following SA and extinction in rats
reinstates drug seeking (Cornish et al 1999). At a cellular level, glutamatergic terminals
originating from the prelimbic cortex, and dopamine originating from the VTA converge
on the same medium spiny neurons; therefore the observation that intra-accumbens
AMPA administration could reinstate cocaine-seeking behavior could be explained by
AMPA directly activating MSN. Since numerous studies have shown that DA release is
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increased within the prelimbic cortex during stress-related behaviors (McFarland et al
2004, Moghaddam 1994, Refojo et al 2011, Thierry et al 1976), and that this increase in
DA modulates pyramidal neuron fringing into the nucleus accumbens it is hypothesized
that increases in glutamatergic transmission in the nucleus accumbens driven in part by
elevated DA in the prelimbic cortex is an important factor for initiating relapse to drug
taking; this has been shown to be involved in drug-primed reinstatement since an AMPA
antagonist, and not a DA antagonist infused into the nucleus accumbens prevents
reinstatement(Cornish & Kalivas 2000).
Neurocircuitry involved in stress-induced drug seeking
The use of a rodent reinstatement model of drug relapse is extremely important in
understanding the neurobiological pathways that mediate drug seeking during periods of
stress. This is especially important since the vulnerability to relapse due to a stressor
persists years after the cessation of drug use. This dissertation will explore different
aspects of this pathway to understand how stress triggers relapse, and hopefully provide
aid in the development of therapeutics that can better manage or prevent drug use that is
stress-related. Chapter 2 will test the hypothesis that beta-2 ARs are required for stressinduced activation of CRF pathways responsible for reinstatement. Work done in our lab,
and others, has suggested that noradrenergic receptors (Leri et al., 2002), specifically
beta-2 ARs (Mantsch et al., 2010; Vranjkovic et al., 2012) may be critically involved in
the interaction with the CRF system. Second, the self-administration model will be used
to test the hypothesis that stress-induced reinstatement is dependent upon a beta-2 AR
regulated vBNST-to-VTA CRF-releasing pathway, wherein stress-induced CRF will

	
  
activate CRFR1 on VTA neurons. Finally, this dissertation will explore how excessive
cocaine use establishes susceptibility to stress-induced relapse by recruiting CRF
regulation of a key stressor-responsive mesocortical dopaminergic pathway.
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Chapter II
Beta-2 adrenergic receptors mediate stress-evoked reinstatement of cocaineinduced conditioned place preference and increases in CRF mRNA in the bed
nucleus of the stria terminalis in mice
Abstract
Rationale: Understanding the mechanisms responsible for stress-induced relapse

is important for guiding treatment strategies aimed at minimizing the contribution of
stress to addiction. Evidence suggests that these mechanisms involve interactions
between noradrenergic systems and the neuropeptide corticotropin-releasing factor
(CRF).
Objectives: The interaction between beta-adrenergic receptors (ARs) and CRF as
it relates to the reinstatement of cocaine-conditioned reward in response to a stressor was
examined in mice. We hypothesized that beta 2-ARs are required for stress-induced
activation of CRF pathways responsible for reinstatement.
Methods: Stress-induced relapse was examined based on the re-establishment of
cocaine-induced conditioned place preference (CPP; 4×15 mg/kg cocaine, i.p.) after
extinction using forced swim (6 min at 22 °C) or an injection of the beta 2-AR agonist,
clenbuterol (4 mg/kg, i.p.). The CRF-R1 antagonist antalarmin (10 mg/kg, i.p.) or the
beta 2-AR antagonist ICI- 118,551 (1 mg/kg, i.p.) were given 30 min prior to reinstating
stimuli. Quantitative PCR was conducted in dissected bed nucleus of the stria terminalis
(BNST) and amygdala, putative sources of CRF that contribute to reinstatement, to
examine the effects of ICI-118,551 on swim-induced increases in CRF messenger RNA
(mRNA) in mice with a cocaine history.
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Results:
Pretreatment with ICI-118,551 or antalarmin blocked swim-induced reinstatement of
CPP. Reinstatement by clenbuterol was also blocked by antalarmin. ICI-118,551
pretreatment prevented swim-induced increases in CRF mRNA in the BNST. Effects in
the amygdala were not observed. Conclusions These findings indicate that, during stress,
norepinephrine, via beta 2-ARs, either directly or indirectly activates CRF-releasing
neurons in the BNST that interface with motivational neurocircuitry to induce
reinstatement of cocaine conditioned reward.
Introduction
Understanding the mechanisms through which stress promotes relapse to drug use
by cocaine addicts continues to be a critical research objective. Outcome measures for
current treatment approaches aimed at relapse prevention remain poor, and stress is a
pervasive trigger for relapse as it is typically unavoidable in daily life. In addition, there
is currently no FDA-approved medication for cocaine addiction, making it a critical
unmet need. Stress-induced relapse to cocaine use can be modeled in mice using a
cocaine-induced conditioned place preference (CPP) approach in which, after extinction,
preference can be re-established (i.e., reinstated) using stressors such as forced
swim(Kreibich et al 2009, Mantsch et al 2010).
A role for noradrenergic signaling in stress-induced reinstatement of cocaineconditioned reward has been established. Using the CPP/reinstatement approach in mice,
our laboratory has found that functional antagonism of noradrenergic neurotransmission
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via administration of the α2-adrenergic receptor (AR) agonist clonidine blocks swiminduced reinstatement of extinguished CPP(Mantsch et al 2010), while disinhibition of
noradrenergic activity via administration of yohimbine or the highly selective α2-AR
antagonist BRL 44,408 is sufficient to reinstate(Mantsch et al 2010, Vranjkovic et al
2012). These findings parallel those in rats demonstrating α2-adrenergic AR agonist
blockade of shock-induced reinstatement following cocaine self-administration (SA;(Erb
et al 2000)) and sufficiency of central administration of norepinephrine or systemic
delivery of yohimbine for reinstatement of cocaine seeking (Brown et al 2011, Brown et
al 2009, Feltenstein & See 2006). More importantly, they are consistent with reports that
α2-AR agonists attenuate drug craving in human cocaine addicts upon presentation of
stress-associated imagery(Jobes et al 2011).
Stress-induced increases in noradrenergic activity appear to induce reinstatement
of cocaine-conditioned reward in part via activation of beta-AR. We have found that
swim-induced reinstatement of cocaine-induced CPP is blocked by the nonselective β-AR
antagonist propranolol (Mantsch et al 2010)and is not observed in beta-AR-deficient
mice (Vranjkovic et al 2012) while the non-selective beta-AR agonist isoproterenol
induces reinstatement (Vranjkovic et al 2012). More specifically, our findings suggest
that beta 2-ARs are necessary for stress-induced reinstatement of cocaine-conditioned
reward, as swim-induced reinstatement of CPP is blocked by the selective beta 2-AR
antagonist ICI-118,551 and administration of the selective beta 2-AR agonist clenbuterol
is sufficient for reinstatement of CPP(Vranjkovic et al 2012).
The sites at which stress-induced increases in beta-AR activation promote
reinstatement behavior appear to include the bed nucleus of the stria terminalis (BNST)
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and central amygdala (CeA), both of which receive dense noradrenergic projections
(Ricardo & Koh 1978, Woulfe et al 1988), express beta-ARs (Asanuma et al 1991,
Cecchi et al 2007, Rainbow et al 1984), and are required for stress-induced reinstatement
of lever pressing following SA in rats (Erb et al 2001, Leri et al 2002, McFarland et al
2004) or cocaine-induced CPP in mice (Briand & Blendy 2010). In rats, delivery of a
cocktail of beta 1- and beta 2-AR antagonists directly into either the BNST or the CeA
prevents shock-induced reinstatement of cocaine seeking following self-administration
(Leri et al 2002). The BNST and CeA are components of the extended amygdala and
serve as key interfaces between the stress and reward systems. Both regions are highly
interconnected with the mesocorticolimbic system through which they likely regulate
drug-seeking behavior and reinstatement of cocaine-conditioned reward, although the
precise pathways and mechanisms through which this regulation occurs are not fully
understood.
The link between the mesocorticolimbic circuitry that has been implicated in
relapse and beta-AR actions in the BNST and amygdala likely involves the neuropeptide,
corticotropin releasing factor (CRF). CRF is a key mediator of stress induced
reinstatement of cocaine seeking following SA in rats(Mantsch et al 2008) (Buffalari et al
2012, Erb et al 2006, Erb et al 1998, Graf et al 2011, Shaham et al 1998) and has been
reported to contribute to stress-induced reinstatement of lever pressing following SA via
actions in the BNST (Erb et al 2001) and the ventral tegmental area (VTA;(Blacktop et al
2011, Wang et al 2005). In the BNST, evidence suggests that stress-induced increases in
CRF arise in part from local release from intrinsic cell populations(Silberman et al 2013).
Moreover, CRF release into the VTA is thought to involve projections from the BNST
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and the CeA(Rodaros et al 2007). In light of the requirement for beta-AR signaling in
these regions for stress-induced cocaine seeking in rats following SA (Leri et al 2002)
and evidence suggesting CRF-dependence of beta-AR actions in BNST (Nobis et al
2011, Silberman et al 2013), we hypothesized that beta 2-AR activation is required for
stress-induced regulation of CRF releasing neurons in one or both of these regions and
for relapse to drug use during periods of stress. In support of this hypothesis, it has been
reported that reinstatement in response to central norepinephrine is CRFdependent(Brown et al 2009).
Here, we further test this hypothesis by (1) investigating the ability of the CRF-R1
receptor antagonist, antalarmin, to prevent reinstatement of cocaine-induced CPP in mice
by a stressor, forced swim, and administration of the beta 2-AR agonist clenbuterol and
(2) testing for the ability of the beta 2-AR selective antagonist ICI-118,551, which blocks
swim-induced cocaine-conditioned reward, to also prevent swim-induced activation of
CRF neurons in the BNST and amygdala, as assessed by increases in CRF mRNA
measured using qPCR quantification in dissected tissue from mice with a prior history of
cocaine administration.

Methods
Subjects: A total of 116 male C57BL/6 mice (8–10 weeks old; 20 mice for CPP
testing and 96 for qPCR testing), purchased from Harlan Laboratories, were housed
individually in a humidity- and temperature-controlled, AAALAC-accredited animal
facility under a 12 h/12 h light/dark cycle (lights on at 0700 hours) with food and water
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available ad libitum, except when in the experimental chambers. All procedures were
carried out in compliance with the NIH guidelines and the Guide for Care and Use of
Laboratory Animals and were approved by Marquette University.
Conditioned place preference apparatus: Behavioral testing was conducted as
previously described (Mantsch et al. 2010; Vranjkovic et al. 2012). Six ENV-3013 mouse
CPP chambers from Med Associates, Inc. were used. The stainless-steel and polyvinyl
chloride chambers consisted of three distinct compartments separated by 5 cm wide×5.9
cm high manual guillotine doors. The two 46.5×12.7×12.7-cm side compartments
consisted of a white compartment with a 6.35×6.35-mm stainless-steel mesh floor and a
black compartment with a stainless-steel grid rod floor consisting of 3.2-mm rods spaced
7.9 mm apart. The side compartments were attached via a gray colored 7.2-cm-long
center compartment with a smooth floor. The clear tops of the compartments were hinged
to permit placement and removal of the mice. Ceiling lights were attached to each top. To
balance unconditioned side preferences, only the light in the black compartment was
illuminated during the training, testing, and extinction phases. Automated data collection
was accomplished by using photobeams (six beams for the white and black test areas and
two beams for the center gray area) that were evenly spaced across the length of the
chamber and interfaced with a computer containing MED-PC software (MED
Associates). Using this automated photobeam system, entry into a side compartment was
defined as consecutive breaks of the first two-photocell beams in that compartment
located adjacent to the door separating that compartment from the center compartment.
Exiting of a side compartment (and entry into the center compartment) was indicated by
occlusion of the beams in the center compartment.
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Cocaine-induced conditioned place preference: Cocaine-induced conditioned

place preference (CPP) was conducted using an unbiased approach by pairing one
compartment with cocaine and the other with saline as previously described (Mantsch et
al. 2010). These assignments were made randomly. On the first day of CPP, mice were
placed into the center compartment of the chamber and given free access to all three
compartments for 30 min in the absence of cocaine or saline to determine preconditioning
preference. During the 8-day conditioning phase of the experiment, mice received
cocaine (15 mg/kg, i.p.) on the odd days and saline injections on the even days.
Immediately after the injection, mice were confined (guillotine door closed) to the drugappropriate compartment for 30 min. A day after the final conditioning session, the mice
were tested for the expression of cocaine-induced CPP by placing them in the center
compartment and allowing them full access to the apparatus for 30 min. CPP was defined
as the change in time spent (in seconds) in the cocaine-paired compartment after
conditioning compared with the initial preconditioning session. Mice were determined to
exhibit a CPP if they spent more time in the cocaine-paired compartment during the postconditioning session compared to the preconditioning session.
Extinction: Daily extinction training was conducted after conditioning. During the
extinction sessions, the mice had free access to the entire apparatus for 30 min following
placement in the center compartment with both guillotine doors open. Mice underwent
daily extinction training until the extinction criterion was met (50 % reduction in the
preference for the cocaine-paired compartment). Mice were tested for reinstatement 24 h
after this criterion was reached.
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Reinstatement: Aside from exposure to a reinstating stimulus, the reinstatement

test sessions were identical to extinction conditions: mice were provided free access to
the entire apparatus for 30 min following placement in the center compartment with both
guillotine doors open. Most mice were tested multiple times for reinstatement. The
sequence of reinstatement test conditions was counter-balanced using a Latin square
design. The mice underwent additional extinction prior to each subsequent test and were
not tested again until the criterion for extinction was once again reached. Reinstatement
was defined as the difference in the time spent (in seconds) in the cocaine-paired
compartment between the reinstatement test day and the prior extinction day.
Drugs: Cocaine HCl (15 mg/kg) was obtained from the National Institute on Drug
Abuse (NIDA) through the NIDA Drug Supply Program. The CRF-R1 antagonist
antalarmin (10 mg/kg), the beta 2-adrenergic receptor (AR) agonist clenbuterol (4
mg/kg), and the beta 2-AR antagonist ICI-118,551 (1 mg/kg) were purchased from
Sigma-Aldrich. Cocaine, clenbuterol, and ICI-118,551 were dissolved in saline (0.9 %
bacteriostatic saline). Antalarmin was dissolved in 5 % DMSO. All drugs were
administered i.p. in a volume of 0.1 ml per 25 g body weight.
Experiment 1: role of beta-2 AR and CRF-R1 receptors in stress-induced
reinstatement of CPP
Forced swim-induced reinstatement Stress-induced reinstatement was induced
using a forced swim (FS) protocol as previously reported(Kreibich & Blendy 2004,
Mantsch et al 2010). Briefly, mice were placed into a 30 cm high× 20 cm deep cylindrical
polypropylene container filled with water (20–25 °C) for 6 min. After the forced swim,
mice were placed back into their home cages for 3 to 4 min before being introduced into
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the center compartment of the CPP apparatus with free access to the entire apparatus for
reinstatement testing, as described above.
The role of beta 2-ARs and CRF-R1 receptors in swim-induced reinstatement We
have previously reported that either pharmacological blockade of the β2-AR or genetic
beta 2-AR deletion prevents stress-induced, but not cocaine-induced, reinstatement of
extinguished cocaine-induced CPP in mice (Mantsch et al. 2010; Vranjkovic et al. 2012).
To confirm the role of beta 2-ARs in swim-induced reinstatement and to determine the
role of CRF-R1 receptors, mice (n = 8) underwent cocaine-induced CPP and extinction as
described above before testing for swim-induced reinstatement following pretreatment
with the beta 2-AR antagonist ICI-118,551 (1 mg/kg i.p.), the CRF-R1 antagonist
antalarmin (10 mg/kg i.p.), or vehicle. The mice received injections 30 min prior to
forced swim. The sequence of the treatments was counter-balanced using a Latin square
design.
Experiment 2: effects of CRF-R1 antagonism on beta 2-AR agonist-induced
reinstatement
We previously reported that the beta-2-AR agonist clenbuterol reinstates
extinguished cocaine-induced CPP (Vranjkovic et al. 2012). To determine if the beta 2AR induces cocaine- conditioned reward via a CRF-dependent mechanism, the mice (n =
12) were tested for reinstatement in response to administration of the beta 2-AR agonist
clenbuterol (4 mg/kg, i.p.) or vehicle 30 min after pretreatment with CRF-R1 receptor
antagonist antalarmin (10 mg/kg, i.p.; Kreibich et al., 2009) or vehicle. The mice were
introduced into the experimental chambers 30 min after clenbuterol administration and
tested for reinstatement. The sequence of the treatments was counter-balanced using a
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Latin square design. Notably, we have found that reinstatement of extinguished CPP by
this dose of clenbuterol is not attenuated by pretreatment with the beta-1 AR antagonist,
betaxolol (10 mg/kg, i.p.), suggesting that its agonist actions are selective for the beta-2
AR and/or that beta-1 AR, if activated, do not con- tribute to reinstatement (Ext: 558.28
± 72.45; Clen/Betax: 1075.11 ± 94.03; Significant reinstatement, paired t test; p < 0.001).
Experiment 3: role of beta 2-ARs in swim-induced effects on crf mRNA in the BNST
and amygdala
In order to examine the role of beta 2-ARs on stress-induced CRF mRNA, mice
received an injection of cocaine (15 mg/kg, i.p.) or saline on alternating days for 8 days.
Following the cocaine treatment, mice were given an 8-day withdrawal period before
exposure to the stressor. Mice were pretreated with either ICI- 118,551 (1 mg/kg, i.p.) or
vehicle 30 min prior to forced swim. After forced swim, the mice were placed back in
their home cages for 30 min prior to sacrifice. The remaining mice did not undergo
forced swim but instead were euthanized 60 min after the ICI-118,551 or vehicle
injection. The groups were as follows: vehicle, vehicle + forced swim, ICI, ICI + forced
swim.
Tissue extraction: Mice were killed by cervical dislocation and their brains were rapidly
removed and flash frozen by submersion for 30 s in a beaker filled with 2-methylbutane
sitting in dry ice and brains were then stored at −80 °C. A cryostat was used to cut one
500-µm-thick coronal section from frozen brain tissue at the level of the BNST (+0.45 to
−0.05 mm from Bregma; Fig. 2.3a), and tissue punches were taken from the BNST using
a tissue punch kit (1.00 mm in diameter), with hemispheres pooled into one sample for
each mouse. In the same brain, a cryostat was used to cut two 500-µm-thick coronal
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sections from frozen brain tissue at the level of the amygdala (−0.82 to −1.82 mm from
Bregma; Fig. 2.3b), and tissue punches were taken from the amygdala, with hemispheres pooled into one sample for each mouse. The tissue punches were stored at −80 °
C for later quantitative real-time polymerase chain reaction (qPCR) analysis.
RNA was extracted from frozen brain punches using a phenol: chloroform
method. Due to the small amount of tissue, tissue from two mice was pooled for each
sample. Briefly, tissue punches were homogenized in Trizol using a 20 ga. followed by a
25 ga. needle. Homogenized samples were incubated at room temperature with
chloroform and then centrifuged at 11,000×g for 15 min. The upper aqueous phase was
separated into a new tube and isopropranolol was added. Following incubation at room
temperature, samples were centrifuged at 12,000×g for 10 min. The isopropranolol was
poured off and samples were washed twice in 70 % ethanol followed by centrifugation at
12,000×g for 5 min. The pellet was finally stored in 70 % ethanol at −20 °C.
Reverse transcription and qPCR: For complementary DNA (cDNA) production, the
ethanol was poured off and the RNA pellet was allowed to air dry before being resuspended in RNAse free water. Samples were then treated with DNAse (Invitrogen) to
remove genomic DNA. Following DNAse treatment, cDNA was created using Oligo(dT)
primers, and a Superscript II reverse transcription kit (Invitrogen). cDNA was diluted 1:3
and stored at −20 °C for qPCR analysis. All qPCR was run using the StepOne real-time
PCR sys- tem (Applied Biosystem). For qPCR analysis, reactions containing PerfeCTa
SYBR Green FastMix with ROX (Quanta Biosciences), 20 µM of forward and reverse
primers, and cDNA were loaded into the wells of a 48-well plate on ice. The cycling
parameters were 95 °C for 30s followed by 40cycles of 95°C (5s), 60°C (15s), and 70°C
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(10s) followed by a melting curve to ensure amplification of a single product. All
reactions were performed in triplicate and the mean threshold cycle for each gene product
for each sample was used for analysis. The mRNA levels of CRF were normalized to the
housekeeping gene, TATA binding protein (TBP). Primer sequences were generously
provided by Dr. Julie Blendy(Cleck et al 2008).
Results
Prior to testing for reinstatement, mice underwent CPP and extinction as
previously described (Mantsch et al. 2010). All mice displayed cocaine-induced CPP and
met criteria for extinction. Five mice were excluded from testing because they did not
display CPP (two mice) or did not extinguish (three mice). The mean time spent in the
cocaine-paired compartment prior to and after conditioning and during extinction for
each CPP experiment (Exp. 1 and 2) is shown in Table 2.1.
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Table 2.1: Cocaine-induced conditioned place preference (CPP) and
extinction. Mice underwent CPP using an unbiased 8-day (4 x alternating 15
mg/kg, ip cocaine and vehicle administration) approach. Data represent the
mean time (sec ± S.E.) spent in the cocaine compartment prior to conditioning
(Pre-Cond.), after conditioning (Post-Cond.), and on the first and last (prior to
the first reinstatement test) days of extinction (First and Last Ext) in mice used
for Experiments 1 and 2. Mice used in both experiments displayed significant
CPP (*p<0.01; paired t-test Post-Cond. vs. Pre-) and showed extinction
(**p<0.001; paired t-test, First Ext. vs. Last).

Experiment 1: role of beta 2-AR and CRF-R1 receptors in stress-induced
reinstatement of CPP
For this experiment, mice (n=8) were tested for the effects of vehicle, the CRF-R1
antagonist antalarmin, and the beta 2-AR antagonist ICI-118,551 on reinstatement of
extinguished CPP following forced swim. The pretreatments in combination with forced
swim were tested in counterbalanced sequence determined using a Latin square design.
The effects are shown in Fig. 2.1.
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FIGURE 2.1 : Stress- (swim-) induced reinstatement of extinguished cocaineinduced CPP requires β-2 adrenergic and CRF-R1 receptor activation. Data
represent the time spent in the compartment previously paired with cocaine (s ±
S.E.) during the preceding extinction session (Ext) or during reinstatement testing
following a 6-min forced swim (22°C) in mice (n=8) pretreated with the β-2 AR
antagonist, ICI-118,551 (1 mg/kg, ip; 1A), the CRF-R1 receptor antagonist,
antalarmin (10 mg/kg, ip; 1B) or Veh. Both ICI-118,551 and antalarmin prevented
swim-induced reinstatement. In both cases, significant reinstatement was observed
in vehicle- but not antagonist-pretreated mice (*p<0.01 vs. Ext) and reinstatement
was significantly lower following antagonist pretreatment (#p<0.01 vs. Veh).

1.1: Effects of the beta 2-AR antagonist, ICI-118,551, on stress- induced reinstatement of
CPP. We previously reported that the beta 2-AR antagonist, ICI-118,551, prevented
swim-induced re- instatement of CPP in mice (Vranjkovic et al. 2012). This effect of ICI118,551 (1 mg/kg, i.p.) was also observed in the present study (Fig. 2.1a). Consistent
with our earlier report, two- way repeated measures ANOVA showed significant overall
effects of forced swim (F(1,7)=22.423; p<0.01) and ICI- 118,551 (F(1,7) = 8.829; p <
0.05) and a significant interaction between swim-induced reinstatement and ICI-118,551
pre- treatment (F(1,7) = 14.272; p < 0.01). ICI-118,551 prevented swim-induced
reinstatement. Post hoc testing showed that significant reinstatement was observed in
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vehicle but not ICI-118,551 pretreated mice (p < 0.01 vs.the prior extinction session) and
was significantly reduced following ICI-118,551 pretreatment (p<0.01 vs. vehicle).

1.2: Effects of the CRF-R1 receptor antagonist, antalarmin on stress-induced
reinstatement of CPP The neuropeptide CRF has also been implicated in stress-induced
cocaine seeking (Erb et al 1998, Shaham et al 1998). To test for the involvement of CRF
in swim-induced reinstatement of CPP, mice received pretreatment with the CRF-R1
receptor antagonist, antalarmin (10 mg/kg, i.p.). Antalarmin prevented reinstatement
following forced swim (Fig. 2.1b). Two-way repeated measures ANOVA showed
significant overall effects of forced swim (F(1,7)= 5.710; p < 0.05) and antalarmin
(F(1,7) = 13.642;p < 0.01) and a significant interaction between swim-induced
reinstatement and antalarmin pretreatment (F(1,7)=67.375; p<0.01). Post hoc testing
showed that significant reinstatement was observed in vehicle-pretreated but not
antalarmin-pretreated mice (p<0.01 vs. extinction) and was significantly reduced
following antalarmin pretreatment (p<0.01 vs. vehicle).
Experiment 2: effects of CRF-R1 antagonism on beta 2-AR agonist-induced
reinstatement
We previously reported that the administration of beta 2-AR agonist, clenbuterol
(4 mg/kg, i.p.), is sufficient to reinstate extinguished cocaine-induced CPP in mice
(Vranjkovic et al. 2012). Here, we demonstrate that, like forced swim, clenbuterolinduced reinstatement is blocked by pretreatment with the CRF-R1 receptor antagonist,
antalarmin. Pretreatment with antalarmin (10 mg/kg, i.p.) prevented clenbuterol- induce
reinstatement (Fig. 2.2).
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FIGURE 2.2: Clenbuterol-induced reinstatement is
significantly decreased by pretreatment with the CRF-R1
receptor antagonist, antalarmin. Data represent the time
spent in the compartment previously paired with cocaine (s ±
S.E.) during the preceding extinction session (Ext) or during
reinstatement testing following administration of clenbuterol (4
mg/kg, ip) after pretreatment with the CRF-R1 receptor
antagonist, antalarmin (10 mg/kg, ip; n=9) or vehicle (n=12).
Significant reinstatement was observed in vehicle- but not
antalarmin-pretreated mice (*p<0.01 vs. Ext) and reinstatement
was significantly lower following antalarmin pretreatment
(#p<0.05 vs. Veh).

Twelve mice were tested for reinstatement following vehicle pretreatment. Nine were
tested for reinstatement following antalarmin. Since some mice were not tested for effects
of both vehicle and antalarmin on clenbuterol-induced reinstatement, a mixed two-way
clenbuterol reinstatement (repeated measure) × antalarmin pretreatment condition
(between subjects measure) ANOVA was used. A significant overall effect of clenbuterol
administration (F(1,19)=26.335; p<0.001) and a significant interaction be- tween
antalarmin pretreatment and clenbuterol-induced rein- statement (F(1,19) =4.294;
p=0.050) were observed. Antalarmin prevented clenbuterol-induced reinstatement.
Significant reinstatement was observed in vehicle-pretreated but not antalarminpretreated mice (p < 0.01 vs. extinction), and time spent in the cocaine-paired
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compartment was increased in mice pretreated with vehicle compared to mice pretreated
with antalarmin (p=0.05).
Experiment 3: Role of beta 2-ARs in stress-induced effects on CRF mRNA in the
BNST and amygdala
Since reinstatement of CPP following administration of the beta 2-AR agonist,
ICI-118,551, was dependent on CRF receptor activation, we hypothesized that beta 2-AR
receptors regulate, either directly or indirectly, CRF-producing neurons in brain regions
previously implicated in CRF-dependent stress- induced cocaine seeking. To test this
hypothesis, we quantified CRF mRNA in the BNST and amygdala dissected from
cocaine-treated mice 30 min following the termination of a 6- min forced swim using
qPCR after pretreatment with ICI- 118,551 (1 mg/kg, i.p.) or vehicle. Schematics
depicting the areas targeted for dissection are included in Fig. 2.3.
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Fig. 3 Tissue dissection schematic for qPCR analysis. (a) For the BNST,
a tissue punch (1.00 mm in diameter) was taken from one 500-μm
section. The punch site is shown in the shaded circle and both the dorsal
and ventral portions of the BNST were collected. (b) For the amygdala, a

tissue punch (1.00 mm in diameter) was taken from two 500-μm sections.
The punch site is shown in the shaded circle and the majority of the
amygdala was collected. For both regions, hemispheres were pooled into
one sample. Adapted from Franklin and Paxinos (2007)

Fig. 2.3 Tissue dissection schematic for qPCR analysis. (a) For the
BNST, a tissue punch (1.00 mm in diameter) was taken from one 500-µm
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Here, we examined the effect of pretreatment with the beta 2-AR antagonist ICI-118,551
(1 mg/kg, i.p.) on swim-induced levels of CRF mRNA in the BNST following cocaine
treatment and withdrawal (Fig. 2.4a).
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FIGURE 2.4: Stress- (forced swim-) induced increases in crf mRNA in
the BNST, but not the amygdala, are blocked by pretreatment with a
beta-2 adrenergic receptor antagonist. Data represent the fold change in
crf mRNA ± S.E. The mRNA changes were assessed using quantitative realtime polymerase chain reaction (qPCR) on tissue from the BNST (A) and
amygdala (B) of mice exposed to a 6-min forced swim (22°C) after cocaine
treatment and withdrawal. The mean threshold cycle for crf was normalized
to the endogenous control TATA binding protein (tbp). Forced swim
significantly increased crf mRNA levels in the BNST in mice that received a
vehicle pretreatment (*p<.05, compared to vehicle alone). However, in mice
that received a pretreatment the beta-2 AR antagonist, ICI-118,551 (1 mg/kg,
ip), forced swim no longer increased crf mRNA levels in the BNST while the
pretreatment of ICI-118,551 alone had no effect on crf mRNA. In contrast, in
the amygdala, neither forced swim nor ICI-118,551 had a significant effect
on crf mRNA.

Two-way ANOVA did not show a significant main effect of forced swim
(F(1,36)=3.737, p= 0.061) or ICI-118,551 (F(1,36)=1.919, p=0.174) on CRF mRNA
levels in the BNST but did show a significant inter- action between forced swim and ICI118,551 (F(1,36)=4.851, p<0.05). Mice that received vehicle pretreatment and forced
swim had significantly higher CRF mRNA levels in the BNST compared to the vehicle
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treatment alone (p < 0.05). However, when mice were pretreated with ICI-118,551,
forced swim no longer increased CRF mRNA levels in the BNST (p>0.05 compared to
vehicle treatment), while the treatment with ICI-118,551 alone had no significant effect
on CRF mRNA levels (p>0.05, compared to vehicle treatment alone).

3.2: Effects on crf mRNA in the amygdala Like the BNST, the amygdala has been
implicated in stress-induced cocaine seeking following SA in rats(McFarland et al 2004).
Moreover, beta-AR signaling in the central nucleus of the amygdala con- tributes to
stress-induced reinstatement(Leri et al 2002) and forced swim following protracted
withdrawal after binge cocaine access has been reported to increase CRF mRNA levels in
the amygdala(Cleck et al 2008). Thus, the amygdala is a potential site at which CRF is
either directly or indirectly regulated by beta 2-ARs to promote cocaine use. Here, we
examined the effect of the beta 2-AR antagonist ICI-118,551 (1 mg/kg, i.p.) on swiminduced levels of CRF mRNA in the amygdala following cocaine treatment and
withdrawal (Fig. 2.4b). In contrast to the BNST, a two-way ANOVA did not show a
significant main effect of forced swim (F(1,39) = 2.033, p = 0.162), ICI-118,551
(F(1,39)=0.046, p=0.83), or an interaction between forced swim and ICI-118,551 on CRF
mRNA in the amygdala (F(1,39)=0.558, p=0.459).
Discussion
The main finding of this study is that an interaction between beta 2-ARs and
CRF-R1 receptors is critical for stress-induced reinstatement of extinguished cocaineinduced CPP in mice. Additionally, beta 2-AR signaling is required for the stress-
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induced regulation of CRF mRNA levels in the BNST. We found that not only is CRFR1 activation necessary for swim induced reinstatement of cocaine-induced CPP but it is
also necessary for reinstatement in response to the beta 2-AR agonist clenbuterol,
suggesting that beta 2-AR signaling is upstream from CRF actions in the neural pathway
responsible for stress- induced reinstatement of cocaine-conditioned reward. In support of
this hypothesis, we also found that forced swim can significantly increase CRF mRNA
levels in the BNST, a region necessary for stress-induced reinstatement, and that this
effect can be prevented by pretreatment with the beta 2-AR antagonist ICI-118,551.
Surprisingly, this effect does not occur in the amygdala. Taken altogether, these data raise
the possibility that beta 2-AR-dependent activation of CRF- expressing neurons in the
BNST mediates stress-induced re- instatement of cocaine-conditioned reward, a process
that likely contributes to relapse.
The BNST is an important site for integration of stress and reward networks
(Flavin & Winder 2013). The BNST receives heavy innervation from most subregions of
the amygdala(Dong et al 2001a, Weller & Smith 1982), a structure known to be involved
in stress, fear and anxiety, and projects to regions involved in neuroendocrine, autonomic
and behavioral control (Dong & Swanson 2006) such as the PVN and the
amygdala(Cullinan et al 1993, Dong et al 2001a, Dong et al 2001b). In addition to its
connectivity with stress-related structures, BNST efferent projections target regions
involved in motivation and reward, such as the nucleus accumbens (Dong et al 2001b)
and the VTA (Georges & Aston-Jones 2001, Georges & Aston-Jones 2002). The BNST
is activated during stress-induced reinstatement (Briand et al 2010, Brown et al 2011) and
is necessary for stress-induced reinstatement in mice and rats (Briand & Blendy 2010,
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Erb & Stewart 1999, Leri et al 2002, McFarland et al 2004). In addition, it is an important
region for CRF actions that mediate stress-induced reinstatement following SA, as CRFR1 activation in the BNST is both necessary (Erb et al. 2001; Erb and Stewart 1999) and
sufficient (Erb and Stewart 1999) for reinstatement, and stress can increase CRF mRNA
in the BNST in rats(Funk et al 2006). Indeed, our own findings support this hypothesis by
demonstrating that CRF-R1 receptor activation is necessary for forced swim induced
reinstatement of CPP in mice and that the same stressor increases CRF mRNA levels in
the BNST of mice with a prior history of cocaine, albeit in the absence of CPP. These
data suggest that the BNST is a major site of regulation of CRF actions during stressinduced reinstatement of cocaine-conditioned reward.
In addition to CRF, the noradrenergic system plays an important role in reward
and stress (Flavin & Winder 2013, Weinshenker & Schroeder 2007). In particular, this
system is heavily involved in stress-induced reinstatement behaviors. For example,
reducing norepinephrine levels through alpha 2-AR agonism blocks stress-induced
reinstatement of cocaine seeking following SA in rats (Erb et al. 2000) and reinstatement
of cocaine-conditioned reward in mice (Mantsch et al. 2010), as well as stress-associated
cocaine craving in humans(Jobes et al 2011). Norepinephrine is also sufficient for
reinstatement as elevation of norepinephrine levels through central administration of
norepinephrine or alpha 2-AR antagonism promotes reinstatement behaviors in both rats
and mice (Brown et al. 2011; Brown et al. 2009; Feltenstein and See 2006; Mantsch et al.
2010).
We have previously demonstrated, using the mouse CPP/ reinstatement approach
that, specifically, beta 2-ARs are required for stress-induced reinstatement (Mantsch et al.
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2010; Vranjkovic et al. 2012). Reinstatement of CPP by either forced swim or yohimbine
is blocked by the beta 2-AR-selective antagonist, ICI-118,551, but not the beta1-ARselective antagonist, betaxolol, while administration of the beta 2-AR-selective agonist,
clenbuterol, is sufficient to reinstate CPP. Our current findings confirm this role for beta
2-ARs. In rats, the BNST, which receives dense noradrenergic innervation through the
ventral noradrenergic bundle (Ricardo & Koh 1978, Woulfe et al 1988) and displays
increased norepinephrine levels following stress (Pacak et al 1995), appears to be a key
site for beta-AR regulation of cocaine seeking during stress. Blockade of beta 1- and beta
2-ARs in the BNST using a cocktail of ICI-118,551 and betaxolol prevents footshockinduced reinstatement of cocaine seeking following SA in rats (Leri et al. 2002).
The precise mechanism through which beta 2-ARs regulate reinstatement of
cocaine seeking and CPP is unclear, but we hypothesize that it involves effects on CRF
neurons in the BNST. Beta-AR activation increases excitatory transmission in the BNST
(Egli et al 2005), and these effects appear to be mediated in part via a CRF-R1-dependent
mechanism(Nobis et al 2011). In addition, norepinephrine-induced reinstatement is
prevented by CRF receptor antagonism, but CRF- induced reinstatement is not blocked
by inhibition of noradrenergic neurotransmission(Brown et al 2009), suggesting that
noradrenergic signaling is upstream from CRF in the chain of events that lead to
reinstatement. Our own findings support this possibility, as we found that reinstatement
of CPP induced by the beta 2-AR agonist clenbuterol is blocked by the CRF-R1
antagonist antalarmin and that stress-induced increases in CRF mRNA in the BNST are
prevented by the beta 2-AR antagonist ICI-118,551. CRF released into the BNST may
originate from CRF-releasing afferent projections to the BNST or from local cell
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populations(Veinante et al 1997). The latter possibility is supported by findings from
Silberman et al. (2013) suggesting that norepinephrine depolarizes CRF- containing
neurons intrinsic to the BNST, thereby releasing CRF locally, which then enhances
glutamatergic neurotransmission via presynaptic effects.
CRF neurons in the BNST also send efferent projections to a number of brain
regions, most notably the VTA (Rodaros et al. 2007). The VTA is a heterogeneous region
that is the source of dopamine neurons that comprise the mesocorticolimbic system and
has a well-established role in stress-induced cocaine seeking(Mantsch et al 2014,
McFarland et al 2004). CRF actions in the VTA are necessary for stress-induced
reinstatement and are mediated by activation of CRF-R1 receptors(Blacktop et al 2011).
Emerging evidence suggests that the BNST-VTA pathway is essential for stress-induced
cocaine seeking and reinstatement of CPP (Mantsch et al. 2014). For example, reinstating
stimuli such as forced swim increase c-fos expression specifically in BNST neurons that
project to the VTA (Briand et al. 2010). The BNST sends both glutamatergic and
GABAergic projections to the VTA(Georges & Aston-Jones 2001, Kudo et al 2012),
which appear to have distinct roles in reward and aversion(Jennings et al 2013).
However, the relative roles of GABAergic vs. glutamatergic projections from the BNST
to the VTA in the regulation of stress-induced reinstatement behaviors are not clear.
Notably, withdrawal from chronic ethanol exposure enhances basal glutamatergic
regulation of VTA-projecting BNST neurons in a CRF-R1 dependent manner (Silberman
et al. 2013). Understanding how projections from the BNST to the VTA promote relapse
to drug use during stress and delineation of the processes in the BNST that regulate these
projections represent important goals for future research.
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In general, the role for CRF and NE in stress-induced reinstatement behaviors, as

demonstrated in the present study, extends to other classes of abused drugs. Antagonism
of CRF receptors prevents stress-induced reinstatement following alcohol (Le et al 2000),
heroin(Shaham et al 1997) , and nicotine (Bruijnzeel et al 2009, Zislis et al 2007)SA, as
does suppression of noradrenergic neurotransmission using alpha-2 AR agonist drugs(Le
et al 2005, Shaham et al 2000, Zislis et al 2007). However, subtle differences in the
mechanisms underlying stress- induced reinstatement appear to exist. For example, the
alpha-1 AR antagonist, prazosin, blocks stress-induced reinstatement (Le et al
2011),while the highly selective alpha-2 AR antagonist, RS-79948, fails to evoke
reinstatement following alcohol SA in rats(Dzung Le et al 2009). Thus, application of the
current findings to other drugs of abuse will require further investigation.
There is some evidence that suggests that targeting ARs in human cocaine addicts
may be an effective treatment strategy. In humans, alpha 2-AR agonists, which
functionally antagonize noradrenergic neurotransmission, reduce stress-induced (Jobes et
al 2011)and cue-induced(Fox et al 2012) cocaine craving. The effectiveness of beta
blockers in cocaine users classified as dependent has also been examined(Kampman et al
2001). It is noteworthy that, while the beta-blocker propranolol did not universally
improve treatment outcome measures, positive responses were observed in subjects who
displayed more severe cocaine withdrawal symptoms. Considering that such symptoms
are largely stress-related, we view these findings as supportive of a role for beta-ARs in
stress-induced relapse.
Similar to the BNST, the amygdala is a region known to be involved in both
reward and stress. The amygdala is comprised of a number of subnuclei that are highly
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interconnected with regions involved in stress-related responses such as the PVN and
BNST, as well those involved in reward-related processes, such as the NAc, the PFC, and
the VTA(McDonald 1991a, McDonald 1991b, Rodaros et al 2007, Silverman et al 1981).
As is the case for the BNST, it has been reported that the amygdala is essential for stressinduced reinstatement (McFarland et al. 2004) and that the CeA sends CRF-positive
projections to the VTA (Rodaros et al. 2007). Moreover, beta 2-AR signaling in the CeA
(Leri et al. 2002) and a projection from the CeA that regulates CRF release in the BNST
(Erb et al. 2001) have been reported to be necessary for stress-induced cocaine seeking
following SA in rats, suggesting that beta 2-AR regulation of CRF neurons may occur in
the amygdala as well. Surprisingly, we found that forced swim stress did not alter CRF
mRNA levels in the amygdala. This is in contrast to a prior study demonstrating swiminduced in- creases in CRF mRNA levels in the amygdala of mice with a prior history of
cocaine(Cleck et al 2008). However, in that study, mice received greater amounts of
cocaine and the increase in CRF mRNA levels was only observed following prolonged
withdrawal (Cleck et al. 2008). Importantly, in the present study, mice were tested for
CRF mRNA responses after repeated exposure to cocaine but in the absence of the CPP
context. It is not clear how conditioning to cocaine and testing for swim effects on CRF
mRNA measured following exposure to the CPP chambers could have influenced our
results. It should also be noted that since our dissections were gross dissections of the
amygdala due to the small amount of tissue yielded from a mouse brain, we cannot
exclude the possibility that a more specific dissection of the CeA may yield different
results. In contrast to its regulatory role in anxiety, CRF actions in the CeA do not appear
to be necessary for stress-induced reinstatement following SA or CPP (Erb and Stewart
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1999; Wang et al. 2006). Our findings also suggest that, while CeA regulation of CRF
release into the BNST is necessary for stress-induced reinstatement behaviors (Erb et al.
2001), the source of CRF may consist of CRF projections from regions other than the
CeA or cells that intrinsic to the BNST and not CRF neurons originating in the CeA.
Our current findings support a hypothesis that places beta2- AR signaling
upstream from CRF actions in the BNST in the neural pathway that mediates stressinduced reinstatement of cocaine-conditioned reward. While there are long-established
roles for AR and CRF individually in stress-induced reinstatement, it has become clear
that an interaction between beta2-AR signaling and CRF producing neurons, possibly in
the BNST is likely critical. For this reason, further investigation of the precise
mechanisms through which beta2-ARs contribute to the stress-induced regulation of CRF
neurons in the BNST is needed. Finally, our findings also suggest that medications
targeting beta2-ARs hold some promise for potential treatment aimed at minimizing the
contribution of stress to relapse.
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Chapter III
Stress-induced cocaine seeking requires a beta-2 adrenergic receptor-regulated
pathway from the ventral bed nucleus of the stria terminalis that regulates CRF
actions in the ventral tegmental area
Abstract
The ventral bed nucleus of the stria terminalis (vBNST) has been implicated in

stress-induced cocaine use. Here we demonstrate that, in the vBNST, corticotropin
releasing factor (CRF) is expressed in neurons that innervate the ventral tegmental area
(VTA), a site where the CRF receptor antagonist antalarmin prevents the reinstatement of
cocaine seeking by a stressor, intermittent footshock, following intravenous selfadministration in rats. The vBNST receives dense noradrenergic innervation and
expresses β adrenergic receptors (ARs). Footshock-induced reinstatement was prevented
by bilateral intra-vBNST injection of the β-2 AR antagonist, ICI-118,551, but not the β-1
AR antagonist, betaxolol. Moreover, bilateral intra-vBNST injection of the β-2 AR
agonist, clenbuterol, but not the β-1 agonist, dobutamine, reinstated cocaine seeking,
suggesting that activation of vBNST β-2 AR is both necessary for stress-induced
reinstatement and sufficient to induce cocaine seeking. The contribution of a β-2 ARregulated vBNST-to-VTA pathway that releases CRF was investigated using a
disconnection approach. Injection of ICI-118,551 into the vBNST in one hemisphere and
antalarmin into the VTA of the contralateral hemisphere prevented footshock-induced
reinstatement, whereas ipsilateral manipulations failed to attenuate stress-induced cocaine
seeking, suggesting that β-2 AR regulate vBNST efferents that release CRF into the
VTA, activating CRF receptors, and promoting cocaine use. Last, reinstatement by

	
  

83	
  

clenbuterol delivered bilaterally into the vBNST was prevented by bilateral vBNST
pretreatment with antalarmin, indicating that β-2 AR-mediated actions in the vBNST also
require local CRF receptor activation. Understanding the processes through which stress
induces cocaine seeking should guide the development of new treatments for addiction.
Introduction
In many cocaine addicts, relapse to drug use is triggered by the onset of craving in
response to episodes of stress. Due to the uncontrollable and often unavoidable nature of
stress, its contribution to relapse is particularly problematic when managing cocaine
addiction.
Using rodent reinstatement models, preclinical researchers have begun to define
the neurocircuitry that underlies stress-induced relapse. One prominent pathway that has
been implicated consists of a dopaminergic projection from the ventral tegmental area
(VTA) to the medial prefrontal cortex, where dopamine D1 receptor activation increases
the activity of a glutamatergic pathway to the nucleus accumbens that is critical for
cocaine seeking (Capriles et al 2003, McFarland et al 2004). During stress, the VTA is
regulated by the neuropeptide corticotropin releasing factor (CRF; (Wang et al 2005), in
part via CRF-R1 receptors (Blacktop et al 2011), to evoke cocaine seeking.
The VTA receives inputs from brain regions involved in integration of the stress
response, including those comprising the “extended amygdala”: the nucleus accumbens
shell, central amygdala, and bed nucleus of the stria terminalis (BNST;(Phillipson 1979).
Among these structures, the BNST, which serves as an interface between stress and
motivational/reward systems, appears to be particularly important for stress-induced

	
  

84	
  

cocaine seeking, in that its inactivation prevents stress-induced reinstatement in rodents
((Briand et al 2010, McFarland et al 2004). A subgroup of neurons projecting from the
BNST to the VTA express CRF (Rodaros et al 2007)and therefore may be responsible for
stress-induced increases in VTA CRF and CRF-dependent cocaine seeking. However,
CRF projections to the VTA from the ventral BNST (vBNST), the subregion implicated
in stress-induced cocaine seeking (McFarland et al., 2004), have not been described. The
BNST, particularly the vBNST, receives dense noradrenergic innervation (Phelix et al
1992) and expresses β adrenergic receptors (ARs; (Cecchi et al 2007)), which have been
reported to regulate efferent projections (Nobis et al 2011), including those that innervate
the VTA (Dumont & Williams 2004, Silberman et al 2013). Both stress-induced
reinstatement (Erb et al 2001, Erb & Stewart 1999) and noradrenergic regulation of
BNST efferents to the VTA (Silberman et al., 2013) require BNST CRF receptor
activation, suggesting that norepinephrine in the BNST promotes local CRF release,
thereby activating a second CRF-releasing pathway to the VTA.
Considering the important role for noradrenergic signaling in stress-induced
reinstatement in rodents (Erb et al 2000, Mantsch et al 2010)and craving in human
cocaine-dependent populations (Jobes et al 2011), AR regulation of a vBNST-to-VTA
CRF-releasing pathway is a likely mechanism through which stress promotes cocaine
seeking. We have found that β-2 AR activation is both necessary and sufficient for stressinduced reinstatement in mouse models (Vranjkovic et al 2012). Moreover, it has been
demonstrated that a mixture of β-AR antagonists, administered into the vBNST, prevents
stress-induced reinstatement(Leri et al 2002). In this study, we demonstrate direct CRF
neuronal projections from the vBNST to the VTA and examine the relationship between
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stress-induced β-2 AR activation in the vBNST and CRF-R1 receptor-dependent actions
in the VTA that lead to cocaine seeking.
Materials and Methods:

Subjects
Male Sprague Dawley rats (Harlan Laboratories) ∼90-d-old at the time of delivery (325
g) were used. Rats were housed singly in a temperature- and humidity-controlled,
Association for Assessment and Accreditation of Laboratory Animal Care accredited
facility under a 12 h light/dark cycle (lights off at 07:00 h) and had access to food and
water at all times, except during the food training periods during which they were kept at
90% of their free-feeding body weight. All procedures were performed in accordance
with the NIH Guide for the Care and Use of Laboratory Animals.
Drugs
Cocaine HCl was acquired from the National Institute on Drug Abuse through its drug
supply program. The selective β-1 AR antagonist betaxolol HCl, the selective β-2 AR
antagonist (-)-(isopropylamino)-1-[(7-methyl-4-indanyl)oxy]butan-2-ol (ICI-118,551)
HCl, the selective β-1 AR agonist dobutamine HCl, the selective β-2 AR agonist
clenbuterol, and the axonal transport inhibitor colchicine HCl were purchased from
Sigma-Aldrich. Cocaine was dissolved in bacteriostatic saline. Other drugs were
dissolved in sterile water. Colchicine was delivered intra cerebroventricularly in a
volume of 2 µl over a 5 min period. Intracranial drug injections occurred in a volume of
0.2 µl/side over a 1 min period.
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Catheter and cannula implantation
For intravenous self-administration (SA) and reinstatement testing, rats were implanted
with catheters into the jugular vein under ketamine HCl (100 mg/kg i.p.) and xylazine (2
mg/kg, i.p.) anesthesia, as described previously (Blacktop et al 2011), along with 11 mm
26-gauge guide cannulae aimed at the vBNST (0.6 mm posterior to bregma; 3.5 mm
lateral to midline; 6.9 mm ventral to the skull surface at a 15° angle), and/or the VTA
(5.6 mm posterior to bregma; 2.2 mm lateral to midline; 6.9 ventral to the skull surface at
a 12° angle) for intracranial injections. The tips of the guide cannulae were aimed 0.5 mm
above the target injection sites.
Cocaine self-administration
Following a 2 week recovery from surgery, rats were trained to self-administer cocaine
(1.0 mg/kg/inf, i.v.) by pressing a response lever under an FR1 schedule in a computerinterfaced operant conditioning chamber (Med Associates) during daily 2 h sessions.
During these sessions, the active (front) lever was extended into the chamber and the
corresponding stimulus light was illuminated. Pressing this lever resulted in a cocaine
infusion (200 µl over 5 s), followed by a 25 s time-out period during which the stimulus
light was extinguished but the lever remained extended. Responding on a second, inactive
lever was recorded but had no programmed consequences. Once stable SA under the FR1
schedule was observed (>15 infusions), the requirements for SA were gradually increased
until rats displayed stable responding under ta FR4 schedule (<10% variation from the
mean over 3 sessions), at which time daily access was increased to 6 h. Rat were
permitted to self-administer daily under these conditions for 14 consecutive days after
which they underwent extinction training.
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Extinction training and reinstatement testing
Extinction sessions were identical to SA conditions except that (1) the sessions were 2 h
in duration and (2) the cocaine solution was replaced with saline. Daily extinction
training sessions were conducted until rats displayed <15 cocaine lever responses for
consecutive sessions (range, 6–10 d) at which time rats were tested for reinstatement.
Reinstatement sessions were identical to extinction sessions except that they were
preceded by exposure to shock and/or intracranial drug delivery. Shocks (0.5 mA, 0.5 s
duration) were delivered on average every 40 s (range, 10–70 s) through the grid floors of
the chambers over a 15 min period that immediately preceded the 2 h reinstatement test
session (Blacktop et al 2011, Graf et al 2011). During the shock session, the levers were
retracted and the stimulus lights were off, but a houselight in the chamber was
illuminated. Reinstatement was defined as an increase in cocaine lever responding
relative to the prior extinction session. When rats were tested multiple times for
reinstatement, test sessions were separated by additional extinction session and were
required to display <15 cocaine lever responses before retesting.
Effects on food-reinforced lever pressing
In most cases where significant reductions in shock-induced reinstatement were
observed, the effects of the same manipulations on lever pressing reinforced by food
delivery (45 mg sucrose-sweetened food pellets; BioServ) were also examined in separate
rats to confirm that reduced reinstatement was not attributable to motor impairment that
interfered with the ability of the rats to press the lever. Following surgical intracranial
implantation of guide cannulae and recovery, these rats were maintained at 90% of their
free-feeding body weights and trained to self-administer food pellets by pressing a lever
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under a FR4 schedule. Effects on food-reinforced responding were tested after stable
patterns of lever pressing were observed (<10% variation from the mean over 3 sessions).
Histological confirmation of injection sites
The accuracy of cannula implantation was confirmed postmortem in each rat after cardiac
perfusion with 60 ml 0.15% NaCl followed by 60 ml of 2.5% buffered neutral formalin
under sodium pentobarbital anesthesia (55 mg/kg). Brains were removed and stored in
2.5% buffered formalin before vibratome sectioning (40 µm), slide mounting, and
staining with cresyl violet for examination using a light microscope. Rats with injection
sites outside of the VTA or the vBNST were excluded from data analysis.
Experiment 1: effects of intra-BNST β AR antagonists on stress-induced reinstatement
We initially examined the role of β-1 and β-2 AR activation in the vBNST in stressinduced reinstatement by testing rats for shock-induced reinstatement following bilateral
intra-vBNST injection of the β-1 AR selective antagonist, betaxolol (1 nmol/307 ng per
side), the β-2 AR antagonist selective antagonist, ICI-118,551 (1 nmol/277 ng per side)
or vehicle (sterile water). Concentrations were selected based on selectivity for human β
receptor subtypes (Baker 2005). Moreover, the antagonist concentrations were previously
used to selectively target brain β ARs(Cecchi et al 2007, Delfs et al 2000, LaLumiere et
al 2010, Leri et al 2002). Rats received vBNST injections 15 min before shock. Nine total
rats were used for this experiment. Five rats were tested for shock-induced reinstatement
following pretreatment with vehicle, betaxolol, and ICI-118,551; two rats were tested
following only vehicle and betaxolol; and two rats were tested for following only vehicle
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and ICI-118,551. An additional group of rats (n = 6) was tested for the effects of ICI118,551 and vehicle on food-reinforced lever pressing.
Experiment 2: reinstatement by intra-vBNST injection of β-AR agonists
To further examine the role of vBNST β-1 and β-2 ARs in stress-induced cocaine
seeking, a separate group of rats was tested for the ability of bilateral intra-vBNST
injection of the β-1 AR selective agonist dobutamine (1 nmol/ 301 ng per side) or the β-2
AR selective agonist clenbuterol (36 pmol/10 ng per side) to induce reinstatement.
Concentrations were again chosen based on selectivity for human β receptor subtypes
(Baker 2010). Further, the clenbuterol dose has been previously used to selectively target
brain β-2 ARs(LaLumiere et al 2010, Roozendaal et al 2008). Ten total rats were used for
this experiment. Seven rats were tested for reinstatement in response to dobutamine,
clenbuterol, and vehicle. An additional three rats were tested only with clenbuterol and
vehicle.
Experiment 3: effect of VTA CRF receptor antagonism on stress-induced
reinstatement
To confirm our earlier finding that shock-induced reinstatement requires CRF receptor
activation in the VTA (Blacktop et al., 2011), we also tested rats for the effects of intraVTA pretreatment with the CRF-R1 receptor antagonist, antalarmin ((Webster et al
1996); 1.32 nmol/500 ng/side). We (Blacktop et al., 2011) and others (Lowery-Gionta et
al 2012) have used this antalarmin dose to investigate CRF-R1 receptor-dependent
contributions to behavior. Six rats were used for this experiment. Each of them was tested
for the effects of both antalarmin and vehicle on shock-induced reinstatement.
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Experiment 4: identification of CRF-positive neurons in the vBNST that project to the
VTA
Retrograde tracing using CTb.
We used cholera toxin B subunit (CTb) as a retrograde tracer to identify neurons in the
vBNST with direct efferent projections to the VTA. Rats were anesthetized with
ketamine and xylazine and placed in a stereotaxic frame. Heat-sterilized Hamilton
syringes were used to pressure inject 0.2 µl biotinylated CTb (List Biological
Laboratories) unilaterally into the VTA over a 10 min period (posterior to bregma −5.6
mm, lateral −2.6 mm, ventral −8.6 mm; Paxinos and Watson, 2006). Syringes were left in
place for 20 min after injections and slowly removed from the brain over a 10 min period.
Colchicine treatment.
Because it has been reported that inhibition of axonal transport using pretreatment with
the microtubule polymerization inhibitor colchicine is necessary for detection of CRFimmunoreactive cell bodies within the vBNST (Sakanaka et al 1986) anesthetized rats
received injections of colchicine (1.25 µmol/500 µg in 2 µl) into a lateral ventricle
(posterior to bregma −1.0 mm, lateral 1.4 mm, ventral −5.3 mm) 10 d after injection with
CTb, thus avoiding interference with retrograde transport of CTb.
Tissue collection and preparation.
Twenty-four hours after the colchicine injections, rats were anesthetized with sodium
pentobarbital (55 mg/kg, i.p.) and perfused transcardially with 30 ml of 0.9% NaCl,
followed by 60 ml of cold (4°C) 4% paraformaldehyde in 0.1 M phosphate buffer, pH
7.0. Brains were quickly removed and immersed in fixative for 24 h at 4°C. Brains were
washed twice in 0.1 Msodium phosphate buffer for 12 h each, after which they were
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cryoprotected in 30% sucrose in 0.1 M-phosphate buffer for 3 d at 4°C. Brains were
rapidly frozen and serial coronal sections (30 µm) were cut on a cryostat. Sections were
stored at −20°C until immunofluorescence procedures were conducted.
Fluorescence immunocytochemistry.
Immunofluorescence for CTb and CRF was conducted on free-floating 30 µm sections.
Sections were rinsed three times for 10 min in 0.05 M KPBS and once for 10 min in
0.1 M glycine in 0.05 KPBS, followed by blocking in 3% normal donkey serum in 0.4%
Triton KPBS for 20 min. Sections were then incubated for 48 h at 4°C with rabbit antiCRF (supplied by Dr Wylie Vale, The Salk Institute) diluted 1:8000 in 0.1% Triton
KPBS with 3% normal donkey serum. Sections were then rinsed 3× 10 min in
0.05 M KPBS, followed by incubation with an AlexaFluor 488-conjugated donkey antirabbit secondary antibody (Catalog #A11008; 1:500; Life Technologies) in 0.05 M KPBS
for 2 h at room temperature, and rinsed three times for 10 min in 0.05 M KPBS. For
detection of biotinylated CTb, sections were incubated for 24 h at 4°C in goat anti-biotin
polyclonal antibody (Catalog # SP 3000; Vector Laboratories) diluted 1:30,000 in 0.1%
Triton KPBS and 3% normal donkey serum. After rinsing, sections were incubated 2 h
with AlexaFluor 598-conjugated donkey anti-goat IgG (Catalog #A-110581; 1:500; Life
Technologies) and washed three times for 10 min in 0.05 M KPBS. Sections were briefly
rinsed in distilled water and mounted onto gel-coated SuperFrost Plus slides and
coverslipped using Vectashield mounting medium with DAPI (Catalog #H-1200; Vector
Laboratories). Photomicrographs were acquired using a Retiga 2000R digital camera
(QImaging) on a Nikon 80i microscope using NIS Elements software (Nikon
Instruments).
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Experiment 5: effects of vBNST and VTA disconnection on stress-induced cocaine
seeking
A disconnection approach was used to determine whether a β 2-AR activated,
CRF-dependent pathway between the vBNST and the VTA is required for stress-induced
cocaine seeking. At the time of catheterization, separate groups of rats were implanted
with two cannulae aimed unilaterally at the vBNST and VTA in either the contralateral or
the ipsilateral hemisphere(s) of the brain. The effect of pathway disconnection was
examined in six rats by injection of the β-2 AR antagonist ICI 118,551 (1 nmol/277 ng)
into the vBNST in one hemisphere and the CRF-R1 receptor antagonist antalarmin (1.32
nmol/500 ng) into the VTA of the other before testing for shock-induced reinstatement.
For comparison, the same rats were tested for shock-induced reinstatement following
injection of vehicle into each region. As a control to ensure that reductions in
reinstatement were attributable to disconnection, a second groups of rats (n = 7) received
a unilateral injection of ICI 118,551 into the vBNST in one hemisphere and a unilateral
injection of antalarmin into the VTA in the same hemisphere before testing for shockinduced reinstatement. These rats were also tested for the effects of ipsilateral vehicle
injections. For this experiment, the hemispheres into which cannulae were implanted
were randomized across rats in each group such that in the contralateral treatment group,
half of the rats received ICI 118,551 injections into the left vBNST and antalarmin
injections into the right VTA, whereas the other half received ICI 118,551 injections into
the right vBNST and antalarmin injections into the left VTA. Likewise, half of the rats in
the ipsilateral treatment group received drug injections into sites in the right hemisphere,
whereas the remaining rats received injections into sites in the left hemisphere. To
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examine the potential contribution of nonspecific behavioral suppression to the effects on
reinstatement, an addition group of rats (n = 6) was tested for the effects of contralateral
drug and vehicle injections on food-reinforced lever pressing.

Experiment 6: role of vBNST CRF-R1 receptors in cocaine seeking induced by
vBNST β-2 AR activation
It has been reported that CRF-R1 antagonist injections directly into the vBNST
can also block stress-induced cocaine seeking (Erb et al 2001, Erb & Stewart 1999). To
determine whether β-2 ARs in the vBNST regulate efferent pathways to the VTA to
produce cocaine seeking via a mechanism that also involves local CRF actions, we tested
for the ability of intra-BNST pretreatment with antalarmin to block reinstatement in
response to local delivery of the beta2 AR agonist clenbuterol. Reinstatement in response
to bilateral intra-BNST delivery of clenbuterol (36 pmol/10 ng per side) was examined
following bilateral intra-BNST pretreatment with antalarmin (1.32 nmol/500 ng/side) or
vehicle (10 min pretreatment) in counterbalanced sequence in six rats. To test the
hypothesis that CRF-R1 receptor activation in the vBNST is downstream from β-2 AR
activation in the sequence of events that mediate stress-induced cocaine seeking, a
separate group of six rats was tested for reinstatement in response to bilateral intravBNST CRF (63 pmol/300 ng/side; Erb and Stewart, 1999) following bilateral intravBNST pretreatment with the selective β-2 AR antagonist, ICI-118,551 (1 nmol/277 ng
per side) or vehicle (10 min pretreatment).
Statistical analyses
Statistical analyses were conducted using Predictive Analytics SoftWare statistics
software (SPSS). Statistical significance was determined using ANOVA followed, when
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appropriate, by further analyses of main effects using ANOVA and/or post hoc testing
using Bonferroni-corrected t tests.
Results
Cocaine SA and extinction in rats used for the various reinstatement experiments are
shown in Table 3.1 and did not differ across experiments.

	
  

Table 1: Cocaine SA and extinction. Data represent cocaine SA (infusions/6-h
session ± S.E) on days 1 and 14 of SA testing and cocaine lever responding
(responses/2-h session ± S.E.) on the first day of extinction training (First Ext)
and the last day of extinction training prior to reinstatement testing (Last Ext) in
rats from each of the reinstatement experiments

In general, each group of rats displayed escalation, as previously demonstrated
under these conditions, and showed reduced cocaine seeking across extinction testing,
which consisted of an average of 8.24 (±0.28) sessions before extinction criteria were
met. The injection sites for rats used for each experiment are depicted in Figure 3.1. A
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total of 11 rats were excluded from analyses due to cannula misplacement. In all cases,
drug effects were not observed with inaccurate injection.

	
  

Figure3.1: Intracranial injection sites. Representative atlas diagrams (Paxinos
and Watson, 2006) of injection sites within the vBNST and the VTA. A, Rats
from Experiments 1, 2 and 5; vBNST hits are depicted as circles and misses as
triangles. B, Food control rats for Experiment 1; hits are depicted as squares and
misses as triangles. C, Rats from Experiment 3; VTA hits are depicted as circles
and misses as triangles. D, Rats used for the Experiment 4; contralateral hits are
depicted as circles, ipsilateral hits are depicted as squares and food-controls are
depicted as triangles.

Experiment 1: effects of intra-BNST β AR antagonists on stress-induced
reinstatement

The effect of bilateral intra-vBNST injection of the β-1 AR antagonist betaxolol
(1 nmol/307 ng per side) on shock-induced reinstatement was examined in seven rats and
is shown in Figure 3.2A. Two-way repeated measures (reinstatement × betaxolol)
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ANOVA showed a significant overall reinstatement effect (F(1,6) = 65.437; p < 0.001) but
no main effect of betaxolol pretreatment or interaction between betaxolol treatment and
reinstatement. Shock produced robust reinstatement regardless of whether rats were
pretreated with betaxolol or vehicle. The effects of bilateral intra-vBNST injection of the
β-2 AR antagonist ICI-118,551 (1 nmol/277 ng per side) pretreatment on shock-induced
reinstatement were also examined in seven rats and are shown in Figure 3.2B. Two-way
repeated-measures ANOVA showed a significant reinstatement effect (F(1,6) =
52.475; p < 0.001) and a significant main effect of ICI-118,551 pretreatment (F(1,6) =
10.224; p < 0.05), as well as a significant reinstatement × ICI-118,551 pretreatment
interaction (F(1,6) = 20.213; p < 0.01). Shock reinstated cocaine seeking in vehicle but not
ICI-118,551 pretreated rats (p < 0.01 vs extinction; Ext) and reinstatement was reduced in
ICI-118,551 pretreated versus vehicle pretreated rats (p < 0.01). To assess potential motor
impairment resulting from intra-vBNST ICI-118,551 delivery that may have
nonspecifically interfered with reinstatement responding, a separate group of six rats was
tested for effects of intra-vBNST ICI-118,551 on sucrose pellet-reinforced responding.
ICI-118,551 pretreatment failed to alter lever pressing under these conditions (Fig. 3.2C).
In three of the rats that were tested, guide cannulae were misplaced such that they
received injections into areas that comprise the dorsal BNST. Notably, in these rats,
shock-induced reinstatement was observed in both vehicle-pretreated (Ext: 8.67 ± 1.76
responses vs shock: 32.33 ± 2.03) and ICI-118,551-pretreated (Ext: 12.67 ± 1.76
responses vs shock: 28.33 ± 4.81) rats. Effects of shock were specific to the previously
active lever as shock failed to increase responding on a previously inactive lever in
vehicle-pretreated rats (Ext: 1.37 ± 0.51 responses vs shock: 1.02 ± 0.44). Neither
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betaxolol nor ICI-118,551 affected inactive lever responding during reinstatement testing
(vehicle: 1.02 ± 0.44 responses; betaxolol: 1.00 ± 0.33; ICI-118,551: 0.75 ± 0.31).

	
  

Figure3.2: Footshock-induced reinstatement of cocaine seeking is blocked
by intra-vBNST injection of the β-2 AR antagonist, ICI-118,551, but not the
β-1 AR antagonist, betaxolol. Data represent the effects of bilateral intravBNST injections of betaxolol (1 nmol/307 ng per side; A; n = 7) or ICI-118,551
(1 nmol/277 ng per side; B; n = 7) or vehicle on reinstatement (responses/2 h
session ± SE) by electric footshock. Significant reinstatement was observed
following intra-vBNST pretreatment with vehicle or betaxolol (*p < 0.05 vs
Ext), but not ICI-118,551. Likewise, responding following ICI-118,551, but not
#
betaxolol, was significantly reduced compared with vehicle pretreatment ( p <
0.05 vs vehicle). By contrast, intra-vBNST ICI-118,551 failed to altered foodreinforced lever pressing (C; n = 6).

Experiment 2: reinstatement by intra-vBNST injection of β-AR agonists
Following SA and extinction, bilateral intra-vBNST delivery of clenbuterol (36
pmol/10 ng per side) but not dobutamine (1 nmol/ 301 ng per side), reinstated cocaine
seeking (Fig. 3.3). A paired t test showed that, compared with vehicle, pretreatment with
clenbuterol significantly increased previously active lever pressing (t(9) = 11.156; p <
0.001). Neither dobutamine (0.88 ± 0.22 responses) nor clenbuterol (0.83 ± 0.55
responses) increased responding on a previously inactive lever relative to vehicle
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pretreatment (0.63 ± 0.18) responses. Guide cannulae were misplaced in three rats such
that they received injections into sites within the dorsal BNST. In contrast to rats that
received intra-vBNST injections, neither clenbuterol (Ext: 8.67 ± 1.99 vs clenbuterol:
5.33 ± 5.95) nor dobutamine (Ext: 10.00 ± 2.07 vs dobutamine: 9.33 ± 7.60) produced
reinstatement in these rats.

	
  
Figure3.3: Reinstatement of extinguished cocaine seeking by
bilateral injection of the β-2 AR selective agonist, clenbuterol, but
not the β-1 AR selective agonist, dobutamine, into the vBNST. Data
represent responding on the cocaine lever (responses/2 h session ± SE;
active) or a previously inactive lever. Intra-vBNST clenbuterol (36
pmol/10 ng per side; n = 10), but not dobutamine (1 nmol/301 ng per
side; n = 7) reinstated extinguished cocaine seeking (*p < 0.05 vs
vehicle). Neither dobutamine nor clenbuterol increased “inactive” lever
responding
Experiment 3: effect of VTA CRF receptor antagonism on stress-induced
reinstatement

As previously reported (Blacktop et al., 2011), bilateral injection of the CRF-R1 receptor
selective antagonist, antalarmin (1.32 nmol/500 ng per side) into the VTA prevented
reinstatement. The effect of bilateral intra-VTA antalarmin pretreatment on shockinduced reinstatement was examined in six rats as shown in Figure 3.4. Two-way
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repeated-measures ANOVA showed a significant reinstatement effect (F(1,5) =
12.971; p < 0.05) and a significant main effect of antalarmin pretreatment (F(1,5) =
9.175; p < 0.05), as well as a significant reinstatement × antalarmin pretreatment
interaction (F(1,5) = 8.461; p < 0.05). As previously reported, shock reinstated cocaine
seeking in vehicle but not antalarmin pretreated rats (p < 0.05 vs Ext) and reinstatement
was reduced in antalarmin pretreated versus vehicle-pretreated rats (p < 0.05). As we
have already demonstrated that intra-VTA antalarmin delivery does not alter foodreinforced lever pressing (Blacktop et al., 2011), we did not test for these effects in this
study. In two of the rats that were tested, guide cannulae were misplaced such that they
received injections outside of the VTA. Notably, in these rats, shock-induced
reinstatement was observed in both vehicle-pretreated (Ext: 13 and 12 responses vs
shock: 35 and 29 responses) and antalarmin-pretreated (Ext: 5 and 12 responses vs shock:
39 and 41 responses) rats.

	
  

Figure3.4: Bilateral injection of the
CRF receptor antagonist,
antalarmin, into the VTA prevents
shock-induced reinstatement of
cocaine seeking. Data represent the
effects of bilateral intra-vBNST
delivery of antalarmin (1.32 nmol/500
ng per side; Fig. 2A; n = 6) or vehicle
on reinstatement (responses/2 h session
± SE) following electric footshock.
Significant reinstatement was observed
after intra-vBNST pretreatment with
vehicle (*p < 0.05 vs Ext) but not
antalarmin. Likewise, responding
following antalarmin was significantly
reduced compared with vehicle
#
pretreatment ( p < 0.05).
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Effects of shock were specific to the previously active lever as shock failed to
increase responding on a previously inactive lever in vehicle-pretreated rats (Ext: 1.12 ±
0.29 responses vs shock: 0.89 ± 0.65). Antalarmin did not affect inactive lever
responding during reinstatement testing (vehicle: 0.89 ± 0.65 responses; antalarmin: 0.81
± 0.52).

Experiment 4: identification of CRF-positive neurons in the vBNST that project to
the VTA
To determine whether CRF-positive neurons within the vBNST project to the
VTA, we injected CTb unilaterally into the VTA and looked for the presence of
CTb/CRF double-labeled perikarya in the vBNST in four rats. Representative
photomicrographs from one rat are shown in Figure 5. CTb-immunoreactive (CTb-ir)
perikarya were observed in the vBNST ipsilateral, to the VTA injection site (average of
45 CTb-ir perikarya/ipsilateral vBNST). By contrast, and consistent with a previous
report (Dong & Swanson 2006)CTb immunoreactivity in the vBNST contralateral to the
VTA injection site was minimal (average of four immunoreactive cells/contralateral
vBNST). CRF-like-immunoreactive (CRF-ir) perikarya and fibers were observed in the
vBNST (Fig. 3.5). Under higher-magnification, three cell types were observed in the
vBNST: CTb-ir/CRF-immunonegative, CTB-ir/CRF-ir, and CTb-immunonegative/CRFir cells. Notably, most CRF-positive cells in the ipsilateral vBNST were also CTbimmunoreactive (∼80%). By contrast, dual-labeled CRF- and CTb-positive cells were not
observed in the contralateral vBNST.
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Figure3.5: CRF neurons within the vBNST project to the VTA. A, Line drawing
(adapted from Paxinos and Watson, 2006) of a coronal section containing the area of
the VTA targeted for CTb microinjections and depicted in B. B, Representative
photomicrograph depicting the VTA in brightfield, and CTb immunofluorescence in
red. C, Line drawing of a coronal section containing the vBNST used for
immunostaining of CRF and CTb. D–G, Representative photomicrographs depicting
immunostaining for CRF (green) and CTb (red) in the BNST ipsilateral to the VTA
injection site. Rectangle in D indicates area shown at higher-magnification in E. E,
White arrowheads indicate CRF-ir/CTb-ir (VTA-projecting) neurons; white arrows
indicate CTb-ir/CRF-immunonegative neurons; black arrowhead indicates a CRFir/CTb-immunonegative cell. Rectangles in E represent areas shown at highermagnification in indicated panels. F, CRF-ir/CTb-ir neurons in vBNST. G, CRFpositive/CTb-immunonegative cell in BnST. Scale bars: B, D, 500 µm; E, 100 µm; F,
G, 33 µm. ac, Anterior commissure; Aq, cerebral aqueduct; f, fornix; fr, fasciculus
retroflexus; Fu, bed nucleus of the stria terminalis, fusiform part; PAG,
periaqueductal gray; PBP, parabrachial pigmented nucleus of the VTA; SN,
substantia nigra; STLV, bed nucleus of the stria terminalis, lateral division, ventral
part; STMV, bed nucleus of the stria terminalis, medial division, ventral part.
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Experiment 5: effects of vBNST and VTA disconnection on stress-induced cocaine
seeking

To determine the role of a β-2 AR regulated pathway originating in the vBNST
that releases CRF into the VTA in stress-induced cocaine seeking, we used a
disconnection approach in which we delivered ICI-118,551 (1 nmol/277 ng) into the
vBNST of one hemisphere and antalarmin (1.32 nmol/500 ng) into the contralateral VTA
(n = 6 rats). To confirm that any effect on reinstatement was attributable to pathway
disconnection, a second group of rats (n = 5) received ICI-118,551 into the vBNST of
one hemisphere and antalarmin into the ipsilateral VTA. Contralateral but not ipsilateral
antagonist delivery prevented shock-induced reinstatement (Fig. 3.6A), suggesting that,
during stress, β-2 AR in the vBNST regulate one or more pathways that release CRF into
the VTA to induce cocaine seeking. A three-way ANOVA showed a significant
interaction between reinstatement test condition (shock vs extinction; repeated measure),
antagonist pretreatment (ICI-118,551/antalarmin vs vehicle/vehicle treatment; repeated
measure), and injection site (contralateral vs ipsilateral; between-subjects; F(1,9) =
7.169; p < 0.05). Further analysis revealed a significant interaction between antagonist
treatment and shock-induced reinstatement only in rats that received contralateral
antagonist injections (F(1,5) = 25.851; p < 0.01).Post hoc testing showed that significant
shock-induced

reinstatement

was

observed

following

vBNST/VTA

vehicle

(contralaterally or ipsilaterally) and following ipsilateral intra-vBNST ICI-118,551 and
intra-VTA antalarmin pretreatments (p< 0.05 for each comparison) but not following
contralateral antagonist delivery. Furthermore, shock-induced reinstatement was
significantly reduced following contralateral antagonist injections relative to either
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vehicle pretreatment or ipsilateral antagonist delivery (p < 0.05 for each comparison). To
assess potential motor impairment resulting from the disconnection approach that may
have nonspecifically interfered with reinstatement responding, a separate group of six rats
were tested for effects on sucrose pellet-reinforced responding. Contralateral intravBNST ICI-118,551 and intra-VTA antalarmin delivery failed to alter lever pressing
under these conditions (Fig. 3.6B).

Figure	
   3.6:	
   Disconnection	
   of	
   a	
   β-‐2	
   AR-‐regulated	
   vBNST-‐to-‐VTA	
   CRF-‐
releasing	
   pathway	
   prevents	
   stress-‐induced	
   cocaine	
   seeking.	
   To	
  
determine	
   the	
   role	
   of	
   a	
   β-‐2	
   AR	
   regulated	
   pathway	
   originating	
   in	
   the	
  
vBNST	
   that	
   releases	
   CRF	
  into	
  the	
  VTA	
  in	
  stress-‐induced	
  cocaine	
  seeking,	
  
we	
   used	
   a	
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  ICI-‐118,551	
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  vBNST	
  of	
  one	
  hemisphere	
  and	
  antalarmin	
  into	
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  VTA	
  (n	
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   6	
   rats)	
   and	
   tested	
   for	
   shock-‐induced	
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   that	
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   reinstatement	
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   to	
   pathway	
   disconnection,	
   a	
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   rats	
   (n	
   =	
   5)	
   received	
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   ICI-‐118,551	
   injection	
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   and	
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   reinstatement	
   was	
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   following	
  
vBNST/VTA	
   vehicle	
   (contralaterally	
   or	
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   and	
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   intra-‐vBNST	
   ICI-‐118,551/intra-‐VTA	
   antalarmin	
  pretreatment	
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   but	
   not	
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   contralateral	
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   delivery	
   (A).	
  
Furthermore,	
   shock-‐induced	
   reinstatement	
   was	
   significantly	
   reduced	
  
following	
   contralateral	
   antagonist	
   injections	
   relative	
   to	
   either	
   vehicle	
  
#
pretreatment	
   or	
   ipsilateral	
   antagonist	
   delivery	
   ( p	
   <	
   0.05	
   for	
   each	
  
comparison).	
   By	
   contrast,	
   contralateral	
   antagonist	
   injections	
   failed	
   to	
  
altered	
  food-‐reinforced	
  lever	
  pressing	
  (B;	
  n	
  =	
  6).
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Effects of shock were specific to the previously active lever as shock failed to
increase responding on a previously inactive lever in vehicle/vehicle-pretreated rats (Ext:
0.88 ± 0.35 responses vs shock: 1.11 ± 0.27). Neither ipsilateral nor contralateral
manipulations affected inactive lever responding during reinstatement testing
(vehicle/vehicle: 1.11 ± 0.27 responses; ipsilateral: 0.97 ± 0.66; contralateral: 0.93 ±
0.66).
Experiment 6: role of vBNST CRF-R1 receptors in cocaine seeking induced by
vBNST β-2 AR activation

Because it has been reported that CRF receptors in the BNST are also required for
stress-induced cocaine seeking (Erb and Stewart, 1999; Erb et al., 2001), and because
BNST β ARs have been proposed to modulate efferent projections to the VTA via
regulation of local CRF actions (Silberman et al., 2013), we hypothesized that
reinstatement induced by vBNST β-2 AR activation requires local CRF receptor
activation. To test this hypothesis we delivered antalarmin (1.32 nmol/500 ng per side)
bilaterally into the vBNST before bilateral vBNST injection of clenbuterol (36 pmol/10
ng per side). As shown in Figure 3.7, intra-vBNST antalarmin delivery prevented intravBNST clenbuterol-induced cocaine seeking (n = 7). Two-way repeated-measures
ANOVA showed a significant reinstatement effect (F(1,6) = 25.910; p < 0.01) and a
significant main effect of antalarmin pretreatment (F(1,6) = 29.883; p < 0.01), as well as a
significant reinstatement × antalarmin pretreatment interaction (F(1,6) = 35.968; p < 0.01).
Clenbuterol reinstated cocaine seeking in vehicle but not antalarmin-pretreated rats (p <
0.01 vs Ext) and reinstatement was reduced in antalarmin- versus vehicle-pretreated rats
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(p < 0.01). By contrast, bilateral intra-vBNST pretreatment with the β-2 AR antagonist,
ICI-118,551 (1 nmol/277 ng per side) failed to attenuate reinstatement in response to
intra-vBNST CRF delivery (63 pmol/300 ng per side).

	
  
Figure3.7:
Reinstatement of cocaine seeking by intra-vBNST clenbuterol
injection requires activation of vBNST CRF-R1 receptors. Data represent the
effects of A: bilateral intra-vBNST pretreatment with antalarmin (1.32 nmol/500 ng
per side) or vehicle on reinstatement (responses/2 h session ± SE) in response to
bilateral intra-vBNST clenbuterol injection (36 pmol/10 ng per side), or B: bilateral
intra-vBNST pretreatment with ICI-118,551 (1 nmol/277 ng per side) or vehicle on
reinstatement in response to bilateral intra-vBNST CRF injection (63 pmol/300 ng
per side). Significant clenbuterol-induced reinstatement was observed in vehicle
but not antalarmin pretreated rats (*p < 0.05 vs Ext). Responding following
#
antalarmin was significantly reduced compared with vehicle pretreatment ( p <
0.05). By contrast, significant CRF-induced reinstatement was observed in both
vehicle and ICI-118,551 pretreated rats (*p < 0.05 vs Ext) and did not significantly
differ between the two pretreatment conditions.

Two-way repeated-measures ANOVA showed an overall effect of CRF (F(1,5) = 46.925)
but no overall effect of ICI-118,551 pretreatment or no CRF × ICI-118,551 interaction.
Altogether, these findings indicate that CRF receptor activation is likely downstream
from β-2 AR activation in the sequence of events responsible for stress-induced
reinstatement. Effects of intra-BNST clenbuterol (2.14 ± 0.67 responses vs 1.38 ± 0.73
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responses during extinction) and CRF (0.66 ± 0.42 vs 0.00 ± 0.00 responses during
extinction) on previously inactive lever responding were not observed. Likewise, neither
intra-BNST antalarmin (antalarmin/clenbuterol: 1.16 ± 0.16 responses) nor intra-BNST
ICI-118,551 (ICI/CRF: 2.5 ± 1.93 responses) significantly altered inactive lever pressing
during reinstatement.
Discussion
Our results extend earlier findings that the reinstatement of cocaine seeking by a
stressor, electric footshock, requires CRF actions in the VTA (Wang et al.,
2005; Blacktop et al., 2011) and vBNST β AR activation (Leri et al., 2002) by showing
that vBNST β-2 AR activation is both necessary and sufficient for stress-induced
reinstatement. Moreover, using a disconnection approach in which we block β-2 ARs in
the vBNST of one hemisphere and VTA CRF-R1 receptors in the contralateral
hemisphere, we demonstrate that vBNST β-2 ARs regulate a CRF-releasing pathway to
the VTA that is necessary for stress-induced cocaine seeking. As VTA CTb delivery
labels CRF-positive cells in the ipsilateral vBNST, it is likely that this pathway consists
(at least partly) of vBNST CRF neurons that project directly to the VTA. Consistent with
reports that CRF actions in the BNST are required for stressor-induced cocaine seeking
(Erb and Stewart, 1999; Erb et al., 2001), we demonstrate that vBNST CRF-R1 activation
is necessary for reinstatement induced by local delivery of the β-2 AR agonist,
clenbuterol, suggesting that β-2 AR-mediated activation of this BNST-to-VTA pathway
also requires local CRF receptor activation.
Findings from laboratory studies in human cocaine addicts (Jobes et al., 2011) and
preclinical experiments in rodents (Erb et al., 2000; Mantsch et al., 2010) point to a role
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for noradrenergic signaling in the stress-induced relapse to cocaine use. Specifically, our
studies in mice suggest that β-2 ARs are critical for stress-induced cocaine seeking
(Vranjkovic et al., 2012). As a target for ascending noradrenergic projections(Ricardo &
Koh 1978, Weller & Smith 1982, Woulfe et al 1990) and a key site for integration of
stress and reward networks (Flavin & Winder 2013, Stamatakis et al 2014), the BNST is
a likely location at which stress-induced increases in norepinephrine regulate drug use.
Although shock-induced increases in norepinephrine have not been reported, a variety of
distinct stressors, including immobilization(Pacak et al 1995), visceral pain(Deyama et al
2009), and exposure to a shock-conditioned stimulus(Onaka & Yagi 1998) ,fox odor
(Fendt et al 2005), or an aversive tastant (Park et al 2012), have been demonstrated to
increase noradrenergic neurotransmission in the BNST. In particular, the vBNST receives
very dense noradrenergic innervation (Egli et al 2005, Georges & Aston-Jones 2001,
Woulfe et al 1990). Moreover, delivery of a mixture of β-1 and β-2 AR antagonists into
the vBNST has been reported to prevent shock-induced reinstatement in rats (Leri et al.,
2002). Our data extend these findings by demonstrating that β-2 but not β-1 AR
activation in the vBNST is necessary for shock-induced cocaine seeking and that intravBNST injection of a β-2 AR- but not a β-1 AR-selective agonist is sufficient to reinstate.
Beta-2 ARs are expressed throughout the BNST (Cecchi et al., 2007). Whereas in
the dorsal BNST β AR activation can have either excitatory or inhibitor effects on
synaptic transmission, β AR effects in the vBNST are predominantly inhibitory (Egli et
al., 2005) and include inhibition of neurons that project directly to the VTA (Dumont and
Williams, 2004). In the dorsal BNST, β-AR regulation of neuronal activity requires CRFR1 activation (Nobis et al., 2011). Although the involvement of CRF in norepinephrine-
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dependent effects in the vBNST has not been established, our finding that local
antalarmin pretreatment blocks reinstatement by intra-vBNST clenbuterol delivery
supports a role for local CRF actions in the regulation of cocaine seeking by
norepinephrine and β-2 AR activation. Consistent with this possibility, previous studies
demonstrated that (1) noradrenergic terminals synapse on the dendrites of CRF-positive
neurons in the vBNST(Phelix et al 1994) (2) β-2 AR-mediated reinstatement requires
CRF-R1 activation(McReynolds et al 2014), and (3) the β-2 AR antagonist, ICI-118,551,
blocks stress-induced increases of BNST CRF mRNA (McReynolds et al., 2014).
Overall, the findings are consistent with reports that cocaine seeking induced by central
norepinephrine delivery is blocked by CRF receptor antagonism, whereas suppression of
noradrenergic function using the α-2 AR agonist, clonidine, does not affect reinstatement
in response to central CRF delivery(Brown et al 2009).
Notably, the magnitude of cocaine seeking in response to intra-vBNST
clenbuterol was lower than that observed following either shock or CRF. This could be
attributed to (1) secondary effects of BNST β-2 AR activation that are not engaged by
shock or CRF and offset responding, (2) unique attributes of clenbuterol itself (e.g.,
pharmacokinetics, ligand-specific receptor desensitization), or (3) the requirement for
additional stress-responsive mediators to fully engage the processes that lead to cocaine
seeking.
Our findings suggest that the vBNST influences cocaine seeking via regulation of
the VTA. Consistent with this possibility, stress-induced reinstatement in mice is
associated with activation of VTA-projecting BNST neurons (Briand et al., 2010) and a
role for a vBNST-VTA pathway in the expression of cocaine seeking has been reported
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(Sartor & Aston-Jones 2012). In light of these findings, it is surprising that vBNST βARs have been found to exert inhibitory effects on neurons that project to the VTA,
likely via stimulation of local GABA release (Dumont and Williams, 2004). Both
GABAergic and glutamatergic projections from the BNST to the VTA have been
identified (Georges & Aston-Jones 2001, Georges & Aston-Jones 2002, Jennings et al
2013, Kudo et al 2012, Sartor & Aston-Jones 2012). Moreover, CRF-positive terminals
within the VTA coexpress either the glutamatergic neuronal marker, vesicular glutamate
transporter 2, or the GABAergic neuronal marker, glutamic acid decarboxylase, and
make contacts that have morphological characteristics of either excitatory or inhibitory
synapses, suggesting that CRF can be coreleased into the VTA along with either GABA
or glutamate (Tagliaferro & Morales 2008) .Further investigation is needed to (1) confirm
the neurochemical phenotype of VTA-projecting vBNST CRF-positive neurons, (2)
clarify the mechanism through which β-2 ARs regulate these neurons and determine how
this regulation might change following cocaine exposure, and (3) examine the likelihood
that β-2 AR in the vBNST may also regulate CRF and/or CRF actions in the VTA via
parallel multisynaptic pathways. Consistent with the last possibility, BNST efferents can
influence the VTA through multisynaptic pathways that include regions, such as the
lateral habenula and rostromedial tegmental area(Dong & Swanson 2006, Kaufling et al
2009, Lammel et al 2012).
It has been found that (1) shock elevates VTA CRF levels (Wang et al., 2005), (2)
intra-VTA CRF delivery is sufficient to induce cocaine seeking (Wang et al.,
2005; Blacktop et al., 2011), and (3) VTA CRF receptor activation is required for stressinduced reinstatement (Wang et al., 2005; Blacktop et al., 2011) in rats. Our
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demonstration that intra-VTA antalarmin delivery prevents shock-induced reinstatement
is consistent with these reports. As the antalarmin dose used may also block CRF-R2
receptors, our findings are not definitive regarding which CRF receptor subtype is
involved. However, we have reported that, in rats tested under identical conditions, intraVTA delivery of a CRF-R2-selective antagonist does not prevent shock-induced
reinstatement, whereas intra-VTA injection of a CRF-R1 but not a CRF-R2-selective
agonist is sufficient to induce cocaine seeking (Blacktop et al., 2011).
CRF actions in the VTA are complex and involve both excitatory and inhibitory
effects that vary depending on the receptor and site(Beckstead et al 2009, Hahn et al
2009, Riegel & Williams 2008, Ungless et al 2003, Wanat et al 2013, Wanat et al 2008).
Likely VTA targets for CRF include mesocortical DA cells, which are activated during
stress(Deutch et al 1991). Elevated medial prefrontal cortex DA, via activation of DA
receptors, is necessary for stress-induced reinstatement (Capriles et al., 2003; McFarland
et al., 2004). We demonstrate that the mechanisms through which vBNST β-2 ARs
regulate this CRF projection to the VTA requires local CRF actions, likely at CRF-R1.
This finding is consistent with reports that (1) depolarization of BNST neurons by the
nonselective β-AR agonist, isoproterenol, is CRF-dependent (Nobis et al., 2011), (2) CRF
in the BNST depolarizes neurons that project to the VTA (Silberman et al., 2013), and (3)
stress-induced increases in CRF mRNA in the BNST in mice are β-2 AR-dependent
(McReynolds et al., 2014). Moreover it is consistent with reports that intra-BNST
antalarmin delivery prevents stress-induced cocaine seeking (Erb and Stewart, 1999; Erb
et al., 2001). Although the requirement for vBNST CRF is evident, the source of this
CRF has not been identified and could include intrinsic cell populations within the BNST
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and/or CRF-releasing projections originating in other regions (e.g., the central amygdala).
A clearer mechanistic understanding awaits determination of BNST β-2 AR receptor
localization as it relates to that of CRF and CRF-R1.
Although it is likely that the mechanisms through which stress promotes relapse
are not identical across drug classes, both CRF-R1 receptor activation(Bruijnzeel et al
2009, Deutch et al 1991, Le et al 2000, Shaham et al 1997) and central noradrenergic
signaling(Erb et al 2000, Le et al 2005, Shaham et al 2000, Yamada & Bruijnzeel 2011)
are necessary for stress-induced reinstatement of heroin-, nicotine-, and alcohol-seeking
in rats. Moreover, in the case of heroin, stress-induced drug seeking requires CRF (Wang
et al 2006) and noradrenergic (Wang et al 2001)signaling within the BNST. Notably,
similar processes in the BNST may be engaged during withdrawal from ethanol
(Francesconi et al 2009, Huang et al 2010, Silberman et al 2013)and opioids(Delfs et al
2000, Fuentealba et al 2000), suggesting that this pathway to the VTA, or parallel
pathways originating in other BNST subregions may also contribute to withdrawalrelated drug seeking.
To summarize, we report that, during stress, norepinephrine released into the
vBNST activates β-2 ARs, which via a CRF-dependent process, activate neurons that
release CRF into the VTA, thereby leading to cocaine seeking. Identification of the
processes responsible for stress-induced cocaine seeking should guide the development of
new treatment approaches aimed at managing relapse, particularly in individuals whose
use is stress-related.

	
  

113	
  

Chapter IV
Enhanced CRFR1 receptor-dependent regulation of a ventral tegmental area
to prelimbic cortex projection establishes susceptibility to stress-induced cocaine
seeking
ABSTRACT
The ability of stress to trigger cocaine seeking in humans and rodents is variable
and is determined, in part, by the amount and pattern of prior drug use. This study
examined the role of a corticotropin releasing factor- (CRF-) regulated dopaminergic
projection from the ventral tegmental area (VTA) to the prelimbic cortex in shockinduced cocaine seeking and its recruitment under self-administration conditions that
establish relapse vulnerability. Rats with a history of daily long-access (LgA; 14 x 6
hrs/day) but not short-access (ShA; 14 x 2 hrs/day) self-administration showed robust
shock-induced cocaine seeking. This was associated with a heightened shock-induced
prelimbic cortex Fos response and activation of VTA neurons that project to the
prelimbic cortex, as defined by Fos co-labeling with the retrograde tracer, cholera toxin
B.

Both shock-induced reinstatement and the prelimbic cortex Fos response were

prevented by bilateral intra-VTA injections of the CRFR1 receptor antagonist,
antalarmin.

Pharmacological disconnection of the CRF-regulated dopaminergic

projection to the prelimbic cortex by injection of antalarmin into the VTA in one
hemisphere and the D1R antagonist SCH23390 into the prelimbic cortex of the
contralateral hemisphere prevented shock-induced cocaine seeking, while antagonist
administration within the same hemisphere or disconnection of the VTA projection to
infralimbic cortex was without effect. LgA, but not ShA, cocaine self-administration
resulted in increased CRFR1 mRNA levels in the VTA as measured using in situ
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hybridization. Altogether, these findings suggest that excessive cocaine use establishes
susceptibility to stress-induced relapse by recruiting CRF regulation of a key stressorresponsive mesocortical dopaminergic pathway.
INTRODUCTION
Relapse to drug use remains a barrier to the effective treatment of cocaine addiction.
While a number of stimuli can elicit relapse, stress is a particularly problematic relapse
trigger due to its unpredictable and often unavoidable nature. Stress-induced relapse is
studied in rats using the self-administration (SA)/reinstatement approach in which the
ability of a stressor, most commonly electric footshock, to re-establish extinguished
cocaine-directed lever pressing is assessed (Mantsch et al., 2015). Studies using this
approach have begun to define the neurocircuitry and mechanisms that contribute to
stress-related relapse and have demonstrated involvement of dopamine D1 receptor
activation in the prelimbic cortex (Capriles et al 2003; McFarland et al 2004) and
corticotropin releasing factor (CRF) activation of CRFR1 receptors in the ventral
tegmental area (VTA; Blacktop et al 2011). Based on these findings, a role for a CRFregulated dopamine projection from the VTA to the prelimbic cortex in stress-induced
cocaine seeking has been proposed but has not been directly demonstrated.
The mesocortical dopamine system has long been known to be highly responsive
to stress (Thierry et al., 1976; Reinhard Jr et al 1982; Deutch et al 1985; Speciale et al
1986). Moreover, VTA dopamine cells that project to the prelimbic cortex are activated
by stressors, as measured ex vivo using Fos immunoreactivity or slice electrophysiology
in neurons labeled by retrograde tracers injected into the prelimbic cortex (Deutch et al
1991; Lammel et al 2011). Although studies examining the regulation of mesocortical
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dopamine by VTA CRF have produced mixed results (see e.g., Kalivas et al., 1987),
reports that icv CRF increases dopaminergic neurotransmission in the prefrontal cortex
(Dunn and Berridge, 1987; Lavicky and Dunn, 1993) and that CRF promotes excitation
of VTA dopamine neurons via both pre- and post-synaptic mechanisms (Ungless et al
2003; Korotkova et al 2006; Riegel and Williams 2008; Wanat et al 2008, Beckstead et al
2009; Hahn et al 2009, Williams et al 2014) suggest that stress-induced CRF release into
the VTA may underlie increases in mesocorticolimbic dopamine release. Consistent with
this possibility, Refojo et al (2011) reported that selective deletion of CRFR1 receptors in
VTA dopamine neurons significantly reduced stress-induced increases in dopamine in the
prefrontal cortex in mice.
Evidence that CRF regulation of mesocortical dopamine is responsible for stressinduced cocaine seeking is indirect. Stress-induced reinstatement is associated with
elevated extracellular CRF in the VTA (Wang et al., 2005) and extracellular dopamine in
the prelimbic cortex (McFarland et al 2004) and VTA (likely reflecting somatodendritic
release; Wang et al, 2005). Moreover, CRF receptor antagonism in the VTA prevents
both stress-induced cocaine seeking (Wang et al, 2005; Blacktop et al 2011) and
increases in VTA dopamine (Wang et al, 2005), while stress-induced cocaine seeking is
prevented by D1 receptor antagonism in the prelimbic cortex (Capriles et al 2003;
McFarland et al 2004). In this study we more directly test the hypothesis that stressinduced reinstatement requires CRF regulation of a dopaminergic pathway from the VTA
to the prelimbic cortex.
We have found that stress-induced cocaine seeking depends on the prior history of
cocaine use. Under our experimental protocol, footshock induces reinstatement in rats
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with a history of long-access (LgA; 14 x 6 hrs/day) but not short-access (ShA; 14 x 2
hrs/day) cocaine SA (Mantsch et al 2008). Moreover, cocaine seeking in response to
intra-VTA CRF delivery is also only observed following SA under LgA conditions
(Blacktop et al., 2011), suggesting that cocaine use promotes stress-induced cocaine
seeking by recruiting CRF regulation of the mesocortical pathway. Although a role for
VTA CRF-R2 receptors in stress-induced cocaine seeking has been reported (Wang et al
2005), we and others have demonstrated a role for CRFR1 receptors (Blacktop et al 2011;
Chen et al 2014). Therefore, in the present study we also test the hypothesis that stress
regulation of the mesocortical dopamine pathway is recruited following LgA SA as a
result of increased VTA CRFR1 receptor expression.
MATERIALS AND METHODS
Subjects
Adult male Sprague Dawley rats (Harlan Laboratories) ~ 90-d old at the time of
delivery (325g) were housed individually in a temperature- and humidity-controlled,
Association for Assessment and Accreditation of Laboratory Animal Care accredited
facility under a 12 h/12h dark/light cycle (lights off at 700h) and had access to food and
water at all times, except during food training periods during which they were maintained
at 90% of their free-feeding body weight. All procedures were performed in accordance
with NIH Guide for the Care and Use of Laboratory Animals.
Drugs
Cocaine HCl was acquired from the National Institute on Drug Abuse through its
Drug Supply Program. The selective dopamine D1 receptor antagonist SCH-23390 and
the CRFR1 receptor antagonist antalarmin were purchased from Sigma-Aldrich. All
drugs were dissolved in bacteriostatic saline. Intracranial drug doses were selected based

	
  

117	
  

on previously published results (Blacktop et al 2011; Capriles et al 2003; Vranjkovic et al
2014).
Self-Administration and Extinction
All rats in the study underwent cocaine or saline self-administration followed by
extinction training.

Rats self-administered cocaine/saline through indwelling jugular

catheters implanted under ketamine HCl (100mg/kg i.p.) and xylazine (2mg/kg, i.p.)
anesthesia, as described previously (Blacktop et al., 2011; Vranjkovic et al., 2014).
Following a 5-day post-surgery recovery period, rats were trained to self-administer
cocaine (0.5 mg/kg/inf, i.v.) by pressing a lever under a FR1 schedule of reinforcement in
computer-interfaced operant conditioning chambers (Med Associates) during daily 2-h
sessions. During these sessions, the active lever was extended into the chamber and the
corresponding light was illuminated. Pressing this lever resulted in activation of a pump,
which infused cocaine (200µl over 5 sec) followed by a 5-sec time-out phase during
which the stimulus light was extinguished, but the lever remained extended. Responding
during the time-out phase did not activate the pump. Responding on a second (inactive)
lever was also recorded but had no consequences. Once stable self-administration under
the FR1 schedule was observed (>15 infusions for three consecutive days), the criterion
for self-administration was gradually increased until rats displayed stable responding
under a FR4 schedule (within 10% of the 3-session mean) at which time they entered into
self-administration testing. Depending on the experiment and experimental group, the
conditions under which self-administered cocaine during the 14-day testing phase varied.
Some rats continued to have access to cocaine (0.5 mg/kg/inf) during 2-h daily sessions
(short-access; ShA rats).

Some rats were provided daily access to cocaine (0.5

mg/kg/inf) during 6-h sessions (long-access; LgA rats). Saline control rats were provided
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daily access to saline during 2-h sessions (Sal rats). Following completion of the 14-day
self-administration phase, rats underwent extinction training. During the 2-h extinction
training sessions, the cocaine solution was replaced with saline (saline control rats
continued to have access to saline).

The experimental conditions were otherwise

identical to those during self-administration. Depending on the experiment, extinction
training either continued for ten days (Experiments 1, 2, 3, and 5) or until a response
based criterion was reached (<15 active lever responses two consecutive sessions;
Experiment 4).

Following extinction training, rats were tested for shock-induced

reinstatement of cocaine seeking and/or were killed and their brains processed for
immunohistochemistry or in situ hybridization.
Shock-Induced Reinstatement
With the exception of rats in Experiment #5, all rats were tested for shockinduced reinstatement of extinguished lever pressing. The 2-hr reinstatement sessions
were identical to the extinction sessions except that they were preceded by the delivery of
intermittent mild non-noxious footshock, in some cases following intracranial drug
injections. Shocks (0.5mA, 0.5sec duration) were delivered on average every 40 seconds
(range 10- 70 sec) throughout the grid floors of the self-administration chambers over a
15 min period that immediately preceded the 2hr reinstatement test session (Blacktop et
al., 2011; Vranjkovic et al., 2014). During the shock period, the levers were retracted and
the stimulus lights were not illuminated; the levers were extended into the chamber and
the lights turned on immediately following the shock period. Reinstatement was defined
as an increase in active lever responding relative to the prior extinction session.
Statistical Analyses
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Statistical analyses were conducted using Predictive Analytics SoftWare statistics

software (SPSS, Inc.). Statistical significance was determined using ANOVA followed,
when appropriate, by further analyses of main effects using ANOVA and/or post-hoc
testing using Bonferroni-corrected t-tests.
Experiment #1: Relationship between prefrontal cortical Fos immunoreactivity and
shock-induced reinstatement of cocaine seeking.
We have previously shown that robust shock-induced reinstatement of
extinguished cocaine seeking is observed following daily long-access (LgA; 6 hrs) but
not short-access (ShA; 2 hrs) cocaine self-administration (Mantsch et al., 2008). To
examine the relationship between shock-induced cocaine seeking and activation of the
prelimbic and infralimbic regions of the prefrontal cortex, separate groups of rats
underwent 14 days of self-administration testing under ShA (14 x 0.5 mg/kg/inf cocaine;
2 hrs/day) or LgA (14 x 0.5 mg/kg/inf cocaine; 6 hrs/day) conditions or were provided
access to saline for two hours daily (14 x saline; 2 hrs/day; Sal).

Following self-

administration, rats received extinction training (2 hrs daily, as described above). As it
has been reported that many cocaine-induced neurobiological alterations that contribute
to drug seeking depend on the time period that has elapsed following self-administration
(Grimm et al., 2001; Conrad et al., 2009; Ma et al., 2014), for these experiments we
chose not to use extinction criteria for reinstatement testing/Fos determination. Rather,
all rats underwent extinction training for ten consecutive days. Following extinction, all
rats were tested for reinstatement in response to shock (ShA rats, n=8; LgA rats, n=7; Sal
rats, n=10) or under shock-free conditions (ShA rats, n=10; LgA rats, n=10; Sal rats,
n=10) and, immediately after the 2-h reinstatement session, were anesthetized with
sodium pentobarbital (55 mg/kg, i.p.) and perfused transcardially with 0.9% NaCl,
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followed by 60 ml of cold (4°C) 4% paraformaldehyde in 0.1 M phosphate buffer, pH
7.0. Brains were removed and post-fixed in paraformaldehyde over-night at 4°C. Brains
were then washed twice in 0.1M sodium phosphate buffers for 12 hrs. Afterwards, brains
were cryoprotected in 30% sucrose in 0.1 M phosphate buffer for 3 days at 4°C. Brains
were frozen and serial coronal sections (25 µm) containing the prelimbic and infralimbic
cortices (+3.24 to 2.54) were cut at 200 µm intervals on a freezing microtome and placed
in cryoprotectant. Sections were stored at -20°C until immunohistochemistru procedures
were conducted. Immunohistochemical analysis of Fos expression was performed on
free-floating sections by using an avidin-biotin peroxidase protocol (Hoffman et al.,
2008). Fos immunolocalization was visualized using the primary polyclonal rabbit antiFos antibody (sc-52, Santa Cruz Biotechnology; 1:10,000). Free-floating sections were
washed 3 times for 5 min in 0.5M KPBS and then incubated in 2% hydrogen peroxide in
0.5MKPBS containing 0.4% triton for 15 min to block endogenous peroxidase activity.
Sections were washed three more times and then incubated in 3% natural donkey serum
for one hour. Afterwards the sections were incubated in the primary antibody containing
0.4% triton X-100 for 24 hours in 4°C. Next, sections were washed again, and then
incubated for one hour in biotinalyed horse anti-rabbit IgG secondary antibody (PI1000;Vector Laboratories; 1:600). Sections were washed once again and then incubated
for one hour in ABC solution (PK-4000; Vectastain Elite ABC kit; Vector Laboratories).
After another series of washes, sections were incubated 3 times for 5min each in 0.175 M
sodium acetate (7.0 pH). Sections were treated with a nickel-enhanced diaminobenzide
method (black-nuclear reaction) (SK-4100 DAB; Vector Laboratories) and the sections
were again incubated in 0.175 M sodium acetate and then washed in KPBS. Tissue was
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then mounted on super-frost slides and dehydrated the next day. Fos immunoreactivity
was quantified using Image J software. The total numbers of Fos-positive cells within
each cortical region (i.e., the sum across regions all sections) were determined and
compared across groups.
Experiment #2: Role of VTA CRFR1 receptors in shock-induced cocaine seeking
and cortical subregion activation
Rats were implanted with jugular catheters bilateral cannula (11-mm, 22-gauge)
aimed at the caudal VTA (5.6 mm posterior to bregma; 2.2 mm lateral to midline; 6.9
ventral to skull surface at a 12° angle; Paxinos and Watson, 2006) and underwent cocaine
self-administration under LgA conditions and extinction prior to testing for reinstatement
in response to shock or under shock-free conditions. Prior to the 2-hour reinstatement
session, rats received bilateral intra-VTA injections with the CRFR1 receptor antagonist,
antalarmin (1.32 nmol/500 ng/side; n=9) or vehicle (n=8). We (Blacktop et al., 2011;
Vranjkovic et al., 2014) and others (e.g., Lowery-Gionta et al., 2012) have used this
antalarmin dose to investigate CRF-R1 receptor-dependent contributions to behavior.
Microinfusions were delivered in a volume of 0.25 µl/side over a 1-min period followed
by an additional 1-min period to allow for drug diffusion, ten minutes prior to the 15-min
shock or shock-free period. Immediately after the 2-hr session, rats were processed (as
described for Exp #1) for immunohistochemical analysis of Fos expression in the
prelimbic and infralimbic cortices. The accuracy of cannula implantation into the VTA
was confirmed post-mortem following staining of sections containing VTA with cresyl
violet for examination using a light microscope. Rats with injection sites outside of the
targeted regions were excluded from data analysis.
Experiment #3: Relationship between Fos immunoreactivity in VTA neurons that
project to the prelimbic cortex and shock-induced reinstatement of cocaine seeking.
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To determine if activation of VTA neurons that project to the prelimbic cortex is
associated with shock-induced reinstatement of extinguished cocaine seeking, rats
underwent LgA self-administration for 14 days and received bilateral injections with the
retrograde tracer cholera toxin b subunit (CTb) into the prelimbic cortex. Rats were
anesthetized with ketamine and xylazine and placed in a stereotaxic frame. Heatsterilized Hamilton syringes were used to pressure inject 0.2µl biotinylated CTb (10%;
List Biological Laboratories; #104; Campbell, CA) unilaterally into the prelimbic cortex
over a 10-min period ( at a 6 degree angle anterior to Bregma 3.2 mm; lateral 0.4 mm;
ventral 3.2 mm; Paxinos and Watson, 2006). Syringes were left in place for 20 min after
injections and slowly removed from the brain over a 10-min period.

Following

injections, rats were allowed to recover for seven days prior to undergoing daily
extinction training until the extinction criterion was reached (<15 responses for 3
consecutive sessions) at which point they were tested for cocaine seeking in response to
shock (n=6) or under shock-free conditions (n=5).

Immediately following the 2-h

reinstatement session, rats were processed (as described above) for CTb/Fos labeling of
VTA neurons using dual immunohistochemistry. Fos was visualized using a nickelenhanced DAB reaction as described above. CTb was visualized by similar methods
except for the addition of an avidin-biotin blocking step (SP-2100) prior to incubation
with the CTb primary antibody (List Biology #703; 1:8000).

After the 24-hour

incubation period, sections were washed and incubated in horse anti-goat secondary
antibody (PI-9500; Vector Laboratories; 1:1,000). Sections were washed again and
incubated for one hour in ABC solution. Sections were then washed and treated with
sodium acetate and were treated using the DAB method (brown cytoplasmic staining) for
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visualization of CTb. Sections were washed and then mounted on super-frost slides and
dehydrated the next day. Photomicrographs were acquired using a Retiga 2000R digital
camera (QImaging) on a Nikon 80i microscope using NIS Elements software (Nikon
Instruments). Fos-, CTb- and dual Fos/CTb- immunoreactive cells were identified and
counted using Image J software.

Using a similar approach, it has been previously

reported that restraint stress selectively increases Fos expression in VTA neurons that
project to the prelimbic cortex in rats (Deutch et al., 1991).
Experiment #4: Effect of pharmacological disconnection of the CRF-regulated
dopaminergic pathway from the VTA to the prelimbic cortex on shock-induced
cocaine seeking.
A disconnection approach was used to determine whether a CRFR1 receptor-activated
dopaminergic projection from the VTA to the prelimbic cortex is required for stressinduced cocaine seeking. At the time of catheterization, separate groups of rats were
implanted with two cannulae each aimed unilaterally at the VTA (at a 12 degree angle
posterior to Bregma -5.6 mm; lateral 2.2 mm; ventral -6.9 mm; Paxinos and Watson,
2006) or the prelimbic cortex (at a 6 degree angle anterior to Bregma 3.2 mm; lateral 0.4
mm; ventral 3.2 mm; Paxinos and Watson, 2006) in either the contralateral or ipsilateral
hemisphere(s) of the brain. The effect of pathway disconnection was examined by
injection of the CRF-R1 receptor antagonist antalarmin (1.32 nmol/500 ng) into the VTA
in one hemisphere and the dopamine D1 receptor antagonist SCH23390 (1.38mM/200
ng) into the prelimbic cortex of the other prior to testing for shock-induced reinstatement
(n=5).

For comparison, the same rats were tested for shock-induced reinstatement

following injection of vehicle into each region. As a control to ensure that reductions in
reinstatement were attributable to disconnection, a second groups of rats (n=4) received a
unilateral injection of antalarmin into the VTA in one hemisphere and a unilateral
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injection of SCH23390 into the prelimbic cortex in the same hemisphere prior to testing
for shock-induced reinstatement. These rats were also tested for the effects of ipsilateral
vehicle injections.

For this experiment, the hemispheres into which cannulae were

implanted were randomized across rats in each group such that in the contralateral
treatment group, half of the rats received antalarmin injections into the left VTA and
SCH23390 injections into the right prelimbic cortex, while the other half received
antalarmin injections into the right VTA and SCH23390 injections into the left prelimbic
cortex.

Likewise, half of the rats in the ipsilateral treatment group received drug

injections into sites in the right hemisphere, while the remaining rats received injections
into sites in the left hemisphere. A third group of rats (n=4) were implanted with
cannulae for disconnection of CRFR1-regulated VTA dopaminergic inputs into the
infralimbic cortex. As with the prelimbic cortex disconnection experiment, these rats
received an antalarmin injection into the VTA of one hemisphere and a SCH23390
injection into the infralimbic cortex of the other. The accuracy of cannula implantation
was confirmed post-mortem in each rat after cardiac perfusion with 60-ml 0.15% NaCl
followed by 60-ml 2.5% buffered neutral formalin under sodium pentobarbital anesthesia
(55 mg/kg). Brains were removed and stored in 2.5% buffered formalin prior to
vibratome sectioning (40 µm), slide mounting, and staining with cresyl violet for
examination using a light microscope. Rats with injection sites outside of the targeted
regions were excluded from data analysis.
Experiment #5: Effects of cocaine self-administration under conditions that promote
shock-induced cocaine seeking on CRFR1 mRNA in the VTA
We previously reported that intra-VTA CRF injections reinstate cocaine seeking in rats
with a history of LgA, but not ShA self-administration (Blacktop et al., 2011). To
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determine if LgA self-administration recruits CRFR1-dependent regulation of VTA
dopamine neurons that project to the prelimbic cortex to increase susceptibility to shockinduced cocaine seeking, we used in situ hybridization to examine differences in the
expression of CRFR1 mRNA within the VTA resulting from self-administration under
ShA (n=8), LgA (n=8) and saline control (n=8) conditions. All rats were tested under
their respective conditions and underwent ten days of extinction. 24 hrs after the final
extinction session brains were extract following rapid decapitation in the absence of
anesthesia and were placed in methyl-2-butane for one minute at a temperature between 25 and -35°C, and placed in a -80°C freezer until sectioning. The tissue was sectioned on
a cyrostat to 14 µm thickness and placed onto superfrost plus slides and stored in a -80 °C
freezer until in situ hybridization analysis was conducted. A 1138 bp fragment of the rat
CRF-R1 cDNA (NCBI NM_030999, nucleotides 99-1236) was isolated by PCR from rat
cortex cDNA and subcloned into pCRII-TOPO (Invitrogen) to create pCRII-TOPOrCRHR1-1. For antisense riboprobe synthesis, the pCRII-TOPO-rCRHR1-1 plasmid was
linearized with BamHI and transcribed with T7 RNA polymerase (Promega). The
riboprobe was double labeled with 35S-CTP and 35S-UTP (Perkin-Elmer; 1250 Ci/mmol)
and free nucleotides were removed using a Micro Bio-Spin column (Bio-Rad). In situ
hybridization was performed as previously described with minimal modifications (Speert
et al, 2002, Westphal et al 2010). Briefly, slides were post-fixed for 1 h in 4% phosphatebuffered paraformaldehyde and washed three times in 2X SSC. Sections were incubated
in 0.1M triethanolamine containing 0.25% acetic anhydride for 10 minutes with stirring,
rinsed in dH2O, dehydrated and air-dried. Slides were then hybridized overnight at 55C
with the

35

S-labeled CRHFR1 riboprobe (2x106 cpm/slide) in 50% formamide
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hybridization cocktail (Ameresco) containing 10 mM DTT. After hybridization, excess
unhybridized probe was removed by 2X SSC washes and by incubating slides in RNase
A (37 C, 1 h). Slides were then washed in decreasing salt solutions (2x, 1x, and 0.5x
SSC) before a final high-stringency wash in 0.1x SSC (65 C, 1 h). Slides were then
dehydrated in ethanol, air-dried, and apposed to Kodak BioMax MR autoradiography
film (Carestream) for 7 days. Four to five slides (1 slide/series with 4 sections/slide)
from each rat were included and were processed simultaneously to allow direct
comparisons in the same regions and minimize variation. Autoradiography films were
scanned and analyzed using densitometry in ImageJ (Version 1.48g5). Signal pixels
within the area of interest were defined as having a gray value of 3.5 standard deviations
above the mean gray value of the background region. Both the number of pixels (area)
and average gray values (mean optic density/OD) above background were determined
and multiplied to generate an integrated densitometric measurement (integrated OD).
CRFR1 signal from multiple sections (spanning bregma -5.2 to -6.4) was analyzed and
averaged to generate one single integrated OD per region per rat/per rat. Based on prior
functional/anatomical distinctions (Oades et al., 1987), the VTA was subdivided into
rostral (-5.2 to -5.6 mm bregma) and caudal regions (-5.6 to -6.2 bregma). The caudal
VTA did not include the VTA tail (rostromedial tegmental area; -6.6 to -6.9 mm bregma
(Jhoun et al., 2009; Matsui and Williams, 2011; Barrot et al., 2012).
RESULTS
Cocaine self-administration and extinction
Self-administration (infusions on days 1 and 14 of self-administration testing and total
mg/kg cocaine intake across all sessions) and extinction data (responses during the final
2-h session prior) for each experiment are shown in Table 1.
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Table 1
Exp.

Group

SA (infusions/session ± S.E.)
SA Day 1

Exp. 1

Exp. 2

Exp. 3

Exp. 4

Exp. 5

SA Day 14

Total Intake
(mg/kg)

Last Ext
(resp/session ± S.E.)

Saline/No Shock

14.2 ± 3.5

4.3 ± 0.9

---

6. ± 1.58

Saline/Shock

9.9 ± 1.2

3.8 ± 6.7

---

5.3 ± 1.2

ShA Coc/No Shock

27.9 ± 1.5

18.4 ± 4.7

354.9 ± 19.8

9.4 ± 2.8

ShA Coc/Shock

27.7 ± 1.3

22.7 ± 4.7

363.8 ± 31.4

5.1 ± 1.4

LgA Coc/No Shock

79.3 ± 3.9

82.8 ± 9.2

1062.3 ± 83.1

11.7 ± 2.3

LgA Coc/Shock

75.1 ± 3.5

83.7 ± 7.7

1027.0 ± 77.2

11.5 ± 3.0

Vehicle/No Shock

83.6 ± 4.3

91.6 ± 6.3

1007.0 ± 48.0

8.0 ± 1.8

Vehicle/Shock

76.0 ± 9.1

94.0 ± 4.9

1092.3 ± 107.5

8.0 ± 1.8

Antalarmin/No Shock

78.0 ± 9.0

105.0 ± 11.2

1076.3 ± 109.4

6.8 ± 2.4

Antalarmin/Shock

90.0 ± 5.0

94.0 ± 4.9

1126.6 ± 115.1

8.0 ± 2.8

Shock

58.4 ± 8.2

80.4 ± 9.4

887.2 ± 98.7

2.8 ± 1.8

No Shock

71.8 ± 9.0

88.0 ± 10.6

1086.6 ± 60.0

9.3 ± 2.4

Prelimbic/contralateral

62.6 ± 4.6

74.8 ± 5.3

907.6 ± 77.8

5.8 ± 2.2

Prelimbic/ipsilateral

68.0 ± 5.9

92.3 ± 3.5

1063.75 ± 94.2

8.3 ± 1.9

Infralimbic/contralateral

68.5 ± 3.1

77.8 ± 3.7

959.8 ± 67.5

7.3 ± 3.3

Saline

3.6 ± 1.8

3.3 ± 0.8

---

3.2 ± 0.9

ShA Coc

28.7 ± 2.6

21.2 ± 4.0

348.2 ± 52.5

26.7 ± 7.7

LgA Coc

79.3 ± 5.9

77.6 ± 10.8

994.1 ± 69.5

20.2 ± 6.6

!

Experiment #1: Relationship between prefrontal cortical Fos immunoreactivity and
shock-induced reinstatement of cocaine seeking
Rats underwent daily cocaine self-administration for 14 days under ShA (2
hrs/day; total intake ~359.4 mg/kg) or LgA (6 hrs/day; total intake ~1045 mg/kg) or were
provided access to saline for self-administration, prior to undergoing ten days of
extinction after which they were tested for cocaine seeking under shock-free conditions
or following shock exposure and their brains were processed for cortical Fos analysis.
Shock-induced cocaine seeking is shown in Figure 1A. Similar to previous reports
(Mantsch et al., 2008), robust shock-induced reinstatement was observed in rats
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following LgA cocaine self-administration but not following ShA self-administration and
shock did not increase lever-pressing in control rats provided access to saline. A 3-way
ANOVA reinstatement testing (extinction vs. reinstatement test; repeated measure) x
self-administration (ShA, LgA, vs. Sal) x shock condition (shock vs. no shock) ANOVA
showed a significant interaction among all three variables (F2,38= 12.67; p<0.001). Posthoc testing showed that shock-induced cocaine seeking, as defined by increased lever
pressing relative to the prior extinction session and compared to non-shock controls, was
only observed following long-access/high-intake self-administration (p<0.01 for each
comparison).

Moreover, cocaine seeking following shock was significantly higher

following LgA self-administration than it was after ShA self-administration or in saline
controls (p<0.01 for each comparison).
The numbers of Fos-positive cells in the prelimbic and infralimbic cortex
following behavioral testing under shock and shock-free conditions were recorded in
each group and are shown in Figures 1C (prelimbic cortex) and 1D (infralimbic cortex).
Figure 1E represents a schematic identifying the regions in which Fos immunoreactivity
was analyzed (Paxinos and Watson, 2013). Representative immuno-labeled sections
including the cortical regions of interest from each condition/group are shown in Figures
1E-1L. A 2-way shock x SA condition ANOVA showed a significant overall effect of
shock (F1,45=51.08; p<0.001) and self-administration condition on the number of Fospositive cells in the prelimbic cortex (F2,45=8.310; P=0.001) and a significant shock x
self-administration condition interaction (F2,46=12.828; p<0.001).

Post-hoc testing

showed that shock increased the number of Fos-positive cells in rats tested under each
condition (p<0.05 vs. No Shock). This increase was significantly greater in rats tested
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under longer-access/high-intake conditions (p<0.001 vs. Sal and ShA).

Shock also

modestly but significantly increased the number of Fos immunoreactive cells in the
infralimbic cortex (2-way ANOVA; overall effect of shock; F1,45=28.08; p<0.001).
However, no overall effect of SA condition or SA condition x shock interaction was
observed.
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Figure 1: Stress-induced cocaine seeking is associated with a heightened Fos
response in the prelimbic cortex. Data in Figures 1A and 1B represent lever pressing
during extinction (Ext) and reinstatement testing either following either shock delivery or
in the absence of shock in rats with a history of self-administration under short-access
(ShA; 0.5 mg/kg/infusion cocaine; 14 x 2 hrs/daily), long-access (LgA; 0.5
mg/kg/infusion cocaine; 14 x 6 hrs/daily), or saline control (Sal; 14 x 2 hrs/daily)
conditions. Shock only increased lever pressing during reinstatement testing following
LgA SA (*p<0.01 vs. prior Ext, responding in No Shock controls, and reinstatement in
Sal/ShA rats). Data in Figures 1C and 1D represent the corresponding Fos responses in
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the prelimbic cortex and infralimbic cortex. Shock produced overall increases in the
number of Fos-positive cells in each region (#p<0.05; overall effect of Shock) and, in the
prelimbic cortex, this response was heightened following LgA self-administration
(*p<0.01 vs. No Shock controls and Sal/ShA rats). A schematic and image illustrating
the analyzed regions (1E and 1F) and representative images depicting Fos
immunoreactivity in the prelimbic cortex in each group comprise Figures 1G-L.
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seeking and the corresponding Fos response in the prelimbic cortex. Bilateral intraVTA injection sites for the CRFR1 receptor antagonist, antalarmin, are shown in 2A.
Shock reinstated cocaine-seeking in vehicle control rats (*p<0.01 vs. prior Ext and No
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pretreatment) without affecting Fos in the infralimbic cortex (2D). Representative
images showing the Fos responses in the prelimbic cortex following intra-VTA vehicle or
antalarmin injections are shown in Figures 2E and 2F.
Experiment #2: Role of VTA CRFR1 receptors in shock-induced cocaine seeking
and cortical subregion activation
Bilateral intra-VTA injections of the CRFR1 receptor antagonist, antalarmin, prevented
shock-induced cocaine seeking rats following LgA cocaine self-administration and
extinction and eliminated the corresponding increase in the number Fos immunoreactive
neurons in the prelimbic cortex. Antalarmin/vehicle injection sites in the posterior VTA
are shown in Figure 2A. Figure 2B shows the effects of intra-VTA antalarmin on shockinduced cocaine seeking.

A 3-way reinstatement (extinction vs. reinstatement test;

repeated measure) x shock condition (shock vs. no shock) x antalarmin pretreatment
(VTA antalarmin vs. veh) ANOVA showed a significant interaction among all three
variables (F1,12=10.79; p<0.01). Post-hoc testing revealed that shock-induced cocaine
seeking was observed following intra-VTA vehicle injections (p>0.01 vs. the prior
extinction session or shock-free controls) but not after intra-VTA antalarmin delivery.
Moreover, cocaine seeking in rats that received intra-VTA antalarmin injections prior to
shock delivery was significantly lower than in intra-VTA vehicle controls (p<0.01).
Figure 2C shows the effects of intra-VTA antalarmin on the Fos response to
shock in the prelimbic cortex.

A 2-way antalarmin x shock-induced reinstatement

ANOVA showed significant overall effects of shock (F1,17=77.86; p<0.001) and intraVTA antalarmin (F1,17=61.36; p<0.001) on the number of Fos-positive cells in the
prelimbic cortex and a significant shock x antalarmin interaction (F1,17=73.47; p<0.001).
Shock increased the number of Fos-immunoreactive cells in the prelimbic cortex in
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vehicle- but not antalarmin-pretreated rats (p<0.01 vs. no shock controls) and the number
of Fos-positive cells in prelimbic cortex following antalarmin was significantly lower
than in rats pretreated with vehicle (p<0.01). By contrast, neither shock nor intra-VTA
antalarmin altered Fos-positive cell numbers in the infralimbic cortex (Figure 2D).
Immuno-labeled sections including the prelimbic cortex from representative rats that
received VTA vehicle or antalarmin are shown in Figures 2E and 2F.
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Figure 3: Shock-induced cocaine seeking induces Fos expression in VTA neurons
that project to the prelimbic cortex. To determine if shock-induced cocaine seeking is
associated with activation of VTA neurons that project to the prelimbic cortex, cholera
toxin b subunit (CTb) was injected bilaterally into the prelimbic cortex and Fos
expression in CTb-labeled cells in the VTA was quantified. Cocaine seeking was
increased when rats received shock (*p<0.01 vs. prior Ext and No Shock controls; Fig
3A). There was no difference in CTb labeling between rats that underwent shockinduced reinstatement and non-shock controls, but the total number of cells expressing
Fos was increased by shock (Fig 3B; *p<0.05 vs. No Shock Controls). Moreover, the
percentage of CTb-labeled cells expressing Fos was increased in rats tested for shockinduced reinstatement relative to controls (Fig 3C; *p<0.05 vs. No Shock Controls). The
CTb injection site and CTb, Fos and CTb/Fos-labeled cells in the VTA in brain
representative sections from each group are shown in Figure 3D-F.
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Experiment #3: Relationship between Fos immunoreactivity in VTA neurons
that project to the prelimbic cortex and shock-induced reinstatement of cocaine
seeking
To determine if shock-induced cocaine seeking was associated with activation of
VTA neurons that project to the prelimbic cortex, rats were injected bilaterally with the
retrograde tracer, CTb, into the prelimbic cortex and Fos expression in CTb-labeled cells
in the VTA was assessed following testing for shock-induced reinstatement or under
shock-free conditions. As expected, footshock reinstated extinguished cocaine seeking
(Fig 3A). A 2-way shock condition (shock vs. no shock) x reinstatement condition
(extinction vs. test session) ANOVA revealed a significant shock condition x
reinstatement testing interaction (F1,11=20.24; p=0.001). Post-hoc testing showed that
cocaine seeking was increased after exposure to shock compared to the preceding
extinction session and non-shocked controls (p<0.01).
Shock-induced reinstatement was associated with an increase in the total number
of Fos-positive cells in the VTA (2-tailed t11=2.63; p<0.05), while the number of CTblabeled VTA neurons did not differ between shocked and non-shocked rats (Fig 4B).
Moreover, the percentage of CTb-positive neurons in the VTA that were co-labeled for
Fos was significantly increased in rats tested for shock-induced reinstatement compared
to rats tested in the absence of shock (2-tailed t11=2.95; p<0.05), suggesting that shockinduced cocaine is associated with activation of VTA neurons that project to the
prelimbic cortex(Fig. 4C). The CTb injection site and CTb, Fos and CTb/Fos-labeled
cells in the VTA in brain representative sections from each group are shown in Figure
4D-F.

	
  

134	
  

Figure 4: A CRFR1 receptor-regulated dopaminergic projection to the
prelimbic cortex is required for stress-induced cocaine seeking.
To determine the role of a CRFR1 receptor-regulated dopaminergic projection
from the VTA to the prelimbic cortex in stress-induced cocaine seeking, we used a
disconnection approach in which we delivered antalarmin into the VTA of one
hemisphere and SCH23390 into the contralateral prelimbic cortex (n=5 rats) and tested
for shock-induced cocaine seeking. To confirm that any effect on reinstatement was
attributable to pathway disconnection, a second group of rats (n=4) received an
antalarmin injection into the VTA of one hemisphere and a SCH23390 injection into the
ipsilateral prelimbic cortex.

Significant shock-induced reinstatement was observed

following VTA/prelimbic cortex vehicle (contralaterally or ipsilaterally) and following
ipsilateral intra-VTA antalarmin/prelimbic SCH23390 pretreatment (*p<0.05 vs. Ext) but
not following contralateral antagonist delivery (Fig 4A). Furthermore, shock-induced
reinstatement was significantly reduced following contralateral antagonist injections
relative to either vehicle pretreatment or ipsilateral antagonist delivery (#p<0.05 for each
comparison). By contrast, disconnection of the VTA pathway to the infralimbic cortex
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failed to alter cocaine seeking (4B; n=4). Intra-VTA and cortical injection sites for rats
used for analysis are shown in Figure 4C.
Experiment #4: Effect of pharmacological disconnection of the CRF-regulated
dopaminergic pathway from the VTA to the prelimbic cortex on shock-induced
cocaine seeking.
To determine the role of a CRFR1 regulated pathway originating in the VTA that
releases dopamine into the prelimbic cortex in stress-induced cocaine seeking, we used a
disconnection approach in which we delivered antalarmin (250 ng) into the VTA of one
hemisphere and the dopamine D1 receptor antagonist, SCH 23390 (200 ng) into the
contralateral prelimbic (Figure 4A; n=5 rats).

A 3-way repeated measures reinstatement

condition (extinction vs. reinstatement test) x shock condition (shock vs. no shock) x
disconnection (antalarmin/SCH 23390 vs. veh/veh) ANOVA revealed a significant
interaction among all three variables (F1,4=29.02; p<0.01). Post-hoc testing showed that
significant shock-induced cocaine seeking as defined as an increase relative to the prior
extinction session and responding by shock-free controls, was observed in vehicle control
rats but not in rats that underwent pharmacological disconnection (p<0.01/comparison).
Moreover, cocaine seeking following shock was significantly lower in rats that received
contralateral VTA antalarmin/prelimbic SCH 23390 relative to vehicle/vehicle controls
(p<0.01).
To confirm that the effects of contralateral drug delivery on cocaine seeking were
attributable to pathway disconnection, a second group of rats (Figure 4A; n=4) received
antalarmin into the VTA of one hemisphere and SCH 23390 into the ipsilateral prelimbic
cortex.

In contrast to rats that received antagonists into the contralateral regions,
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administration of antalarmin and SCH23390 to the VTA/prelimbic cortex within the
ipsilateral hemisphere did not prevent shock-induced cocaine seeking. A 3-way repeated
measures reinstatement condition (extinction vs. reinstatement test) x shock condition
(shock vs. no shock) x ipsilateral drug treatment (antalarmin/SCH 23390 vs. veh/veh)
ANOVA revealed a significant shock x reinstatement condition interaction (F1,3=56.72;
p<0.01). However, no main effect of or interactions involving antagonist administration
were observed. Overall shock produced cocaine seeking as defined by significant shockinduced increases in all groups relative to extinction and non-shock controls (p<0.05 for
each comparison)
In contrast to the prelimbic cortex, disconnection of the pathway from the VTA to
the infralimbic cortex through antalarmin delivery into the VTA in one hemisphere and
SCH 23390 delivery into the infralimbic cortex of the other hemisphere failed to alter
shock-induced cocaine seeking (Figure 4B; n=4).

A 3-way repeated measures

reinstatement condition (extinction vs. reinstatement test) x shock condition (shock vs. no
shock) x disconnection (antalarmin/SCH 23390 vs. veh/veh) ANOVA revealed a
significant shock x reinstatement condition interaction (F1,3=82.78; p<0.01). However,
no main effect of or interactions involving antagonist administration were observed.
Overall shock produced cocaine seeking as defined by significant shock-induced
increases in all groups relative to extinction and non-shock controls (p<0.05 for each
comparison).
VTA antalarmin/veh and cortical SCH 23390/veh injection sites are shown in Figure 4C.
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Figure 5: Cocaine self-administration under conditions that establish CRFdependent shock-induced cocaine seeking and corresponding activation of the
prelimbic cortex increases CRFR1 mRNA in the caudal VTA. CRFR1 receptor
mRNA levels in the VTA were quantified by in situ hybridization using a 35S-labeled
CRFR1 riboprobe. Representative images of film exposed to hybridized sections
containing VTA from rats following self-administration under ShA, LgA, or saline
control conditions are shown in Figure 5A. Rostral (-5.2 to -5.6 mm bregma) and caudal
(-5.6 to -6.2 bregma) VTA were analyzed separately and mean integrated optical
densities (IODs) in each region are shown in Figure 5B. No alterations in the rostral
VTA were observed. However, CRFR1 mRNA levels were significantly increased in the
caudal VTA following LgA self-administration (*p<0.05 vs. saline controls).
Experiment #5: Effects of cocaine self-administration under conditions that promote
shock-induced cocaine seeking on CRFR1 mRNA in the VTA
To determine if the recruitment of the CRF-regulated pathway from the VTA to
the prelimbic cortex was the result of increased CRFR1 receptor expression, in situ
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hybridization was used to quantify VTA CRFR1 mRNA levels following selfadministration and extinction in rats provided access to cocaine under ShA and LgA
conditions and saline controls (Fig 5). The VTA is a complex heterogeneous structure
with anatomically defined subregions that have distinct functionality (Kaufling et al;
Lammel et al). The tail of the VTA notwithstanding, a key anatomical demarcation is the
division of the VTA into rostral (anterior to -5.6 mm bregma) and caudal (posterior to 5.6 bregma) regions (ref). Specifically, our work examining shock-induced cocaine
seeking has focused on CRF effects in the caudal VTA (ref). Thus, in this experiment,
CRFR1 receptor mRNA levels were analyzed separately in the rostral (-5.2 mm to -5.6
mm bregma) and caudal (-5.6 mm to -6.2 mm bregma). Representative images of films
exposed to CRFR1 riboprobe hybridized brain sections from each group containing the
caudal VTA are shown in Figure 5A. Mean integrated optical rostral and caudal film
densities (IOD) are shown in Figures 5B and 5C. Separate one-way ANOVAs were used
to compare CRFR1 mRNA in rostral and caudal VTA across self-administration
conditions. A significant overall effect of access condition was found in the caudal, but
not rostral, VTA (F2,23=5.53; p<0.05). Post-hoc testing showed that CRFR1 mRNA was
increased relative to saline controls following LgA, but not ShA self-administration and
extinction (p<0.05).
DISCUSSION
Although stress has been identified as a key contributor to relapse, the
relationship between stress and drug-seeking behavior is complex and it has been
reported that the onset of stress does not always serve as a reliable trigger for cocaine use
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(Preston and Epstein, 2011; Furnari et al., 2015). A key determinant of stress-induced
cocaine seeking appears to be the extent/pattern of prior use. High-frequency cocaine
abusers display increased drug craving, anxiety and associated cardiovascular and
hypothalamic-pituitary-adrenal responses upon exposure to stress imagery when
compared to lower-frequency abusers (Fox et al., 2005).

Consistent with this

observation, we have found that reliable stress-induced reinstatement of cocaine seeking
is observed in rats with a history of cocaine self-administration under conditions of long
access (LgA)/high cocaine intake but not under conditions of short access (ShA) drug
availability where intake is lower (Mantsch et al., 2008).
The glutamatergic projection from the prelimbic cortex to the nucleus accumbens
core has been shown to be critical for cocaine seeking. Pharmacological inhibition of this
pathway using baclofen/muscimol (McFarland et al., 2004) or TTX (Capriles et al., 2003)
delivery into the prelimbic cortex prevents stress-induced cocaine seeking and associated
increases in nucleus accumbens core glutamate levels (McFarland et al., 2004). Here we
demonstrate that stress-induced reinstatement is associated with a heightened Fos
response in the prelimbic and the infralimbic cortex.
The mesocortical dopamine projection, via dopamine D1 receptor activation in
the prelimbic cortex, is a key regulator of this cortico-accumbens pathway. Injections of
the D1 receptor antagonist SCH23390 (Capriles et al 2003) or the non-selective
dopamine receptor antagonist fluphenazine (McFarland et al., 2004) but not the D2-like
receptor antagonist raclopride (Capriles et al., 2003) injected into the prelimbic but not
infralimbic cortex prevent stress-induced cocaine seeking. D1 receptors in the prelimbic
cortex are predominantly expressed post-synaptically on pyramidal neurons where they
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promote excitability (Seamanns et al., 2001; Gonzalez-Islas and Hablitz, 2003; Tseng and
O’Donnell, 2004; Sun et al., 2006). Not only do our present findings confirm that D1
receptors in the prelimbic cortex are required for shock-induced reinstatement, but they
suggest that stress-induced cocaine seeking is associated with activation of VTA
dopamine neurons that project to the prelimbic cortex. These findings are consistent with
an earlier report by Deutch et al (1991) demonstrating a similar stress-induced response
in cocaine-naïve rats. Notably, in that study, shock selectively activated VTA neurons
that project to the prelimbic cortex without activating VTA neurons that project to the
nucleus accumbens, consistent with reports that the mesocortical dopamine pathway is
selectively activated by aversive stimuli (Lammel et al 2012).
Much evidence points to CRF in the VTA as a key regulator of the mesocortical
dopamine pathway and stress-induced drug seeking. Shock-induced reinstatement of
cocaine seeking is associated with increased CRF levels in the VTA (Wang et al., 2005)
and intra-VTA CRF injections are sufficient to reinstate (Wang et al., 2005; Blacktop et
al., 2011). Moreover, pharmacological antagonism of (Blacktop et al., 2011; Vranjkovic
et al 2014) or shRNA-mediated knockdown of (Chen et al., 2014) of the CRFR1 receptor
in the VTA prevents stress-induced cocaine seeking. Although studies examining the
regulation of mesocortical dopamine by VTA CRF have produced mixed results (see e.g.,
Kalivas et al., 1987), reports that icv CRF increases dopaminergic neurotransmission in
the prefrontal cortex (Dunn and Berridge, 1987; Lavicky and Dunn, 1993) and that CRF
promotes excitation of VTA dopamine neurons via both pre- and post-synaptic
mechanisms (Ungless et al 2003; Korotkova et al 2006; Riegel and Williams 2008;
Wanat et al 2008, Beckstead et al 2009; Hahn et al 2009; Williams et al 2014) suggest
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that stress-induced release of CRF into the VTA may underlie increases in
mesocorticolimbic dopamine release. Consistent with this possibility, Refojo et al (2011)
reported that selective deletion of CRFR1 receptors in VTA dopamine neurons
significantly reduced stress-induced increases in dopamine in the prefrontal cortex in
mice while Wang et al (2005) have demonstrated that increases in VTA dopamine levels
associated with shock-induced reinstatement are CRF-dependent.
Here we report that the increase in Fos in the prelimbic cortex associated with
shock-induced reinstatement of cocaine is prevented by intra-VTA delivery of the
CRFR1 receptor antagonist, antalarmin. Further, we directly tested the role of CRFR1
regulation the mesolimbic dopamine pathway in stress-induced cocaine seeking using a
pharmacological disconnection approach.

Bilateral disconnection of the proposed

pathway by injection of antalarmin into the VTA of one hemisphere and the D1R
antagonist SCH23390 into the prelimbic cortex of the contralateral hemisphere prevented
shock-induced reinstatement. By contrast administration of VTA antalarmin and PL
SCH23390 in the ipsilateral hemisphere or disconnection of the CRF regulated pathway
to the infralimbic cortex failed to block shock-induced reinstatement. These data suggest
that, during stress, CRF released into the VTA, possibly from neurons that originate in
the BNST (Rodaros et al 2007; Silberman et al 2013; Vranjkovic et al 2014), activates
CRFR1 receptors on mesocortical neurons thereby promoting prelimbic dopamine release
and D1 receptor activation to induce drug seeking behavior.
Consistent with other reports that CRF actions in the VTA depend on a prior
history of cocaine exposure (Wang et al, 2005; Beckstead et al 2009; Hahn et al 2009;
Williams et al 2014), we have found that intra-VTA CRF-induce reinstatements is only
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observed in rats with a prior history of cocaine SA under daily extended-access/highintake conditions. Thus, the observed heightened sensitivity to stress-induced cocaine
seeking (Mantsch et al., 2008 and current findings) and the corresponding enhancement
of stress regulation of the mesocortical pathway to stress can likely be attributed to
increased CRFR1 receptor responsiveness at the level of the VTA. In support of this
possibility, we found that CRFR1 mRNA in the posterior VTA (the site at which CRF
regulates cocaine seeking) is increased following long-access SA.

Notably, it has

previously been reported that repeated cocaine administration increases CRF binding in
the VTA (Goeders et al., 1990) and establishes CRFR1 regulation of excitatory
transmission (Hahn et al., 2009). Although we assume that alterations in CRFR1 mRNA
are localized to dopaminergic neurons, confirmation of this requires further investigation.
To summarize, the present findings demonstrate that 1) stress-induced cocaine
seeking requires the activation of a CRFR1-regulated dopaminergic pathway from the
VTA to the prelimbic cortex and 2) repeated cocaine use under patterns/intake levels
observed in many cocaine abusers can establish stress-reactivity of this pathway via
upregulation of CRFR1. Further understanding the regulation of this pathway and how it
is recruited with excessive cocaine use (e.g., elevated glucocorticoid levels; Graf et al.,
2011) should provide important insight into the addiction process.
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General Discussion
Addiction is a tremendous health and financial burden on our society. Our current

understanding of the brain circuitries involved in addiction is far from complete. Drug
use is a stress-driven behavior partially because of the unpredictable and often
uncontrollable nature of stress. The work in this dissertation will hopefully aid in the
development of new and more effective treatment strategies aimed at either preventing
stress-induced relapse or minimizing the role of stress in the addiction cycle. Research in
our lab has focused on the idea that chronic cocaine use, as displayed by the long-access
self-administration paradigm (Ahmed and Koob, 1998), increased the vulnerability to
relapse during periods of stress (Mantsch et al., 2008) in a manner dependent on an
escalating pattern of cocaine use, which may be dependent on the interactions of
glucocorticoids and epinephrine (Mantsch et al., 2008). Findings within this dissertation
will hopefully aid in the development of better treatment options. To summarize, we have
found that stress-dependent relapse occurs through a corticotropin releasing factor (CRF)
pathway from the bed nucleus of the stria terminalis (BNST) to the ventral tegmental area
(VTA) that activates dopamine (DA) neurons that project into the prelimbic cortex to
precipitate cocaine use (figure 4.1). In addition, we have found that CRF expression is
increased within the BNST following a stressor that is dependent on beta-2 adrenergic
receptor (AR) activation. Furthermore, long-access cocaine use significantly increased
the expression of CRFR1 within the caudal VTA. This increase in CRFR1 expression
primes the activity of VTA neurons that specifically project into the prelimbic cortex, and
therefore causes an increase of prelimbic pyramidal activity through a dopamine receptor
1 (D1R) mechanism.
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Neuroanatomical projections involved in stress-induced cocaine seeking figure 4.1: An electric footshock stressor will
activate a noradrenergic projection from the ventral noradrenergic bundle into the ventral bed nucleus of the stria terminalis.
Here norepinephrine will activate beta-2AR receptors and release corticotropin releasing factor (CRF). CRF will increase the
drive on CRF ventral tegmental area (VTA) projecting neurons. A CRF projection from the vBNST into the VTA will be
activated, and CRF will be released within the VTA. CRF will activate CRFR1 on VTA dopamine neurons that project into
the prelimbic cortex. DA within the prelimbic cortex will activate D1R and increase the firing rate of pyramidal neurons that
project into the core of the nucleus accumbens. This will activate sub-motor circuits to engage in drug seeking behavior.
(Figure adapted from Mantsch et al., 2015)

Beta-noradrenergic receptors within the BNST regulate relapse of cocaine
seeking during periods of stress
Clinical and preclinical research has determined that inhibition of the
noradrenergic system, through the actions of alpha-2 AR agonists such as clonidine and
guanfacine, can block stress-induced craving of opiates (Sinha et al., 2007), cocaine
(Jobes et al., 2011, Mantsch et al., 2010), and nicotine (Fox et al. 2012, McKee at., 2014).
These studies are based on the assumption that alpha-2 ARs are presynaptic autoreceptor,
although post-synaptic alpha-2 AR effects that could interfere with cocaine seeking in
regions such as the prefrontal cortex have been reported. Based on these studies, we have
focused our research on determining the contribution of the noradrenergic system to
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stress-related relapse to cocaine use. Earlier studies have indicated that a cocktail
antagonism of both beta-1 and beta-2 ARs within the bed nucleus of the stria terminalis
(BNST), and the central nucleus of the amygdala (CeA) blocks footshock-induced
reinstatement of cocaine seeking (Leri et al 2002). Based on these results, our lab has
tested the sufficiency and necessity of activation of the individual beta-AR receptors for
stress-induced relapse in both the self-administration and conditioned place preference
models.
Our results indicate that the beta-2 AR is both necessary and sufficient in
mediating forced swim-induced drug seeking in extinguished conditioned place
preference mice (Mantsch et al 2010, McReynolds et al 2014, Vranjkovic et al 2012).
Specifically, we showed that the beta-2 AR antagonist ICI 118,551 blocked forced swiminduced reinstatement (Chapter 2; Mantsch et al 2010, McReynolds et al 2014) while the
non-selective beta-AR agonist isoproterenol was sufficient to induce drug seeking
(Vranjkovic et al 2012), and the selective beta-2 AR agonist clenbuterol was also
sufficient to induce drug-seeking behavior (McReynolds et al 2014, Vranjkovic et al
2012). In addition, using footshock-induced reinstatement in our rat self-administration
model, we have shown that stress-induced reinstatement is specific to beta-2 ARs in the
ventral BNST (vBNST) as intra-vBNST administration of the beta-2 AR antagonist ICI
118,551 blocked stress-induced drug seeking and intra-vBNST administration of the
beta-2 AR agonist clenbuterol was sufficient to evoke stress-induced reinstatement
(Chapter 3; Vranjkovic et al 2014).
Interestingly, we were able to block isoproterenol-induced reinstatement with
both the selective beta-1 AR antagonist betaxolol, and the selective beta-2 AR antagonist
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ICI 118,551 (Vranjkovic et al 2012). It is also important the signal redundancy in that
both receptors signal through Gs. This indicates that beta-AR receptors may exert their
affects on different cell types. This was interesting because antagonism of the beta-1 AR
failed to block forced swim-induced reinstatement, in the CPP model, and footshockinduced reinstatement, in the self-administration model, when administered into the
vBNST. This indicates that either the drugs bind to other receptors, or that there is an
unknown role for beta-1 ARs in stress-induced reinstatement. Studies have shown that
stress can increase the expression of both beta-1 and beta-2 ARs within the BNST
(Cecchi et al 2007), and that chronic cocaine administration can decrease the beta-1 ARmediated excitatory post-synaptic potential within the BNST (Nobis et al 2011). Our
results indicate that beta-2AR receptors are important in contributing to stress-induced
relapse; however, their localizations within the central nervous system is not clear.
Unfortunately, beta-AR antibodies have been extremely unreliable in determining the
cellular localization; however studies employing electrophysiology have determined that
beta-ARs are located on glutamatergic terminals within the BNST to enhance the
excitatory drive of these neurons through a CRF-dependent mechanism (Nobis et al 2011;
Silberman et al 2013). In addition, experiments using HA-tags mutated onto the Cterminus of the alpha-2 AR have been used to localize the alpha-2 AR (Flavin et al 2014).
This technique can be used to identify the localization of the beta-1 and beta-2-ARs
within the synapse.
It is interesting that both beta-1 ARs and beta-2ARs work through the same
second messenger system. Both beta-1 and beta-2 ARs are Gs-coupled receptors
suggesting that downstream activation of cAMP, PKA, or CREB are involved in the
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reinstatement process during stress. Interestingly, studies have shown that cAMP and
CREB activation are required for forced swim- but not cocaine-induced reinstatement of
conditioned place preference (Kreibich and Blendy, 2004). Therefore, it is necessary to
understand the localization of these receptors within the synapse, and how their
trafficking, expression, or down-stream mechanisms may change due to chronic drug use
or during periods of stress.
Moreover, beta-1 ARs have a higher affinity for norepinephrine than beta-2 ARs,
but here we show that the effect of stress on reinstatement is dependent upon the beta-2
AR specifically. This may be attributed to elevated norepinephrine levels during periods
of stress (Pacak et al 1995), during which it is possible that the high affinity beta-1 AR is
saturated and therefore is either internalized, or non-functional. This would allow for the
low affinity beta-2 AR to be activated. In support of this, a similar type of affinity is seen
with glucocorticoid receptors within the stress circuit as high affinity mineralocorticoid
receptors are saturated under basal cortisol levels whereas low affinity glucocorticoid
receptors are activated by cortisol during periods of elevated cortisol levels that are
typically observed during stress. In addition, beta-2 ARs seem to have both genomic and
non-genomic effects within the BNST. Electrophysiology studies have indicated that
beta-ARs enhance excitatory transmission within the BNST (Nobis et al 2011), possibly
through a CRF-releasing event (Silberman et al., 2013). However, we have shown that a
forced swim stressor increases crf mRNA within the BNST, and that this increase can be
blocked with antagonism of the beta-2 AR(McReynolds et al., 2014). This suggests that
beta-2 ARs serve as a mechanism to reload CRF pools either within local CRF-positive
neurons in the BNST or CRF-projecting neurons that originate within the BNST, and
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beta-2AR receptors may also stimulate the release of CRF within the BNST. This is
important because it shows that beta-ARs and CRF have a crucial interaction within the
BNST.
Beta-2 ARs act upstream from CRFR1 to mediate stress-induced drug
seeking
Data from our lab and others has suggested that norepinephrine drives
reinstatement through a beta-AR dependent engagement of the CRF system within the
BNST (Brown et al 2009, Erb et al 2000, McReynolds et al 2014, Vranjkovic et al 2014).
In this dissertation we have shown this in mice wherein administration of a beta-2 AR
antagonist blocked stress-dependent increases of crf mRNA within the BNST, and the
CRFR1 antagonist antalarmin blocked clenbuterol-induced reinstatement. In addition,
using the rat self-administration model, we have shown that intra-BNST clenbuterolinduced reinstatement is blocked by pretreatment with the CRFR1 antagonist antalarmin
(Chapter 3; Vranjkovic et al 2014). Furthermore, we have shown that intra-BNST CRF
administration induces drug-seeking behavior, and this effect is not blocked by
administration of the beta-2 AR antagonist ICI 118,551 (Vranjkovic et al 2014).
This strongly suggests that beta-2 AR activation releases CRF within the BNST.
This data is consistent with other studies that have shown that beta-AR activation within
the BNST produces an enhancement of excitatory synaptic mechanisms (Egli et al., 2005;
Nobis et al., 2011) that was dependent upon CRFR1 activation (Silberman et al., 2013). It
is important to note that even though CRF signaling in the BNST is necessary for relapse
(Chapter 3; Erb et al., 2001; Vranjkovic et al 2014), the source of this CRF is not know as
it could be released from local CRF neurons (Veinante & Freund-Mercier 1997) or from
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CRF-ergic afferents from other regions (Rodaros et al., 2007). In addition, our own data
suggest that beta-2 ARs regulate CRF release within the BNST though a more direct
examination of this effect is still needed.
Several different methods can be employed to study whether beta-2 AR activation
is necessary for direct CRF signaling in stress-induced reinstatement in the different
reinstatement models. Studies have started employing the human diphtheria toxin (toxic
to humans, but not mice) receptor to selectively destroy cell bodies in a cre-depndent
manner (Silberman et al., 2015). For this example, CRF-cre mice would be injected with
a cre-dependent virus expressing the diphtheria toxin receptor and this virus could be
specifically injected into either the BNST or CeA to produce the receptor on CRFpositive cells. Subsequently, mice would be chronically injected with the diphtheria toxin
to destroy any cells expressing the diphtheria toxin receptor (Silberman et al., 2015).
Using this, studies could examine whether depletion of CRF by diphtheria toxin could 1)
induce forced-swim dependent reinstatement of CPP in mice; this study could examine
whether CRF in cells in either the CeA or the BNST is necessary for stress-induced
reinstatement. 2) This study could be used to confirm a relationship between beta-2 AR
and CRFR1 activation in stress-induced reinstatement; injections of the beta-2 AR
agonist clenbuterol should not be sufficient in reinstating drug-seeking behavior. 3)
Electrophysiology studies could be conducted to determine whether beta-AR activation
within the BNST still causes enhancement of glutamatergic transmission within the
BNST that is dependent on CRFR1 activation. Beta-AR and CRFR1 could be working
separately to enhance glutamatergic signaling independent from each other. In addition,
injections of an AAV virus containing shRNA for CRF (Grieder et al 2014) could be
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used to test whether local or CeA CRF input into the BNST regulates reinstatement. In
addition, microdialysis studies may be employed to directly measure CRF release within
the BNST during either a footshock stressor, or through reverse dialyzing the beta-2 AR
agonist clenbuterol. These studies would be crucial in understanding the direct interaction
of beta-2AR receptors and CRFR1; and their relationship in stress-induced drug seeking.
Excitatory input onto CRF neurons within the BNST
A major challenge in the field of neuroscience research on affective disorders is
identifying the signaling pathways and neural circuits involved in the complex
mechanisms that underlie stress-induced reinstatement. Very little studies have been done
to examine the excitatory afferents that project onto CRF neurons within the BNST.
Optogenetic and genetically encodable reporter strategies may be used to map excitatory
afferents that directly synapse onto CRF neurons within the BNST. Anatomical studies
have suggested that the BNST receives a major glutamatergic input from the infralimbic
cortex, however it is important to understand the upstream structures that activate CRF
neurons within the BNST, or more importantly CRF-positive BNST neurons that project
to downstream structures such the VTA. Currently, the anterior insular cortex, medial
prefrontal cortex, and the parabrachial nucleus have been suggested to send glutamatergic
signaling onto CRF-positive cells within BNST (Swanson et al., 1982).

Activation of beta-2 AR within the BNST activates a CRF projection into the VTA.
Many studies have indicated that a CRF projection into the VTA mediates stressinduced reinstatement, however, no studies have shown a neuronal mechanism or a
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functional location. A major finding in our lab is that beta-2 ARs within the vBNST
recruit a CRF-projecting pathway from the vBNST to the VTA, and this pathway, in part,
mediates stress-induced drug seeking (Chapter 3; Vranjkovic et al., 2014). In addition,
animals that received an intra-VTA cholera toxin subunit b injection (CTb; retrograde
tracer), and underwent dual immunofluorescence for CTb and CRF within the vBNST,
showed that CRF-positive cells within the vBNST project to the VTA (Chapter 3;
Vranjkovic et al., 2014). This directly suggests that activation of the vBNST result in
release of CRF within the VTA, which will bind to CRFR1 to promote drug use during
times of stress. However, data in this dissertation suggests that CRF release within the
VTA is mediated by a beta-2AR, and CRFR1 interaction within the vBNST.
CRF cells that project into the VTA are either glutamatergic or GABAergic
Our studies suggest that CRF-positive neurons originate from the BNST and
project into the VTA, though we did not confirm a direct CRF-releasing pathway
projection. Studies stimulating the BNST through a beta-2 AR mechanism and measuring
CRF release within the VTA in animals that have a knockdown of CRF, and proper
controls, within the vBNST need to be conducted to confirm our theory. Furthermore,
CRF-positive neurons could regulate glutamatergic or GABAergic cells within the
BNST; therefore, one possibility is that CRF-positive projecting neurons could make a
relay projection to another area, from which CRF is coreleased with GABA or glutamate
into the VTA. Furthermore, it is not well known whether the BNST sends a
predominately glutamatergic or GABAergic input into the VTA during periods of stress.
Studies have shown that the majority of BNST neurons that project into the VTA are
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GABAergic (Kudo et al 2012) and it is predicted that they disinhibit VTA dopaminergic
neurons by synapsing onto VTA GABA neurons as studies have shown that BNST to
VTA projections formed symmetric terminals that co-expressed vesicular inhibitory
amino acid transporter (Kudo et al 2012). However, other studies have found that BNST
glutamatergic and GABAergic projections preferentially innervate non-dopaminergic
VTA neurons, and that BNST glutamatergic projection activation resulted in aversive and
anxiogenic behavioral phenotypes, while BNST GABAergic projections produced
rewarding and anxiolytic behavior (Jennings et al 2013). More studies need to be
conducted to understand the regulation of the VTA by BNST glutamatergic/GABAergic
neurons and CRF-projecting neurons, and its involvement in stress-induced
reinstatement.
Studies have shown that CRF-positive terminals within the VTA synapse onto
DA cells that have asymmetric projections, indicating that they are glutamatergic
(Tagliaferro & Morales 2008). However, this study failed to discuss the CRF terminals
that do not synapse onto DA cells. It is my strong opinion that a subset of CRF-positive
terminals originating from the BNST synapse onto either GABAergic interneurons, or
other GABAergic neurons where they act to disinhibit DA neurons. In addition, it is
important to note that studies have shown that both presynaptic and postsynaptic CRFR1
activation can reduce the activity of VTA DA neurons (Wanat et al., 2013; Beckstead et
al., 2008). This indicates that CRF within the VTA can either enhance or inhibit VTA DA
firing. Therefore, it is important to understand under what conditions CRF is released
within the VTA, because CRF undergoes volume transmission, and therefore a single
CRF release event within the VTA may act to activate and inhibit VTA DA neurons. All
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Susceptibility to stress-induced drug seeking is dependent on CRFR1 expression
levels within the caudal VTA
Stress-induced reinstatement to a footshock stressor requires a history of extended

access to cocaine. Different neurobiological mechanisms may contribute to the
susceptibility to relapse during periods of stress. We have shown that CRFR1 activation
is both necessary and sufficient for stress-induced drug seeking (Blacktop et al., 2011). In
this dissertation we have shown that within the caudal VTA, CRFR1 expression is
increased. In addition, a footshock stressor increases Fos immunoreactivity within the
VTA compared to no shock controls. Furthermore, shock increased the activity of
neurons that project to the prelimbic cortex. Moreover the prelimbic Fos response to
shock is dependent on CRFR1 activation in the VTA (Chapter 4). These data suggests
that a footshock stressor recruits a VTA projection, likely dopaminergic, to the prelimbic
cortex via CRFR1 activation within the VTA as we have shown that a disconnection
between VTA CRFR1 and prelimbic D1R prevents footshock-induced reinstatement.
This is interesting because inhibiting dopamine signaling, with either a D1R specific
antagonist, or a non-specific dopamine antagonist, within the prelimbic cortex prevents
footshock-induced drug seeking (Capriles et al 2003, McFarland et al 2004). While we
found that CRFR1 expression is increased within the VTA as a result of long-access
cocaine self-administration, other mechanisms could be recruited to prime the activity of
mesocortical neurons.
Cocaine intake-dependent neuroplastic changes within the VTA can increase the
susceptibility to relapse of cocaine use during a stressor. While stress has been shown to
promote CRF release within the VTA that is not dependent on a history of cocaine intake
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(Wang et al., 2005), no studies have examined whether CRF release is increased within
the VTA in animals with a history of extended drug use. Our data from chapter 2
suggests that CRF production is increased within BNST, and that the BNST sends a
direct projection of CRF to the VTA. Therefore, CRF release within the VTA may be
augmented as a result of long-access cocaine use. However, the increase in crf mRNA
observed in chapter 2 may be a reloading effect. Specifically, the beta-2 AR-mediated
increase in CRF production may restore the pools of CRF in VTA terminals that have
been released due to prior stressors. In addition, our lab has shown that bilateral delivery
of CRF directly into the VTA fails to induce drug seeking in rats with a history of shortaccess self-administration (2hr/day) but produced robust drug seeking under long-access
conditions suggesting that some neuroadaptation are needed. We have shown that this
occurs as an increase of CRFR1 expression, but we cannot rule out other processes
downstream (such as changes in the cortico-accumbens pathway), or upstream (such as
actions within the BNST) from the site of CRF actions within the VTA.
Studies have shown that repeated cocaine administration has been shown to
increase CRF receptor binding in the VTA (Goeders et al 1990) and also alter CRF
responsiveness. Repeated cocaine administration has been shown to attenuate CRFR1induced enhancement of GIRK channel-mediated inhibitory post-synaptic currents
(Beckstead et al 2009) and establishes CRFR1-mediated regulation of glutamatergic
synaptic transmission within the VTA (Hahn et al 2009). In addition, a history of cocaine
use is required for CRF regulation of DA and glutamate release within the VTA (Wang et
al., 2005).
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We observed a gross increase in CRFR1 expression throughout the caudal VTA.

However, the VTA consists of not only dopaminergic cells, but also GABAergic and
glutamatergic cells. It would be interesting to see whether the increase in CRFR1
expression occurs in any specific cell type. Furthermore, it is important to determine
whether the increase in CRFR1 expression is observed in any specific cell type that
projects to either the prelimbic cortex, or the nucleus accumbens. While we did not
explore specific projecting patterns, we did observe an increase that was specific to the
caudal VTA. This is important because recent research has suggested that the caudal
medial VTA contains DA neurons that specifically project into the prelimbic cortex
(Lammel et al 2014, Lammel et al 2012). Recent research has shown that CRF expression
is increased in the caudal, but not rostral, VTA of nicotine-dependent mice (Grieder et al
2014). In addition, the RMTg, or the tail of the VTA, has a stress-specific GABAergic
input onto caudal VTA DA neurons that project into the ventral striatum (Barrot et al
2012). However, very little research has been done examining the rostral-caudal axis as it
pertains to cocaine seeking during periods of stress. Studies have suggested that the
rostral VTA is necessary for cocaine-taking behavior (Lee et al 2007). However, recent
breakthroughs in rat and mouse genetics will allow us to specifically target VTA DA
neurons that project to the prelimbic cortex, and therefore determine whether CRFR1
activation enhances the dopaminergic projection during periods of stress. Finally, other
factors may mediate the heightened stress-induced cocaine seeking observed following
LgA self-administration on CRFR1 function, such as downstream signaling pathways.
A VTA CRF-mediated DA projection to the prelimbic cortex is required for stressinduced drug seeking
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Studies have shown that dopamine receptor antagonism within the prelimbic
cortex is necessary for stress-induced reinstatement (Capriles et al., 2003; McFarland et
al., 2004) and that this may be due to activation of CRFR1 (Refojo et al 2011). However,
no direct evidence has indicated that stress-induced reinstatement is dependent on
CRFR1 activation of the mesocortical dopamine pathway or that the stress-induced
activity within the prelimbic cortex is dependent on CRFR1 activation within the VTA.
In chapter 4, we show that inhibition of CRFR1 within the VTA and D1 receptor
inhibition within the prelimbic, but not infralimbic, cortex is sufficient in blocking
footshock-induced drug seeking through a disconnection approach. While it has been
known that stressors increase the activity of the prelimbic and the infralimbic cortex
(Felice et al 2014, Morrow et al 2000) we have shown that a footshock stressor
significantly augments Fos reactivity within the prelimbic cortex in long-access animals
compared to saline and short-access animals, and this effect was not observed in the
infralimbic cortex. Interestingly, the stress-induced increase in Fos activity was blocked
by administration of an intra-VTA CRFR1 antagonist.
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Figure 4.3: CRF enhances excitatory neurotransmission within the VTA. CRF
has been shown to directly excite dopamine neurons in the VTA by either
direct or indirect mechanism through post-synaptic trafficking of NMDA and
AMPA receptors. Furthermore, repeated cocaine exposure has been shown to
enhance AMPA mediated spontaneous miniature EPSC. Furthermore, CRF
promotes GABA release via a presynaptic CRFR1 activation as well as
exciting intrinsic GABA interneurons. In addition, through a CRFR1/GABAB
receptor interaction, CRF promotes IPSC currents in VTA DA cells that we
think project into the nucleus accumbens, because antagonism of CRFR1
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prevented a stress-induced drop in accumbal DA release.
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This suggests that during periods of stress, CRFR1 activation within the VTA
recruits a subset of VTA neurons to enhance the activity of prelimbic cortex (Figure 4.4)	
  .
This is similar to an early finding that showed that a restraint stress specifically increased
Fos activity in DA neurons that project into the prelimbic cortex (Deutch et al 1991).
Unfortunately, we cannot definitively state that VTA DA neurons are the sole driving
force for the increase in prelimbic Fos reactivity. VTA GABAergic neurons may be
driving the stress-dependent effect. In addition, studies have suggested that CRF may also
decrease the activity of VTA DA neurons that project into the accumbens (Twining et al.,
2015), possibly through an interaction between CRFR1 and GABAB mediated inhibition
by activating GIRK channels (Blacktop et al., 2015; Beckstead et al., 2009) (figure 4.3).
The role of the prelimbic and infralimbic cortex in relapse

5
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Although shock increased Fos in the infralimbic cortex, the Fos response in the
prelimbic cortex was much more robust and was more pronounced in long-access rats
that displayed stress-induced reinstatement of cocaine seeking. This is not surprising
because previous studies have suggested that prelimbic glutamate input into the nucleus
accumbens core is involved in extinguished drug seeking to drugs, cues, and a footshock
stressor (Capriles et al 2003, Cornish et al 1999, LaLumiere & Kalivas 2008, McFarland
et al 2004). The infralimbic cortex sends a glutamatergic projection into the shell of the
nucleus accumbens that is thought to be involved in extinction learning (LaLumiere et al
2010, LaLumiere et al 2012). Furthermore, it has been shown that the glutamatergic
projection from the infralimbic cortex to the shell of the accumbens regulates suppression
of drug seeking (Peters et al 2009, Peters et al 2008). Specifically, inactivation of the
infralimbic cortex, or the shell of the nucleus accumbens reinstates drug seeking in the
absence of drugs, cue, or stressful triggers (Peters et al 2008). This is surprising because
we show that a footshock stressor increases the activity of the infralimbic cortex, though
to a lesser degree than the prelimbic cortex.
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Figure 4.4: D1R activation enhances the likelihood of pyramidal
neuron activation by increasing the NMDA/AMPA ratio. During
periods of stress, D1R activation will lead to activation of the
cortico accumbens pathway which mediates stress-induced
relapse. !

The role of the infralimbic cortex as a stop pathway has been recently challenged
(Moorman et al 2014). Studies have shown that both the infralimbic and prelimbic cortex
display rapid, stimulus-evoked activity changes that are closely linked to contextually
appropriate behaviors. This was shown to be independent of whether the behavior
involved execution or inhibition (Moorman & Aston-Jones 2015). Other studies have
shown that activity is increased in the infralimbic cortex following both cue- and contextinduced cocaine, and heroin seeking (Moorman et al 2014). Therefore, our results may
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suggest that within extended access cocaine use, the activity within the infralimbic cortex
may be changed as well. However, our results from chapter 4 have indicated that D1Rmediated DA activity within the infralimbic cortex, as it relates to CRFR1-dependent
activation of VTA DA neurons, is not involved in stress-induced reinstatement since a
disconnection between VTA CRFR1 and infralimbic D1R did not block stress-induced
reinstatement.
Conclusion
The impact of stress on cocaine relapse is very complex. Not only do we report a
beta-2 AR-mediated CRF-dependent activation of a CRFergic afferent pathway from the
bed nucleus of the stria terminalis to the ventral tegmental area is necessary for stressinduced relapse, we also report that animals with a history of extended access cocaine use
are susceptible to reinstatement to a stressor by the recruitment of the mesocortical DA
pathway to the prelimbic cortex. This recruitment may be partially due to an increase in
CRFR1 expression within in the VTA that is specific to extended cocaine use. Human
studies have already shown that clonidine can prevent cocaine craving during periods of
stress in humans (Jobes et al 2011). While other studies have shown that polymorphisms
in genes that encode the CRF receptors is associated with exacerbated stress responses
and the propensity to develop drug addiction (Blomeyer et al 2008, Clarke & Schumann
2009, De Luca et al 2007, Enoch et al 2008, Treutlein et al 2006), we still do not
understand the microcircuitry of CRF signaling within the VTA. Thus, future directions
for investigating the mechanisms by which CRF controls stress-related drug use should
focus on mapping CRF circuitry within the VTA to determine the mechanism by which

	
  

162	
  

CRF may activate, or inhibit specific dopaminergic projections. This can be achieved by
determining the cellular location of CRFR1 and CRFR2 receptors within the VTA in
animals with a history of extended cocaine access. Currently, novel tools are being
developed to determine the microcircuitry within the VTA.
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APPENDIX

Drug	
  	
  
Antalarmin	
  	
  
Antisauvagine	
  
Betaxolol	
  	
  
BRL	
  44408	
  
Clenbuterlol	
  	
  
Clonidine	
  	
  	
  
CP	
  154,526	
  
Dobutamine	
  	
  
Guanfacine	
  	
  
ICI	
  118,551	
  
Isoproterenol	
  
Kynurenic	
  Acid	
  	
  
Prazosin	
  
Propranolol	
  	
  
SCH	
  23390	
  
Yohimbine	
  	
  

Action	
  	
  
Antagonist	
  at	
  CRFR1	
  
Antagonist	
  at	
  CRFR2	
  
Antagonist	
  at	
  Beta-‐1AR	
  
Antagonist	
  at	
  Alpha-‐2AR	
  (2α)	
  
Agonist	
  at	
  Beta-‐2AR	
  
Agonist	
  at	
  Alpha-‐2AR	
  
Antagonist	
  at	
  CRFR1	
  
Agonist	
  at	
  Beta-‐2AR	
  
Agonist	
  at	
  Alpha-‐2A	
  (2α)	
  
Antagonist	
  at	
  Beta-‐2AR	
  
Agonist	
  at	
  Beta-‐1AR	
  and	
  Beta-‐2AR	
  	
  
Antagonist	
  at	
  AMPA,	
  NMDA,	
  and	
  Kianate	
  Receptors	
  	
  
Antagonist	
  at	
  Alpha-‐1AR	
  	
  
Antagonist	
  at	
  Beta-‐1AR	
  and	
  Beta-‐2AR	
  
Antagonist	
  at	
  D1R	
  	
  
Antagonist	
  at	
  Alpha2-‐AR	
  
	
  (2α,	
  alpha1αAR,	
  5HT:	
  1A,1,B,1D,1F,2B	
  and	
  D2)	
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List of abbreviations
Abbreviations
AC
AMPA
AR
BNST
CPP
CRF
CRFR
CTb
DA
EPSC
GABA
IL
IPSC
MSN
Nacc
NE
NMDA
PFC
PL
SA
VP
VTA

Name
Anterior Commissure
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
Adrenergic Receptor
Bed Nucleus of the Stria Terminalis
Conditioned place preference
Corticotropin releasing factor
Corticotropin releasing factor receptor
Cholera Toxin B
Dopamine
Excitatory Postsynaptic Current
Gamma -Aminobutyric Acid
Infralimbic Cortex
Inhibitory Postsynaptic Current
Medium spiny neurons
Nucleus Accumbens
Norepinephrine
N-methyl-D-aspartate receptor
Prefrontal Cortex
Prelimbic Cortex
Self-Administration
Ventral Pallidum
Ventral Tegmental Area

